SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Schedule TO

(Rule 13e-4)

Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934


LATTICE SEMICONDUCTOR CORPORATION

(Name of Subject Company (issuer) and Filing Person (Offeror))


Options to Purchase Common Stock, Par Value $0.01 Per Share

(Title of Class of Securities)


518415104

(CUSIP Number of Common Stock Underlying Securities)


Stephen A. Skaggs

Chief Financial Officer

Lattice Semiconductor Corporation

5555 N.E. Moore Court

Hillsboro, Oregon 97124-6421

Tel: (503) 268-8000

(Name, address and telephone number of person authorized to receive notices and

communications on behalf of filing person)


Copies to:

John A. Fore, Esq.

Wilson Sonsini Goodrich & Rosati

Professional Corporation

650 Page Mill Road

Palo Alto, CA 94304-1050

(650) 493-9300

 

CALCULATION OF FILING FEE

 

 

Transaction Valuation*

Amount of Filing Fee

$36,473,308.00

$3,356.00

 

*

 

Calculated solely for purposes of determining the filing fee.  This amount assumes that options to purchase 12,725,424 shares of common stock of Lattice Semiconductor Corporation having an aggregate value of $36,473,308.00 as of February 11, 2003 will be exchanged or cancelled pursuant to this offer.  The aggregate value of such options was calculated based on the Black-Scholes option pricing model.  The amount of the filing fee, calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, equals $92 for each $1,000,000 of the value of the transaction.

 

o

 

Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

Amount Previously Paid:

 

Not applicable.

 

Form or Registration No.:

 

Not applicable.

 

Filing party:

 

Not applicable.

 

Date filed:

 

Not applicable.

 

o

 

Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

 

o

third party tender offer subject to Rule 14d-1.

 

ý

issuer tender offer subject to Rule 13e-4.

 

o

going-private transaction subject to Rule 13e-3.

 

o

amendment to Schedule 13D under Rule 13d-2.

 

Check the following box if the filing is a final amendment reporting the results of the tender offer:  o

 

 



 

This Tender Offer Statement on Schedule TO relates to an offer by Lattice Semiconductor Corporation, a Delaware corporation (“Lattice” or the “Company”), to exchange (the “Exchange Offer”) options to purchase an aggregate of 12,725,424 shares of Lattice’s common stock held by eligible employees, whether vested or unvested, that have been granted under its 1996 Stock Incentive Plan and its 2001 Stock Plan (i) that have exercise prices equal to or greater than $12.00 per share and (ii) for those employees who elect to exchange options described in (i), that have been granted on or after August 13, 2002, regardless of the exercise price (the “Eligible Options”).  Eligible Options may be exchanged for new options (the “New Options”) that will be granted under the terms and subject to the conditions set forth in: (i) the Offer to Exchange Certain Outstanding Options for New Options, dated February 13, 2003 (the “Offer to Exchange” or “Offer”); (ii) the related Memorandum from Cyrus Y. Tsui, dated February 13, 2003; (iii) the list of Frequently Asked Questions; (iv) the Election Form; and (v) the Withdrawal Form.  These documents, as they may be amended or supplemented from time to time, together constitute the “Disclosure Documents” and are attached to this Schedule TO as Exhibits (a)(1)(a) through (a)(1)(e), respectively.  An “eligible employee” refers to all persons who are employees, including officers, of Lattice or one of its subsidiaries as of February 13, 2003 and remain employees through the cancellation date.

 

The information in the Disclosure Documents, including all schedules and annexes to the Disclosure Documents, is incorporated by reference in answer to the items required in this Schedule TO.

 

Item 1.  Summary Term Sheet.

 

The information set forth under the caption “Summary Term Sheet” in the Offer to Exchange is incorporated herein by reference.

 

Item 2.  Subject Company Information.

 

(a)           Name and Address.

 

Lattice is the issuer of the securities subject to the Exchange Offer.  The address of Lattice’s principal executive office is 5555 N.E. Moore Court, Hillsboro, OR 97124-6421 and the telephone number at that address is (503) 268-8000.  The information set forth in the Offer to Exchange under the caption “The Offer—Information concerning Lattice” is incorporated herein by reference.

 

(b)           Securities.

 

The subject class of securities consists of the Eligible Options.  The actual number of shares of common stock subject to the New Options to be issued in the Exchange Offer will depend on the number of shares of common stock subject to the outstanding options tendered by eligible employees and accepted for exchange and cancelled.  The information set forth in the Offer to Exchange under the captions “Summary Term Sheet” and the sections under the caption “The Offer” entitled “Number of options; expiration date,” “Acceptance of options for exchange and issuance of new options,” and “Source and amount of consideration; terms of new options” is incorporated herein by reference.

 

(c)           Trading Market and Price.

 

The information set forth in the Offer to Exchange under the caption “The Offer—Price range of shares underlying the options” is incorporated herein by reference.

 

 

-2-



 

Item 3.  Identity and Background of Filing Person.

 

(a)           Name and Address.

 

The filing person is the issuer.  The information set forth under Item 2(a) above is incorporated by reference.

 

Pursuant to General Instruction C to Schedule TO, the information set forth on Schedule A to the Offer to Exchange is incorporated herein by reference.

 

Item 4.  Terms of the Transaction.

 

(a)           Material Terms.

 

The information set forth in the Offer to Exchange under the caption “Summary Term Sheet” and the sections under the caption “The Offer” entitled “Eligibility,” “Number of options; expiration date,” “Procedures for electing to exchange options,” “Withdrawal rights and change of election,” “Acceptance of options for exchange and issuance of new options,” “Conditions of the offer,” “Source and amount of consideration; terms of new options,” “Price range of shares underlying the options,” “Status of options acquired by us in the offer; accounting consequences of the offer,” “Legal matters; regulatory approvals,” “Material U.S. federal income tax consequences,” “Terms of the Offer specific to participants residing in foreign jurisdictions,” “Extension of offer; termination; amendment,” and in Schedules D through Q to the Offer to Exchange is incorporated herein by reference.

 

(b)           Purchases.

 

The information set forth in the Offer to Exchange under the caption “The Offer—Interests of directors and officers; transactions and arrangements concerning the options” is incorporated herein by reference.

 

Item 5.  Past Contacts, Transactions, Negotiations and Agreements.

 

(e)           Agreements Involving the Subject Company’s Securities.

 

The information set forth in the Offer to Exchange under the caption “The Offer—Interests of directors and officers; transactions and arrangements concerning the options” is incorporated by reference.  The eligible option plans and related option agreements attached hereto as Exhibits (d)(1) through (d)(4) contain information regarding the subject securities.

 

Item 6.  Purposes of the Transaction and Plans or Proposals.

 

(a)           Purposes.

 

The information set forth in the Offer to Exchange under the captions “Summary Term Sheet” and “The Offer—Purpose of the offer” is incorporated herein by reference.

 

 

-3-



 

(b)           Use of Securities Acquired.

 

The information set forth in the Offer to Exchange under the captions “The Offer—Acceptance of options for exchange and issuance of new options” and “The Offer—Status of options acquired by us in the offer; accounting consequences of the offer” is incorporated herein by reference.

 

(c)           Plans.

 

The information set forth in the Offer to Exchange under the captions “The Offer—Purpose of the offer” and the “The Offer—Information concerning Lattice” is incorporated herein by reference.

 

Item 7.  Source and Amount of Funds or Other Consideration.

 

(a)           Source of Funds.

 

The information set forth in the Offer to Exchange under the captions “The Offer—Source and amount of consideration; terms of new options” is incorporated herein by reference.

 

(b)           Conditions.

 

Not applicable.

 

(d)           Borrowed Funds.

 

Not applicable.

 

Item 8.  Interest In Securities of the Subject Company.

 

(a)           Securities Ownership.

 

The information set forth in the Offer to Exchange under the caption “The Offer—Interests of directors and executive officers; transactions and arrangements concerning the options” is incorporated herein by reference.

 

(b)           Securities Transactions.

 

The information set forth in the Offer to Exchange under the caption “The Offer—Interests of directors and executive officers; transactions and arrangements concerning the options” is incorporated herein by reference.

 

Item 9.  Person/Assets, Retained, Employed, Compensated or Used.

 

(a)           Solicitations or Recommendations.

 

Not applicable.

 

 

-4-



 

Item 10.  Financial Statements.

 

(a)           Financial Information.

 

The information set forth in Schedule B and Schedule C to the Offer to Exchange, in the Offer to Exchange under the captions “The Offer—Information concerning Lattice,” “The Offer—Financial statements,” and “The Offer—Additional information,” in Item 8 of Lattice’s Annual Report on Form 10-K for the year ended December 31, 2001 and in Item 1 of Part I of Lattice’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2002, is incorporated herein by reference.

 

(b)           Pro Forma Information.

 

Not applicable.

 

Item 11.  Additional Information.

 

(a)           Agreements, Regulatory Requirements and Legal Proceedings.

 

The information set forth in the Offer to Exchange under the caption “The Offer—Legal matters; regulatory approvals” is incorporated herein by reference.

 

(b)           Other Material Information.

 

Not applicable.

 

Item 12.  Exhibits.

 

Exhibit

Number

 

Description

(a)(1)(a)

 

Offer to Exchange Certain Outstanding Options for New Options, dated February 13, 2003.

(a)(1)(b)

 

Memorandum from Cyrus Y. Tsui, dated February 13, 2003.

(a)(1)(c)

 

List of Frequently Asked Questions.

(a)(1)(d)

 

Election Form.

(a)(1)(e)

 

Withdrawal Form.

(a)(1)(f)

 

Form of Promise to Grant Stock Option.

(a)(1)(g)

 

Presentation to Employees.

(a)(1)(h)

 

Form of Confirmation of Stock Options Elected for Exchange/Withdrawal.

(a)(1)(i)

 

Form of Reminder Notice about the Exchange Offer to be periodically sent to employees.

(b)

 

Not Applicable.

(d)(1)

 

Lattice Semiconductor Corporation 1996 Stock Incentive Plan, as amended on August 1, 2000.

(d)(2)

 

Form of Stock Option Agreement for 1996 Stock Incentive Plan.

(d)(3)

 

2001 Stock Plan, as amended on August 7, 2001.

(d)(4)

 

Form of Stock Option Agreement for 2001 Stock Plan.

(g)

 

Not applicable.

(h)

 

Not applicable.

 

Item 13.  Information Required by Schedule 13E-3.

 

(a)           Not applicable.

 

 

-5-



 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Schedule TO is true, complete and correct.

 

 

LATTICE SEMICONDUCTOR CORPORATION

 

 

 

        /s/  STEPHEN A. SKAGGS

 

Stephen A. Skaggs

 

Senior Vice President, Chief Financial Officer and

 

Secretary

 

 

Date: February 13, 2003

 

 

 

 

 

-6-



 

INDEX TO EXHIBITS

 

 

Exhibit

Number

 

Description

(a)(1)(a)

 

Offer to Exchange Certain Outstanding Options for New Options, dated February 13, 2003.

(a)(1)(b)

 

Memorandum from Cyrus Y. Tsui, dated February 13, 2003.

(a)(1)(c)

 

List of Frequently Asked Questions.

(a)(1)(d)

 

Election Form.

(a)(1)(e)

 

Withdrawal Form.

(a)(1)(f)

 

Form of Promise to Grant Stock Option.

(a)(1)(g)

 

Presentation to Employees.

(a)(1)(h)

 

Form of Confirmation of Stock Options Elected for Exchange/Withdrawal.

(a)(1)(i)

 

Form of Reminder Notice about the Exchange Offer to be periodically sent to employees.

(b)

 

Not Applicable.

(d)(1)

 

Lattice Semiconductor Corporation 1996 Stock Incentive Plan, as amended on August 1, 2000.

(d)(2)

 

Form of Stock Option Agreement for 1996 Stock Incentive Plan.

(d)(3)

 

2001 Stock, as amended on August 7, 2001.

(d)(4)

 

Form of Stock Option Agreement for 2001 Stock Plan.

(g)

 

Not applicable.

(h)

 

Not applicable.

 

 

 

 

 

 





Exhibit (a)(1)(a)

 

 


 

LATTICE SEMICONDUCTOR CORPORATION


 

OFFER TO EXCHANGE
CERTAIN OUTSTANDING OPTIONS
FOR NEW OPTIONS


 

 

This document constitutes part of the prospectuses relating to the Lattice Semiconductor Corporation

1996 Stock Incentive Plan and the 2001 Stock Plan covering

 securities that have been registered under the Securities Act of 1933.

February 13, 2003

 



 

LATTICE SEMICONDUCTOR CORPORATION

Offer to Exchange Certain
Outstanding Options for New Options

 


 

This offer and withdrawal rights will expire at 5:00 p.m., Pacific Time, on March 14, 2003 unless we extend them.

 


By this offer, we are giving you the opportunity to exchange all of your outstanding options that have exercise prices equal to or greater than $12.00 per share, whether vested or unvested, granted under either our 1996 Stock Incentive Plan or our 2001 Stock Plan, for new options.  If you elect to exchange one or more of your eligible options, you must also exchange all options granted to you on or after August 13, 2002, regardless of the exercise price.  You may participate in this offer if you are an employee of Lattice Semiconductor Corporation or one of our subsidiaries.  Our non-employee directors are not eligible to participate in this offer.

If you participate in this offer, the options that you exchange pursuant to this offer will be exchanged for new options, subject to the terms set forth in this offer.  Your new option will cover four (4) shares of our common stock for every seven (7) shares covered by an option that you elect to exchange, rounded up to the nearest whole share.

We will grant the new options on the first business day that is at least six months and one day after the date on which we cancel the exchanged options.  We refer to this date as the new option grant date.  We expect the new option grant date to be September 18, 2003.  Each new option will be subject to a new two year vesting schedule that will begin on the new option grant date.  The exercise price of the new options will be equal to the closing price of our common stock on the Nasdaq National Market on the new option grant date.  However, the exercise price of the new options granted to those employees who are residents of Italy may be higher due to local laws.

Our common stock is quoted on the Nasdaq National Market under the symbol “LSCC.”  On February 12, 2003, the closing price of our common stock was $6.91 per share.  You should evaluate current market quotes for our common stock, among other factors, before deciding to participate in this offer.

See “Risks of Participating in the Offer” beginning on page 12 for a discussion of risks that you should consider before participating in this offer.

IMPORTANT

If you wish to participate in this offer, you must complete and sign the attached election form, and deliver it via facsimile (fax number (503) 268-8116) or hand delivery to the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421 before 5:00 p.m., Pacific Time, on March 14, 2003.  Only responses that are complete, signed and actually received by the Stock Option Administrator by the deadline will be accepted.

Neither the U.S. Securities and Exchange Commission nor any state or foreign securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this offer.  Any representation to the contrary is a criminal offense.

You should direct questions about this offer to Bob Adam, Manager – Payroll and Benefits, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8675, or to Terry Dols, Vice President – Human Resources, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8120.

Offer to Exchange dated February 13, 2003.



 

You should rely on the information contained in this offer.  We have not authorized anyone to provide you with different information.  We are not making an offer of the new options in any jurisdiction where the offer is not permitted.  However, we may, at our discretion, take any actions necessary for us to make the offer to option holders in any of these jurisdictions.  You should not assume that the information provided in this offer is accurate as of any date other than the date as of which it is shown, or if no date is otherwise indicated, the date of this offer.  This offer summarizes various documents and other information.  These summaries are qualified in their entirety by reference to the documents and information to which they relate.

TABLE OF CONTENTS

 

SUMMARY TERM SHEET

2

RISKS OF PARTICIPATING IN THE OFFER

12

THE OFFER

21

1.

Eligibility

21

2.

Number of options; expiration date

21

3.

Purpose of the offer

22

4.

Procedures for electing to exchange options

23

5.

Withdrawal rights and change of election

25

6.

Acceptance of options for exchange and issuance of new options

26

7.

Conditions of the offer

27

8.

Price range of shares underlying the options

29

9.

Source and amount of consideration; terms of new options

29

10.

Information concerning Lattice

33

11.

Interests of directors and executive officers; transactions and arrangements concerning the options

34

12.

Status of options acquired by us in the offer; accounting consequences of the offer

35

13.

Legal matters; regulatory approvals

36

14.

Material U.S. federal income tax consequences

36

15.

Terms of the offer specific to participants residing in foreign jurisdictions

37

16.

Extension of offer; termination; amendment

37

17.

Fees and expenses

38

18.

Additional information

38

19.

Financial statements

39

20.

Miscellaneous

39

 

SCHEDULE A

Information Concerning the Directors and Executive Officers of Lattice

A-1

SCHEDULE B

Financial Statements of Lattice Semiconductor Corporation included in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2002

B-1

SCHEDULE C

Financial Statements of Lattice Semiconductor Corporation included in its Annual Report on Form 10-K for the year ended December 31, 2001

C-1

SCHEDULE D

Stock Option Exchange Program: A Guide to Issues in Canada

D-1

SCHEDULE E

Stock Option Exchange Program: A Guide to Issues in China

E-1

SCHEDULE F

Stock Option Exchange Program: A Guide to Issues in Finland

F-1

SCHEDULE G

Stock Option Exchange Program: A Guide to Issues in France

G-1

SCHEDULE H

Stock Option Exchange Program: A Guide to Issues in Germany

H-1

SCHEDULE I

Stock Option Exchange Program: A Guide to Issues in Hong Kong

I-1

SCHEDULE J

Stock Option Exchange Program: A Guide to Issues in Israel

J-1

SCHEDULE K

Stock Option Exchange Program: A Guide to Issues in Italy

K-1

SCHEDULE L

Stock Option Exchange Program: A Guide to Issues in Japan

L-1

SCHEDULE M

Stock Option Exchange Program: A Guide to Issues in Korea

M-1

SCHEDULE N

Stock Option Exchange Program: A Guide to Issues in Singapore

N-1

SCHEDULE O

Stock Option Exchange Program: A Guide to Issues in Sweden

O-1

SCHEDULE P

Stock Option Exchange Program: A Guide to Issues in Taiwan

P-1

SCHEDULE Q

Stock Option Exchange Program: A Guide to Issues in the United Kingdom

Q-1

 



 

SUMMARY TERM SHEET

The following are answers to some of the questions that you may have about this offer.  You should carefully read this entire offer, the accompanying memorandum from our Chairman and Chief Executive Officer, Cyrus Y. Tsui, dated February 13, 2003, the list of frequently asked questions and the election and withdrawal forms together with their associated instructions.  This offer is made subject to the terms and conditions of these documents as they may be amended.  The information in this summary is not complete.  Additional important information is contained in the remainder of this offer and the other offer documents.  We have included in this summary references to other sections in this offer to help you find a more complete description of these topics.  References in this offer to “Lattice”, “we”, “us” or “our” refer to Lattice Semiconductor Corporation.

Q1.                               What is the offer?

A1.                                This offer is a voluntary opportunity for eligible employees to exchange outstanding options for new options.  The following is a brief summary of the terms of this offer:

Eligible Employees

                  Each person who is an employee of Lattice or one of our subsidiaries on the date of this offer who remains an employee through the cancellation date is eligible to exchange outstanding options for new options.

Eligible Options

                  All outstanding options with exercise prices equal to or greater than $12.00 per share that have been granted under our 1996 Stock Incentive Plan or our 2001 Stock Plan are eligible for exchange.

                  If you elect to exchange one or more of your eligible options, you must also exchange all options granted on or after August 13, 2002, regardless of the exercise price.  (Section 2)

Exchange Ratio

                  Exchanged options will be replaced with new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.  (Section 2)

For purposes of this offer, including the exchange ratios, the term “option” refers to an option to purchase one share of Lattice common stock.

New Options

                  New options will be granted on the first business day that is at least six months and one day after the cancellation date.  We refer to this date as the new option grant date.  We expect that the new option grant date will be September 18, 2003.

                  All new options will be nonstatutory stock options.

Exercise Price of the New Options

                  The exercise price of new options will be equal to the closing price of our common stock on the Nasdaq National Market on the new option grant date.  Notwithstanding the foregoing, if you are a resident of Italy, your exercise price will be determined as described in Schedule K.  (Section 9)

 

-2-



 

Vesting and Exercisability of New Options

                  The vesting schedule of each new option will be as follows:  12.5% of the shares subject to the new option will vest every three months, with the vesting to commence on the new option grant date, subject to your continued employment with Lattice or one of our subsidiaries. (Section 9)

Terms Used in This Offer

                  offering period” refers to the period from the commencement of this offer to the expiration date.  The offering period will commence on February 13, 2003 and end on March 14, 2003, unless we extend the offering period.

                  exchanged options” refers to all options that you exchange pursuant to this offer.

                  new options” refers to the options issued pursuant to this offer that replace your exchanged options.

                  expiration date” refers to the time and date that this offer expires.  The expiration date will be March 14, 2003 at 5:00 p.m., Pacific Time, unless we extend the offering period.  If we extend the offering period, the term “expiration date” will refer to the time and date at which the extended offering period expires.

                  cancellation date” refers to the first business day after the expiration date.  This is the date when exchanged options will be cancelled.  The cancellation date will be March 17, 2003, unless we extend the offering period.  If we extend the offering period, then the cancellation date will be similarly extended.

                  new option grant date” refers to the first business day that is at least six months and one day after the cancellation date.  This is the date when new options will be granted.  We expect that the new option grant date will be September 18, 2003.  However, if we extend the offering period, then the new option grant date will be similarly extended.

Q2.                               How do I participate in this offer?

A2.                                If you choose to participate in this offer, you must do the following before 5:00 p.m., Pacific Time, on March 14, 2003:

1.                    Properly complete and sign the election form provided by Lattice.

2.              Deliver the completed and signed election form, either via facsimile (fax number: (503) 268-8116) or by hand delivery, to the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421.

This is a one-time offer, and we will strictly enforce the offering period and expiration date.  We reserve the right to reject any options tendered for exchange that we determine are not in appropriate form or that we determine are unlawful to accept.  Subject to the terms and conditions of this offer, we will accept all properly tendered options promptly after the expiration of this offer.  (Section 4)

We may extend the offering period.  If we extend the offering period, we will issue a press release, e-mail or other communication disclosing the extension no later than 6:00 a.m., Pacific Time, on the business day following the previously scheduled expiration date.

 

-3-



 

The delivery of all documents, including election forms, is at your risk.  We intend to confirm the receipt of your election form and/or any withdrawal form within two (2) business days.  If you have not received a confirmation, you must confirm that we have received your election form and/or any withdrawal form.

Q3.                               Why is Lattice making this offer?

A3.                                We believe that this offer will foster retention of our valuable employees and better align the interests of our employees and stockholders to maximize stockholder value.  We issued the currently outstanding options to motivate our employees to perform at high levels and provide an effective means of recognizing employee contributions to our success.  Some of our outstanding options, whether or not they are currently exercisable, have exercise prices that are significantly higher than the current market price for our stock.  These options are commonly referred to as being “underwater.”  By making this offer, we intend to provide eligible employees with the opportunity to own options that over time may have a greater potential to increase in value.

This offer is also designed to decrease Lattice’s option overhang, which is the number of options outstanding as a percent of the total number of common shares outstanding.  The exchange ratio used in this offer is designed to help accomplish this goal.  (Section 3)

Q4.                               What securities are we offering to exchange?

A4.                                We are offering to exchange all outstanding, unexercised options with exercise prices equal to or greater than $12.00 per share held by eligible employees that have been granted under either our 1996 Stock Incentive Plan or our 2001 Stock Plan.  In exchange, we will grant new options under the 1996 Stock Incentive Plan.  Options to purchase our common stock granted under plans other than the 1996 Stock Incentive Plan and our 2001 Stock Plan are not eligible for exchange.  If you elect to participate in the offer, then you must ALSO exchange all options that we have granted to you on or after August 13, 2002, even if those options have exercise prices below $12.00 per share.  (Section 2)

Q5.                               Who may participate in this offer?

A5.                                You may participate in this offer if you are an employee of Lattice or one of our subsidiaries on the date this offer commences and you remain an employee through the cancellation date.  Non-employee members of our board of directors may not participate.  To receive a new option, you must remain an employee of Lattice or one of our subsidiaries through the new option grant date.  (Section 1)

Q6.                               If I am on an approved leave of absence or absent from work due to illness or disability am I still eligible to participate in this offer?

A6.                                If you are an employee of Lattice or one of our subsidiaries and you are on an approved leave of absence or you are absent from work due to an illness or disability, you will be eligible to participate in this offer as long as you remain an employee through the cancellation date.  To receive a new option, you must remain an employee of Lattice or one of our subsidiaries through the new option grant date.

Q7.                               Am I required to participate in this option exchange?

A7.                                No.  Participation in this offer is completely voluntary. (Section 2)

 

-4-



 

Q8.                               If I elect to exchange an eligible option grant do I have to elect to exchange all of the shares covered by that option grant?

A8.                                Yes.  We are not accepting partial tenders of individual option grants.  However, you may elect to exchange the remaining portion of any option that you have partially exercised.  Accordingly, you may elect to exchange one or more of your option grants, but you must elect to exchange all of the unexercised shares subject to a particular grant or none of the shares for that particular grant.  For example and except as otherwise described in this offer, if you hold (1) an eligible option to purchase 1,000 shares at an exercise price of $20.00 per share, 700 of which you have already exercised, (2) an eligible option to purchase 1,000 shares at an exercise price of $25.00 per share, and (3) an eligible option to purchase 2,000 shares at an exercise price of $30.00 per share, you may elect to exchange:

                  your first option covering 300 remaining unexercised shares,

                  your second option covering 1,000 shares,

                  your third option covering 2,000 shares,

                  two of your three options,

                  all three of your options, or

                  none of your options.

These are your only choices in this example.  You may not elect, for example, to exchange your first option with respect to only 150 shares (or any other partial amount) under that grant or less than all of the shares under the second and third option grants.  (Section 2)

Q9.                               How many new options will I receive for the options that I exchange?

A9.                                Exchanged options will be replaced with new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.  Fractional options will be rounded up to the nearest whole option. (Section 2)

The number of new options that you receive will be adjusted if there are any changes in our capitalization, such as stock splits, combinations, subdivisions, stock dividends, reclassifications or other similar events, that occur after the cancellation date but before the new option grant date.  (Section 2)

All new options will be nonstatutory stock options.  (Sections 2 and 6)

Q10.                        Why isn’t the exchange ratio simply one-for-one?

A10.                          Our stock option exchange program must balance the interests of both employees and stockholders.  The exchange ratio selected for this offer will decrease the total number of options outstanding and will benefit stockholders by decreasing potential stockholder dilution.  (Section 3)

Q11.                        What will be the exercise price of my new options?

A11.                          The exercise price per share of the new options will be the closing price of our common stock on the  Nasdaq National Market on the new option grant date, which is expected to be September 18, 2003.

 

-5-



 


Notwithstanding the foregoing, if you are a resident of Italy, your exercise price will be determined as described in Schedule  K.

We cannot predict the exercise price of the new options.  Because we will grant new options on the first business day that is at least six months and one day after the cancellation date, the new options may have a higher exercise price than some or all of your current options.  (Section 9)

Q12.                        Are there any restrictions on when I can exercise any of the new options that are granted to me?

A12.                          Yes.  You cannot exercise your new options until they vest.  Also, if you are a non-U.S. resident, certain additional restrictions may apply.  Please refer to Schedules D through Q for details regarding your specific country.

Q13.                        When will my new options vest?

A13.                          Each new option will have a new two year vesting schedule that will begin on the new option grant date.  Pursuant to the new vesting schedule, 12.5% of the shares subject to the new option will vest and become exercisable on the date three months from the new option grant date and 12.5% of the shares subject to the new option will vest and become exercisable every three months thereafter, subject to your continued employment with Lattice or one of our subsidiaries through each relevant vesting date.  (Section 9)

Q14.                        Are there circumstances under which I would not be granted new options?

A14.                          Yes.  If, for any reason, you are no longer an employee of Lattice or one of our subsidiaries on the new option grant date, you will not receive any new options.  This means that if you quit, with or without a good reason, or die or we terminate your employment with or without cause, before the new option grant date, you will not receive anything for the options that you elected to exchange and that we cancelled.  Unless expressly provided otherwise by the applicable laws of a non-U.S. jurisdiction, your employment will remain “at-will” regardless of your participation in the offer and can be terminated by you or us at any time, with or without cause or notice.  (Section 1)

Moreover, even if we accept your options, we will not grant new options to you if we are prohibited from doing so by applicable laws.  For example, we could become prohibited from granting new options as a result of changes in SEC or Nasdaq rules or the laws of a non-U.S jurisdiction.  We do not anticipate any such prohibitions at this time.  (Section 13)

Q15.                        When will my exchanged options be cancelled?

A15.                          Your exchanged options will be cancelled on the first business day following the expiration date.  We refer to this date as the cancellation date.  We expect that the cancellation date will be March 17, 2003, unless the offering period is extended.  (Section 6)

Q16.                        Once I surrender my exchanged options, is there anything I must do to receive the new options?

A16.                          To receive new options, you must be employed by Lattice or one of our subsidiaries through the new option grant date.

As discussed above, we will grant new options on the first business day that is at least six months and one day after the cancellation date.  We expect that the new option grant date will be September 18,

 

-6-



 


2003.  If, for any reason, you do not remain employed by Lattice or one of our subsidiaries through the new option grant date, you will not receive any new options or other compensation in exchange for your exchanged options.  Unless expressly provided otherwise by the applicable laws of a non-U.S. jurisdiction, your employment remains “at will” and can be terminated by you or us at any time, with or without cause or notice.  (Section 1)

Q17.                        When will I receive my new options?

A17.                          We will send you a promise to grant stock options promptly after the cancellation date.  The promise to grant stock options represents our commitment to grant you a new option on the new option grant date, provided that you remain employed by Lattice or one of our subsidiaries through the new option grant date.

We will grant the new options on the new option grant date.  The new option grant date will be the first business day that is at least six months and one day after the date on which we cancel the options accepted for exchange.  We will not grant the new options before the new option grant date.  We expect the new option grant date will be September 18, 2003.  If the offering period is extended, the new option grant date will be similarly extended.  (Section 6)

Q18.                        Why do I have to exchange options granted on or after August 13, 2002, if I choose to participate?

A18.                          Under current accounting rules, options that were granted during the six-month period before this offer commenced and the six-month period after the cancellation date could be viewed as “replacement” options for the exchanged options.  As such, accounting rules would require unfavorable accounting treatment for these replacement options.  (Section 12)

Q19.                        What evidence will I have of Lattice’s promise to grant new options to me on the new option grant date?

A19.                          Lattice will deliver to you a written promise to grant the new options to you on the new option grant date.  Lattice will deliver the written promise to you promptly after the cancellation date.  (Section 6)

Q20.                        Why won’t I receive my new options immediately after the expiration date of the offer?

A20.                          Accounting rules prohibit us from granting you new options for a period of six months and one day after the cancellation date, without significant adverse consequences to Lattice.  (Section 12)

Q21.                        Can I exchange shares of Lattice common stock that I acquired upon exercise of Lattice options or through the Lattice ESPP?

A21.                          No.  This offer relates only to outstanding Lattice options.  You may not exchange shares of Lattice common stock in this offer.  (Section 2)

Q22.                        If I participate in this offer, may I receive other option grants before I receive my new options?

A22.                          No.  If you participate in this offer, you will not receive any other option grants before the new option grant date.  Accounting rules prohibit us from granting additional options for a period of six months and one day after the cancellation date, without significant adverse consequences to Lattice.  (Sections 6 and 12)

 

-7-



 

Q23.                        If I do not participate in this offer, may I receive any option grants between now and the new option grant date?

A23.                          We have no current plans to grant options to employees except in connection with this offer and in connection with newly hired employees.  Therefore, you should not expect to receive any option grants between now and the new option grant date if you decide not to participate in this offer.  In addition, although we have made annual option grants to our existing employees in the past, we do not currently intend to grant additional options to our employees this year, other than in connection with this offer and to newly hired employees.  (Section 6)

Q24.                        Is this a repricing of options?

A24.                          No.  This is a stock option exchange offer.  The Financial Accounting Standards Board has issued rules that result in unfavorable accounting consequences for companies that reprice options.  If we repriced your options, our potential for profitability in the future would be significantly reduced because we would be required to record a charge against earnings with respect to any future appreciation of our common stock underlying the repriced options.  (Section 12)

Q25.                        Why can’t you just grant me additional options?

A25.                          Granting additional options covering the same aggregate number of shares of common stock as the outstanding eligible options would have a negative impact on our dilution.  Further, Lattice does not have authority to grant a sufficient number of stock options to make grants to employees that would achieve the same benefits to employees and stockholders that this program does, while allowing Lattice to maintain the flexibility it needs to provide ongoing grants, award additional options to recognize employee performance and grant options to newly hired employees.  We believe this program is in the best interests of our employees and stockholders to incent our employees with appropriate stock options, reduce the outstanding stock option overhang, and conserve options for future grants.  (Section 3)

Q26.                        Will I be required to give up all of my rights under the cancelled options?

A26.                          Yes.  Once we have accepted your exchanged options, your exchanged options will be cancelled and you will no longer have any rights under those options.  This means that if you quit, with or without a good reason, or die or we terminate your employment with or without cause, before the new option grant date, you will not receive anything for the options that you elected to exchange and that we cancelled.  We intend to cancel all exchanged options on the first business day following the expiration date.  We refer to this date as the cancellation date.  We expect that the cancellation date will be March 17, 2003.  (Section 6)

Q27.                        Will the terms and conditions of my new options be the same as my exchanged options?

A27.                          The terms and conditions of the new options may vary from the terms and conditions of the options that you tendered for exchange, but, except as described in this offer, such changes generally will not be substantially different from your existing rights. (Section 9)

Q28.                        What if Lattice is acquired by another company?

A28.                          At this time, we are not anticipating being acquired.  However, if Lattice were to be acquired between the time of the cancellation date and the new option grant date, then the acquiror must grant

 

-8-



 


the new option under the same terms as provided in this offer.  The type of stock and the number of shares covered by each new option would be determined in the same way as the consideration received by outstanding option holders would be determined at the time of the acquisition.  Such new option would generally have an exercise price equal to the fair market value of the acquiror’s stock on the new option grant date.  As a result of this adjustment, you could receive options for more or fewer shares of the acquiror’s common stock than the number of options you would have received if no acquisition had occurred.  In addition, if you are located outside of the U.S., the new grant may not be able to be made to you by the acquiror or the terms and conditions of the new option may vary from what is described in this offer.  (Section 9)

Q29.                        What happens to my options if I choose not to participate?

A29.                          If you choose not to participate, your existing options will remain outstanding until they expire by their terms, retain their current exercise price, and retain their current vesting schedule.  (Section 6)

Q30.                        How will Lattice determine whether an option has been properly tendered?

A30.                          We will determine, in our discretion, all questions about the validity, form, eligibility (including time of receipt), and acceptance of any options.  Our determination of these matters will be final and binding on all parties.  We reserve the right to reject any election form or any options tendered for exchange that we determine are not in appropriate form or that we determine are unlawful to accept.  We will accept all properly tendered options that are not validly withdrawn, subject to Section 7 of this offer.  No tender of options will be deemed to have been properly made until all defects or irregularities have been cured or waived by us.  We have no obligation to give notice of any defects or irregularities in any election form and we will not incur any liability for failure to give any notice.  (Section 4)

Q31.                        Will I have to pay taxes if I participate in the offer?

A31.                          If you participate in the offer, you should not be required under current U.S. law to recognize income for U.S. federal income tax purposes at the time of the exchange.  On the new option grant date, you will not be required under current law to recognize income for U.S. federal income tax purposes.  (Section 14)

If you are a tax resident or citizen of a foreign jurisdiction or are otherwise subject to a tax liability in a foreign jurisdiction, your tax consequences with respect to the exchange may vary from those tax consequences described above for United States citizens or permanent residents.  Employees in foreign jurisdictions should refer to Schedules D through Q for a discussion of the tax and legal consequences of electing to participate in the offer.  Tax consequences may also vary depending on each individual option holder’s circumstances.

You should consult with your own tax advisor to determine the personal tax consequences to you of participating in this offer.  If you are a resident of, or subject to the tax laws in, more than one country, you should be aware that there might be additional tax and social insurance consequences that may apply to you.

Q32.                        Will my new options be incentive stock options or nonstatutory stock options?

A32.                          All new options will be nonstatutory stock options for U.S. federal income tax purposes.

 

-9-



 

We recommend that you read the tax discussion in this offer to exchange and discuss the personal tax consequences of nonstatutory stock options with your financial, legal and/or tax advisors.  (Sections 9 and 14)

Q33.                        When will my new options expire?

A33.                          Your new options will expire 10 years from the new option grant date, or earlier if your employment with Lattice or one of our subsidiaries terminates.  (Section 9)

Q34.                        Will I receive a new option agreement?

A34.                          Yes.  All new options will be subject to a new option agreement between you and Lattice. (Section 9)

Q35.                        Is there any chance Lattice will not proceed with the option exchange?

A35.                          The completion of this offer is subject to a number of customary conditions that are described in Section 7 of this offer.  If any of these conditions are not satisfied, we will not be obligated to exchange properly tendered eligible options, though we may do so at our discretion.

In addition, prior to the expiration date, we may change the offer for any or no reason.  (Section 7)

Q36.                        If you extend the offering period, how will you notify me?

A36.                          If we extend the offering period, we will issue a press release or other public announcement disclosing the extension no later than 6:00 a.m., Pacific Time, on the next business day following the previously scheduled expiration date.  We will also send an e-mail to all eligible employees.  (Sections 2 and 16)

Q37.                        How will you notify me if the offer is changed?

A37.                          If we change the offer, we will issue a press release or other public announcement disclosing the change no later than 6:00 a.m., Pacific Time, on the next business day following the day we change the offer.  We will also send an e-mail to all eligible employees.  (Sections 2 and 16)

Q38.                        Can I change my mind and withdraw from this offer?

A38.                          Yes.  You may change your mind after you have submitted an election form and withdraw from the offer at any time before the offer expires at 5:00 p.m., Pacific Time, on March 14, 2003.  If we extend the offering period beyond that time, you may withdraw your election at any time until the extended offering period expires.  You may change your mind as many times as you wish, but you will be bound by the last properly submitted election or withdrawal form we receive before the offer expires.  (Section 5)

Q39.                        How do I withdraw my election?

A39.                          To withdraw your election, you must do the following before the expiration date:

1.               Properly complete and sign the withdrawal form provided by Lattice.

2.               Deliver the completed and signed withdrawal form to the Stock Option Administrator either by facsimile at (503) 268-8116 or by hand delivery to the Payroll and Stock Option

 

-10-



 


Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421.  (Section 5)

Q40.                        What if I withdraw my election and then decide again that I want to participate in this offer?

A40.                          If you have withdrawn your election to participate and then decide again that you would like to participate in this offer, you may re-elect to participate by submitting a new properly completed election form that is signed and dated after the date of your withdrawal form.  The new election form must be submitted before the offer expires.  (Section 5)

Q41.                        Are you making any recommendation as to whether I should exchange my eligible options?

A41.                          No.  We are not making any recommendation as to whether you should accept this offer.  You must make your own decision as to whether or not to participate in this offer.  For questions regarding personal tax implications or other investment-related questions, you should talk to your own legal counsel, accountant and/or financial advisor.  (Section 3)

Q42.                        Who can I talk to if I have questions about the offer, or if I need additional copies of the offer documents?

A42.                          If you have questions about this offer, you should contact:

 

 

Bob Adam
Manager – Payroll and Benefits
Lattice Semiconductor Corporation
5555 N.E. Moore Court
Hillsboro, OR 97124-6421
(503) 268-8675

Terry Dols
Vice President – Human Resources
Lattice Semiconductor Corporation
5555 N.E. Moore Court
Hillsboro, OR 97124-6421
(503) 268-8120

If you need additional copies of the offer documents, you should contact:

Stock Option Administrator

Payroll and Stock Option Department

Lattice Semiconductor Corporation

5555 N.E. Moore Court

Hillsboro, OR 97124-6421

(503) 268-8382

 

The offer documents are also available in the Human Resource Department at the following domestic locations: LHQ, LSV, LTX and LPA; on our intranet site at http://intra.latticesemi.com/; and in the Schedule TO relating to this offer that we filed with the SEC, which can be accessed on the SEC’s web site at www.sec.gov.  (Section 10)

 

 

-11-



 

RISKS OF PARTICIPATING IN THE OFFER

Participating in the offer involves a number of risks, including those described below.  This list and the risk factors under the heading entitled “Factors Affecting Future Results” in our annual report on Form 10-K for the fiscal year ended December 31, 2001, and in our quarterly reports on Form 10-Q for the fiscal quarters ended March 31, 2002, June 30, 2002 and September 30, 2002, filed with the Securities and Exchange Commission (SEC), highlight the material risks of participating in this offer.  You should carefully consider these risks and are encouraged to speak with an investment and tax advisor as necessary before deciding to participate in the offer.  In addition, we strongly urge you to read the sections in this offer to exchange discussing the tax consequences in the United States, as well as the rest of this offer to exchange for a more in-depth discussion of the risks that may apply to you before deciding to participate in the exchange offer.

In addition, this offer and our SEC reports referred to in this offer contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act.  Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. We use words or phrases such as “anticipate,” “estimate,” “plans,” “project,” “continuing,” “ongoing,” “expect,” “management believes,” “we believe,” “we intend” and similar words or phrases to identify forward-looking statements.  Forward-looking statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this offer. Among the key factors that could cause our actual results to differ materially from the forward-looking statements are delay in product or technology development, change in economic conditions of the various markets we serve, lack of market acceptance or demand for our new products, dependencies on silicon wafer suppliers and semiconductor assemblers, the impact of competitive products and pricing, opportunities or acquisitions that we pursue, and the availability and terms of financing. You should not unduly rely on forward-looking statements because our actual results could materially differ from those expressed in any forward-looking statements made by us. Further, any forward-looking statement applies only as of the date on which it is made. We are not required to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

The following discussion should be read in conjunction with the financial statements and notes to the financial statements attached as Schedule B and Schedule C, as well as our most recent periodic reports on Forms 10-K and 10-Q and current reports on Form 8-K.

Economic Risks

If the price of our common stock increases after the date on which your options are cancelled, your cancelled options might be worth more than the new options that you receive in exchange for them.

For example, if you cancel options with an exercise price of $15.00 per share, and the price of our common stock increases to $18.00 per share when the new options are granted, your new option will have a higher exercise price than the cancelled option.

If you participate in the offer, you will be ineligible to receive any additional option grants until September 18, 2003, at the earliest.

Employees generally are eligible to receive option grants at any time that we choose to make such grants.  However, if you participate in the offer, you will not be eligible to receive any additional option

 

-12-



 

grants until September 18, 2003, at the earliest.  In addition, although we have made annual option grants to our existing employees in the past, we do not currently intend to grant additional options to our employees this year, other than in connection with this offer and to newly hired employees

If we are acquired by or merge with another company, your cancelled options might be worth more than the new options that you receive in exchange for them.

A transaction involving us, such as a merger or other acquisition, could have a substantial effect on our stock price, including significantly increasing the price of our common stock.  Depending on the structure and terms of this type of transaction, option holders who elect to participate in the offer might be deprived of the benefit of the appreciation in the price of our common stock resulting from the merger or acquisition.  This could result in a greater financial benefit for those option holders who did not participate in this offer and retained their original options.

If your employment terminates before we grant the new options, including as the result of a reduction-in-force or another company’s acquisition of us, you will neither receive a new option nor have any of your cancelled options returned to you.

Once we cancel the options that you elect to exchange, all of your rights under the options terminate.  Accordingly, if your employment with Lattice or one of our subsidiaries terminates for any reason, including as the result of your death, a reduction-in-force or another company acquiring Lattice, before the grant of the new options, you will have the benefit of neither the cancelled option nor any new option.

Our revenues depend on the health of the economy and the growth of our customers and potential customers.  If the economic conditions in the United States remain stagnant or worsen or if a wider or global economic slowdown occurs, we may experience a material adverse impact on our business, operating results, and financial condition and may undertake various measures to reduce our expenses including a reduction-in-force.  Should your employment be terminated as part of any such reduction-in-force, you will have the benefit of neither the cancelled option nor any new option.

If another company acquires us, that company may, as part of the transaction or otherwise, decide to terminate some or all of our employees before the new option grant date.  If your employment terminates for this or any other reason before the new option grant date you will not receive a new option, nor will you receive any other compensation for your options that were cancelled.

Tax-Related Risks for Non-U.S. Residents

Tax-related risks for tax residents of non-U.S. countries.

If you are a tax resident or citizen of a foreign jurisdiction, you should refer to Schedules D through Q for a discussion of some of the tax and legal consequences that may apply to you.

Tax-related risks for tax residents of multiple countries.

If you are subject to the tax laws in more than one jurisdiction, you should be aware that there may be tax and social security consequences that may apply to you in more than one jurisdiction.  You should be certain to consult your own tax advisor to discuss these consequences.

 

-13-



 

Business-Related Risks

A continuing downturn in the communications equipment and computing end markets has caused a reduction in demand for our products and limited our ability to maintain or increase our revenue and profit levels.

A significant portion of our revenue is derived from customers in the communications equipment and computing end markets.  A downturn in the overall global economy or in the economies of the countries where we derive significant revenue could lead to a contraction of capital spending on information technology.  This in turn could lead to a reduction in the demand for communications or computing equipment and for our products.

Due to a deterioration in overall economic conditions and a significant reduction in information technology capital spending, the communications and computing end markets are currently experiencing significant and prolonged downturns.  In addition, the abrupt transition from an environment of rapid growth to the current environment in these end equipment markets resulted in an excess of component inventory within our end customers.  At present and in the future when these or other similar conditions exist, there is likely to be an adverse effect on our operating results.

The cyclical nature of the semiconductor industry may limit our ability to maintain or increase revenue and profit levels during current or future industry downturns.

The semiconductor industry is highly cyclical, to a greater extent than other less dynamic or less technology-driven industries.  Our financial performance has periodically been negatively affected by downturns in the semiconductor industry.  Factors that contribute to these industry downturns include: the cyclical nature of the demand for the products of semiconductor customers;

                  general reductions in inventory levels by customers;

                  excess production capacity;

                  general decline in end-user demand; and

                  accelerated declines in average selling prices.

Beginning in 2001, the semiconductor industry experienced a significant downturn.  At present and in the future when these or other similar conditions exist, there is likely to be an adverse effect on our operating results.

We may experience unexpected difficulties integrating the FPGA business which we recently purchased from Agere.

On January 18, 2002, we acquired the field programmable gate array, or FPGA, business of Agere Systems and are currently in the process of completing the integration of this business with our operations.  If our integration is unsuccessful, more difficult or more time consuming than originally planned, we may incur unexpected disruptions to our ongoing business.  These disruptions could harm our operating results.  Further, the following specific factors may adversely affect our ability to integrate the FPGA business of Agere:

                  we may experience unexpected losses of key employees or customers;

 

-14-



 

                  we may not achieve expected levels of revenue growth, cost reduction and profitability improvement;

                  we may not be able to coordinate our new product and process development in a way which permits us to bring future new products to the market in a timely manner;

                  we may experience unexpected costs and discover unexpected liabilities; and

                  we may experience difficulties or delays in conforming the standards, processes, procedures and controls of our two businesses.

In addition, as part of our acquisition, we entered into agreements with Agere to obtain certain manufacturing, intellectual property and transition support and services.  These support agreements with Agere do not have a material impact upon costs.  However, in the event that Agere fails to provide this support and service, or provides such support and service at a level of quality and timeliness inconsistent with the historical delivery of such support and service, our ability to integrate the FPGA business will be hampered and our operating results may be harmed.

We may be unsuccessful in defining, developing or selling new products required to maintain or expand our business.

As a semiconductor company, we operate in a dynamic environment marked by rapid product obsolescence.  Our future success depends on our ability to introduce new or improved silicon and software products that meet customer needs while achieving acceptable margins.  If we fail to introduce these new products in a timely manner or these products fail to achieve market acceptance, our operating results would be harmed.

The introduction of new silicon and software products in a dynamic market environment presents significant business challenges.  Product development commitments and expenditures must be made well in advance of product sales.  The market reception of new products depends on accurate projections of long-term customer demand, which by their nature are uncertain.

Our future revenue growth is dependent on market acceptance of our new silicon and software product families and the continued market acceptance of our products.  The success of these products is dependent on a variety of specific technical factors including:

                  successful product definition;

                  timely and efficient completion of product design;

                  timely and efficient implementation of wafer manufacturing and assembly processes;

                  product performance; and

                  the quality and reliability of the product.

If, due to these or other factors, our new silicon and software products do not achieve market acceptance, our operating results would be harmed.

 

-15-



 

Our products may not be competitive if we are unsuccessful in migrating our manufacturing processes to more advanced technologies or alternative fabrication facilities.

To develop new products and maintain the competitiveness of existing products, we need to migrate to more advanced wafer manufacturing processes that use larger wafer sizes and smaller device geometries.  We also may need to use additional foundries.  Because we depend upon foundries to provide their facilities and support for our process technology development, we may experience delays in the availability of advanced wafer manufacturing process technologies at existing or new wafer fabrication facilities.  As a result, volume production of our advanced process technologies at the fabs of Seiko Epson, United Microelectronics Corporation, which we refer to in this prospectus as UMC, Chartered Semiconductor or future foundries may not be achieved.  This could harm our operating results.

In late 2001, UMC informed us that as part of an overall capacity rationalization they were planning to close certain of their fabrication facilities.  We were developing an advanced wafer manufacturing process at one of the UMC fabs that has been closed.  With UMC’s support, we have transferred this process to another UMC fab.  However, as a result, our new product introduction schedules were delayed.  This could harm our operating results.

Our marketable securities, which we hold for strategic reasons, are subject to equity price risk and their value may fluctuate.

Currently we hold substantial equity in UMC Corporation, which we acquired as part of a strategic investment to obtain certain manufacturing rights.  The market price and valuation of these equity shares has fluctuated widely due to market and other conditions over which we have little control.  During the year ended December 31, 2001, we recorded a $152.8 million pre-tax impairment loss related to this investment.  In the future, UMC shares may continue to experience significant price volatility.  In the second quarter of 2002, we sold a portion of our UMC shares, but have otherwise not attempted to reduce or eliminate this equity price risk through hedging or similar techniques and hence substantial, sustained changes in the market price of UMC shares could impact our financial results.  To the extent that the market value of our UMC shares experiences a significant decline for an extended period of time, our net income could be reduced.

Our future quarterly operating results may fluctuate and therefore may fail to meet expectations.

Our quarterly operating results have fluctuated and may continue to fluctuate.  Consequently, our operating results may fail to meet the expectations of analysts and investors.  As a result of industry conditions and the following specific factors, our quarterly operating results are more likely to fluctuate and are more difficult to predict than a typical non-technology company of our size and maturity:

                  general economic conditions in the countries where we sell our products;

                  conditions within the end markets into which we sell our products;

                  the cyclical nature of demand for our customers’ products;

                  excessive inventory accumulation by our end customers;

                  the timing of our and our competitors’ new product introductions;

                  product obsolescence;

 

-16-



 

                  the scheduling, rescheduling and cancellation of large orders by our customers;

                  our ability to develop new process technologies and achieve volume production at the fabs of Seiko Epson, UMC, Chartered Semiconductor or at other foundries;

                  changes in manufacturing yields;

                  adverse movements in exchange rates, interest rates or tax rates; and

                  the availability of adequate supply commitments from our wafer foundries and assembly and test subcontractors.

As a result of these factors, our past financial results are not necessarily a good predictor of our future results.

Our stock price may continue to experience large short-term fluctuations.

In recent years, the price of our common stock has fluctuated greatly.  These price fluctuations have been rapid and severe and have left investors little time to react.  The price of our common stock may continue to fluctuate greatly in the future due to a variety of company specific factors, including:

                  quarter-to-quarter variations in our operating results;

                  shortfalls in revenue or earnings from levels expected by securities analysts; and

                  announcements of technological innovations or new products by other companies.

Presently, our stock price is trading near our consolidated book value.  A sustained decline in our stock price may result in a write-off of goodwill.

Our wafer supply may be interrupted or reduced, which may result in a shortage of finished products available for sale.

We do not manufacture finished silicon wafers.  Currently, our silicon wafers are manufactured by Seiko Epson in Japan, UMC in Taiwan and Chartered Semiconductor in Singapore.  If Seiko Epson, through its U.S. affiliate, Epson Electronics America, UMC or Chartered Semiconductor significantly interrupts or reduces our wafer supply, our operating results could be harmed.

In the past, we have experienced delays in obtaining wafers and in securing supply commitments from our foundries.  At present, we anticipate that our supply commitments are adequate.  However, these existing supply commitments may not be sufficient for us to satisfy customer demand in future periods.  Additionally, notwithstanding our supply commitments we may still have difficulty in obtaining wafer deliveries consistent with the supply commitments.  We negotiate wafer prices and supply commitments from our suppliers on at least an annual basis.  If any of Seiko Epson, Epson Electronics America, UMC or Chartered Semiconductor were to reduce its supply commitment or increase its wafer prices, and we cannot find alternative sources of wafer supply, our operating results could be harmed.

Many other factors that could disrupt our wafer supply are beyond our control.  Since worldwide manufacturing capacity for silicon wafers is limited and inelastic, we could be harmed by significant industry-wide increases in overall wafer demand or interruptions in wafer supply.  Additionally, a future disruption of

 

-17-



 

Seiko Epson’s, UMC’s or Chartered Semiconductor’s foundry operations as a result of a fire, earthquake or other natural disaster could disrupt our wafer supply and could harm our operating results.

If our foundry partners experience quality or yield problems, we may face a shortage of finished products available for sale.

We depend on our foundries to deliver reliable silicon wafers with acceptable yields in a timely manner.  As is common in our industry, we have experienced wafer yield problems and delivery delays.  If our foundries are unable for a prolonged period to produce silicon wafers that meet our specifications, with acceptable yields, our operating results could be harmed.

The majority of our revenue is derived from products based on a specialized silicon wafer manufacturing process technology called E2CMOS.  The reliable manufacture of high performance E2CMOS semiconductor wafers is a complicated and technically demanding process requiring:

                  a high degree of technical skill;

                  state-of-the-art equipment;

                  the absence of defects in the masks used to print circuits on a wafer;

                  the elimination of minute impurities and errors in each step of the fabrication process; and

                  effective cooperation between us and the wafer supplier.

As a result, our foundries may experience difficulties in achieving acceptable quality and yield levels when manufacturing our silicon wafers.

If our assembly and test subcontractors experience quality or yield problems, we may face a shortage of finished products available for sale.

We rely on subcontractors to assemble and test our devices with acceptable quality and yield levels.  As is common in our industry, we have experienced quality and yield problems in the past.  If we experience prolonged quality or yield problems in the future, our operating results could be harmed.

The majority of our revenue is derived from semiconductor devices assembled in advanced packages.  The assembly of advanced packages is a complex process requiring:

                  a high degree of technical skill;

                  state-of-the-art equipment;

                  the absence of defects in lead frames used to attach semiconductor devices to the package;

                  the elimination of raw material impurities and errors in each step of the process; and

                  effective cooperation between us and the assembly subcontractor.

As a result, our subcontractors may experience difficulties in achieving acceptable quality and yield levels when assembling and testing our semiconductor devices.

 

-18-



 

Deterioration of conditions in Asia may disrupt our existing supply arrangements and result in a shortage of finished products available for sale.

All three of our major silicon wafer suppliers operate fabs located in Asia.  Our finished silicon wafers are assembled and tested by independent subcontractors located in China, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand.  A prolonged interruption in our supply from any of these subcontractors could harm our operating results.

Economic, financial, social and political conditions in Asia have historically been volatile.  Financial difficulties, governmental actions or restrictions, prolonged work stoppages or any other difficulties experienced by our suppliers may disrupt our supply and could harm our operating results.

Our wafer purchases from Seiko Epson are denominated in Japanese yen.  The value of the dollar with respect to the yen fluctuates.  Substantial deterioration of dollar-yen exchange rates could harm our operating results.

Export sales account for a substantial portion of our revenues and may decline in the future due to economic and governmental uncertainties.

Our export sales are affected by unique risks frequently associated with foreign economies including:

                  changes in local economic conditions;

                  exchange rate volatility;

                  governmental controls and trade restrictions;

                  export license requirements and restrictions on the export of technology;

                  political instability or terrorism;

                  changes in tax rates, tariffs or freight rates;

                  interruptions in air transportation; and

                  difficulties in staffing and managing foreign sales offices.

For example, our export sales have historically been affected by regional economic crises.  Significant changes in the economic climate in the foreign countries where we derive our export sales could harm our operating results.

We may not be able to successfully compete in the highly competitive semiconductor industry.

The semiconductor industry is intensely competitive and many of our direct and indirect competitors have substantially greater financial, technological, manufacturing, marketing and sales resources.  If we are unable to compete successfully in this environment, our future results will be adversely affected.

The current level of competition in the programmable logic market is high and may increase as our market expands.  We currently compete directly with companies that have licensed our products and technology or have developed similar products.  We also compete indirectly with numerous semiconductor

 

-19-



 

companies that offer products and solutions based on alternative technologies.  These direct and indirect competitors are established multinational semiconductor companies as well as emerging companies.  We also may experience significant competition from foreign companies in the future.

We may fail to retain or attract the specialized technical and management personnel required to successfully operate our business.

To a greater degree than most non-technology companies or larger technology companies, our future success depends on our ability to attract and retain highly qualified technical and management personnel.  As a mid-sized company, we are particularly dependent on a relatively small group of key employees.  Competition for skilled technical and management employees is intense within our industry.  As a result, we may not be able to retain our existing key technical and management personnel.  In addition, we may not be able to attract additional qualified employees in the future.  If we are unable to retain existing key employees or are unable to hire new qualified employees, our operating results could be adversely affected.

If we are unable to adequately protect our intellectual property rights, our financial results and competitive position may suffer.

Our success depends in part on our proprietary technology.  However, we may fail to adequately protect this technology.  As a result, we may lose our competitive position or face significant expense to protect or enforce our intellectual property rights.

We intend to continue to protect our proprietary technology through patents, copyrights and trade secrets.  Despite this intention, we may not be successful in achieving adequate protection.  Claims allowed on any of our patents may not be sufficiently broad to protect our technology.  Patents issued to us also may be challenged, invalidated or circumvented.  Finally, our competitors may develop similar technology independently.

Companies in the semiconductor industry vigorously pursue their intellectual property rights.  If we become involved in protracted intellectual property disputes or litigation we may utilize substantial financial and management resources, which could have an adverse effect on our operating results.

Our industry is characterized by frequent claims regarding patents and other intellectual property rights of others.  We have been, and from time-to-time expect to be, notified of claims that we are infringing the intellectual property rights of others.  If any third party makes a valid claim against us, we could face significant liability and could be required to make material changes to our products and processes.  In response to any claims of infringement, we may seek licenses under patents that we are alleged to be infringing.  However, we may not be able to obtain a license on favorable terms or without our operating results being adversely affected.

 

-20-



THE OFFER

1.             Eligibility.

 

                You are an “eligible employee” if you are an employee, including an officer, of Lattice or one of our subsidiaries on the date this offer commences and you remain employed by Lattice or one of our subsidiaries through the date on which the exchanged options are cancelled.  Non-employee members of our board of directors are not eligible to participate in the offer.  Our directors and officers are listed on Schedule A to this offer.

 

                To receive a new option, you must remain employed by Lattice or one of our subsidiaries through the new option grant date, which will be the first business day that is at least six months and one day after the cancellation date.  If we do not extend the offering period, the new option grant date will be September 18, 2003.  If, for any reason, you do not remain an employee through the new option grant date, you will not receive any new options or other compensation in exchange for your options that have been accepted for exchange.  For this purpose, employment would not include a period of garden leave and/or notice period pursuant to local law.  This means that if you quit, with or without a good reason, or die or we terminate your employment with or without cause, before the new option grant date, you will not receive anything for the options that you elected to exchange and that we cancelled.  If you are an employee of Lattice or one of our subsidiaries and you are on an approved leave of absence or you are absent from work due to an illness or disability, you will be eligible to participate in this offer as long as you remain an employee through the cancellation date.  Unless expressly provided by the applicable laws of a non-U.S. jurisdiction, your employment will remain “at-will” and can be terminated by you or us at any time, with or without cause or notice.

2.             Number of options; expiration date.

 

                Subject to the terms and conditions of this offer, we will accept for exchange all eligible options that are properly elected to be exchanged, and are not validly withdrawn, before the expiration date.  “Eligible options” mean all outstanding, unexercised options with exercise prices equal to or greater than $12.00 per share, whether vested or unvested, that have been granted under either our 1996 Stock Incentive Plan or our 2001 Stock Plan and that are held by eligible employees.  Options to purchase our common stock granted under plans other than our 1996 Stock Incentive Plan and our 2001 Stock Plan are not eligible for exchange.  In addition, no shares of Lattice common stock, including common stock acquired upon exercise of Lattice options or through the Employee Stock Purchase Plan of Lattice, may be exchanged in this offer.

 

                Each option grant that you elect to exchange must be for the entire portion that is outstanding and unexercised.  We are not accepting partial tenders of options.  However, you may elect to exchange the remaining portion of an option that you have partially exercised.  As a result, you may elect to exchange one or more of your option grants, but you must elect to exchange all of the unexercised shares subject to each grant or none of the shares for that particular grant.

 

                For example and except as otherwise described in this offer, if you hold (1) an option to purchase 1,000 shares at $20.00 per share, 700 of which you have already exercised, (2) an option to purchase 1,000 shares at an exercise price of $25.00 per share, and (3) an option to purchase 2,000 shares at an exercise price of $30.00 per share, you may elect to exchange:

      your first option covering 300 remaining unexercised shares,

 

-21-



 

      your second option covering 1,000 shares,

      your third option covering 2,000 shares,

      two of your three options,

      all three of your options, or

      none of your options.

 

                These are your only choices in the above example.  You may not, for example, elect to exchange your first option with respect to only 150 shares, or any other partial amount, under that grant or less than all of the shares under the second and third option grants.

 

                If you participate in this offer, you must also exchange all of your options that were granted to you on or after August 13, 2002.  This rule applies even if these options have exercise prices less than $12.00 per share.  For example, if you received an option grant in January 2001 and a grant in October 2002 and you want to exchange your January 2001 option grant, you also must exchange your October 2002 option grant.  This includes all options granted to you between the commencement of this offer on February 13, 2003 and the expiration date.

 

                Subject to the terms of this offer and upon our acceptance of your properly tendered options, your exchanged options will be cancelled and you will be granted new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.  Fractional options will be rounded up to the nearest whole option.

 

                The number of new options is subject to adjustment for any changes in our capitalization, such as stock splits, combinations, subdivisions, stock dividends, reclassifications or other similar events, that occur after the cancellation date but before the new option grant date.  Each new option will be granted under our 1996 Stock Incentive Plan.  All new options will be subject to the terms of the 1996 Stock Incentive Plan and to a new option agreement between you and Lattice.  A copy of the 1996 Stock Incentive Plan and the form of option agreement are attached as exhibits to the Schedule TO with which this offer has been filed.

 

                The expiration date for this offer will be 5:00 p.m., Pacific Time, on March 14, 2003, unless we extend the offering period.  We may, in our discretion, extend the offering period, in which event the expiration date shall refer to the latest time and date at which the extended offering period expires.  See Section 16 of this offer for a description of our rights to extend, terminate and amend the offer.

3.             Purpose of the offer.

 

                We believe that this offer will foster retention of our valuable employees and better align the interests of our employees and stockholders to maximize stockholder value.  We issued the currently outstanding options to motivate our employees to perform at high levels and provide an effective means of recognizing employee contributions to our success.  Some of these options, whether or not they are currently exercisable, have exercise prices that are significantly higher than the current market price for our stock.  These options are commonly referred to as being “underwater.”  By making this offer, we intend to provide eligible employees with the opportunity to own options that over time may have a greater potential to increase in value.

 

 

-22-



 

 

                Another purpose of this offer is to decrease Lattice’s option overhang, which is the number of options outstanding as a percent of the total number of common shares outstanding.  The exchange ratio used in this offer is designed to help accomplish this goal, which will benefit our stockholders by decreasing dilution.

 

                Except as otherwise disclosed in this offer or in our SEC filings, Lattice presently has no plans or proposals that relate to or would result in:

                  any extraordinary transaction, such as a merger, reorganization or liquidation involving Lattice;

                  any purchase, sale or transfer of a material amount of our assets;

                  any material change in our present dividend rate or policy, or our indebtedness or capitalization;

                  any change in our present board of directors or management, including a change in the number or term of directors or to fill any existing board vacancies or to change any executive officer’s material terms of employment;

                  any other material change in our corporate structure or business;

                  our common stock being delisted from a national securities exchange or not being authorized for quotation in an automated quotation system operated by a national securities association;

                  our common stock becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended (the Exchange Act);

                  the suspension of our obligation to file reports pursuant to Section 15(d) of the Exchange Act;

                  the acquisition by any person of an amount of our securities or the disposition of an amount of any of our securities; or

                  any change in our certificate of incorporation or bylaws, or any actions that may impede the acquisition of control of us by any person.

 

                Neither we nor our board of directors makes any recommendation as to whether you should accept this offer, nor have we authorized any person to make any such recommendation.  You should evaluate carefully all of the information in this offer and consult your own investment and tax advisors.  You must make your own decision about whether to exchange your options.

4.             Procedures for electing to exchange options.

Proper Election to Exchange Options.

 

                Participation is this offer is voluntary.  To participate in this offer, you must, in accordance with the instructions of the election form, properly complete, sign and deliver the election form via facsimile (fax number (503) 268-8116) or by hand delivery to the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, along with any other required documents.  The Stock Option Administrator must receive the properly completed and signed election forms before the expiration date.  The expiration date will be 5:00 p.m., Pacific Time, on March 14, 2003 unless we extend the offering period.

 

 

-23-



 

 

                If you elect to exchange any options through this offer, you must also elect to exchange all options that we granted to you on or after August 13, 2002, regardless of the exercise price.  Even if you submit an election form but fail to list the options that are required to be elected to be exchanged, they automatically will be tendered for exchange under this offer, unless you properly withdraw your options in accordance with the terms of this offer.

 

                The delivery of all documents, including election forms, is at your risk.  We intend to confirm the receipt of your election form and/or any withdrawal form within two (2) business days.  If you have not received a confirmation, you must confirm that we have received your election form and/or any withdrawal form.

 

                Neither our receipt of your election form nor our delivery of a confirmation of receipt to you will constitute an acceptance of your options for exchange.  For purposes of this offer, we will be deemed to have accepted options for exchange that are validly elected to be exchanged and are not properly withdrawn as of the time when we give oral or written notice to the option holders generally of our acceptance of options for exchange.  We may issue this notice of acceptance by press release, e-mail or other methods of communication.  Options accepted for exchange will be cancelled on the cancellation date, which we presently expect will be March 17, 2003.

Determination of validity; rejection of options; waiver of defects; no obligation to give notice of defects.

 

                We will determine, in our discretion, all questions as to the validity, form, eligibility (including time of receipt) and acceptance of any options.  Our determination of these matters will be final and binding on all parties.  We reserve the right to reject any election form or any options elected to be exchanged that we determine are not in appropriate form or that we determine are unlawful to accept.  We will accept all properly tendered options that are not validly withdrawn, subject to Section 7 of this offer.  We also reserve the right to waive any of the conditions of the offer or any defect or irregularity in any tender of any particular options or for any particular option holder, provided that if we grant any such waiver, it will be granted with respect to all option holders and tendered options.  No tender of options will be deemed to have been properly made until all defects or irregularities have been cured by the tendering option holder or waived by us.  Neither we nor any other person is obligated to give notice of any defects or irregularities in tenders, nor will anyone incur any liability for failure to give any notice.  This is a one-time offer.  We will strictly enforce the offering period and expiration date, subject only to an extension that we may grant in our discretion.

Our acceptance constitutes an agreement.

 

                Your election to exchange options through the procedures described above constitutes your acceptance of the terms and conditions of this offer.  Our acceptance of your options for exchange will constitute a binding agreement between Lattice and you upon the terms and subject to the conditions of this offer.

 

                To administer this offer, we must collect, use and transfer certain information regarding you and your option grants, and may have to pass that information on to third parties who are assisting with the offer.  By submitting an election form or a withdrawal form, you agree to such collection, use and transfer of your personal data by us and the third parties assisting us with the offer, but only for the purpose of administering your participation in this offer.  By submitting an election form or a withdrawal form, you also acknowledge and agree that:

 

 

-24-



 

                  the parties receiving this data may be located outside of the United States, and the recipient’s country may have different data privacy laws and protections than the United States,

                  the data will be held only as long as necessary to administer and implement the program,

                  you can request from us a list of the parties that may receive your data,

                  you can request additional information about how the data is stored and processed, and

                  you can request to view the data and that the data be amended if it is incorrect.

 

                If you are an option holder in certain foreign jurisdictions, you can withdraw your consent to the collection, use and transfer of your data by contacting us.  However, if you withdraw your consent, you may not participate in this offer.  Please contact us if you have any questions.

5.             Withdrawal rights and change of election.

 

                You may withdraw some or all of the options that you previously elected to exchange only in accordance with the provisions of this section.

 

                You may withdraw options that you previously elected to exchange at any time before the expiration date, which is expected to be 5:00 p.m., Pacific Time, on March 14, 2003.  If we extend the offering period, you may withdraw your options at any time until the extended expiration date.

 

                In addition, although we intend to accept all validly tendered options promptly after the expiration of this offer, if we have not accepted your options by 9:00 p.m., Pacific Time, on April 10, 2003, you may withdraw your options at any time thereafter.

 

                To validly withdraw some or all of the options that you previously elected to exchange, you must deliver via facsimile (fax:  (503) 268-8116) or by hand to the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, CA 97124-6421 in accordance with the procedures listed in Section 4 above, a signed and dated withdrawal form with the required information, while you still have the right to withdraw the options.

 

                You may not rescind any withdrawal, and any options that you withdraw will be deemed not properly tendered for purposes of the offer, unless you properly re-elect to exchange those options before the expiration date.  To re-elect to exchange all of your withdrawn options, you must submit a new election form to the Stock Option Administrator before the expiration date by following the procedures described in Section 4 of this offer.  This new election form must be properly completed, signed and dated after your original election form and after your withdrawal form.  You will be bound by the last properly tendered election or withdrawal form we receive before the expiration date.

 

                Neither we nor any other person is obligated to give you notice of any defects or irregularities in any withdrawal form or any new election form, nor will anyone incur any liability for failure to give any notice.  We will determine, in our discretion, all questions as to the form and validity, including time of receipt, of withdrawal forms and new election forms.  Our determination of these matters will be final and binding.

 

                The delivery of all documents, including any withdrawal forms and any new election forms, is at your risk.  We intend to confirm the receipt of your withdrawal form and/or any election form

 

 

-25-



 

 

within two (2) business days.  If you have not received a confirmation, you must confirm that we have received your withdrawal form and/or any election form.

6.             Acceptance of options for exchange and issuance of new options.

 

                Upon the terms and conditions of this offer and promptly following the expiration date, we will accept for exchange and cancel all options properly elected for exchange and not validly withdrawn before the expiration date.  Once the options are cancelled, you no longer will have any rights with respect to those options.  Subject to the terms and conditions of this offer, if your options are properly tendered by you for exchange and accepted by us, these options will be cancelled as of the cancellation date, which we anticipate to be March 17, 2003.

 

                For purposes of the offer, we will be deemed to have accepted options for exchange that are validly tendered and are not properly withdrawn as of the time when we give oral or written notice to the option holders generally of our acceptance for exchange of the options.  This notice may be made by press release, e-mail or other method of communication.  Our delivery of a confirmation of receipt of your election form will not constitute our acceptance of any options tendered by you for exchange.  Subject to our rights to terminate the offer, discussed in Section 16 of this offer, we currently expect that we will accept promptly after the expiration date all properly tendered options that are not validly withdrawn.

 

                Promptly after the expiration date, we will issue to you a promise to grant stock options.  The promise to grant stock options represents our commitment to grant you a new stock option on the new option grant date, provided that you remain an employee of Lattice or one of our subsidiaries through the new option grant date.  This promise to grant stock options will list the number of new options you will receive.

 

                We will grant the new options on the new option grant date, which will be the first business day that is at least six months and one day after the cancellation date.  We expect the new option grant date to be September 18, 2003.  All new options will be nonstatutory stock options and will be granted under our 1996 Stock Incentive Plan.

 

                If, for any reason, you are not an employee of Lattice or one of our subsidiaries through the new option grant date, you will not receive any new options or other compensation in exchange for your options that have been cancelled pursuant to this offer.

 

                If we accept options you elect to exchange in the offer, we will not grant you any other options before the new option grant date.  Consequently, we will not grant you any new options until at least six months and one day after any of your options have been cancelled.

 

                If you do not participate in this offer, you may receive new option grants between now and the new option grant date.  However, we do not currently intend to grant options to employees this year, other than in connection with this offer and to newly hired employees, even though we have made annual option grants to our employees in the past.  Therefore, you should not expect to receive any option grants this year if you decide not to participate in this offer.

 

                Options that we do not accept for exchange will remain outstanding until they expire by their terms and will retain their current exercise price and current vesting schedule.

 

 

-26-



 

7.             Conditions of the offer.

 

                Notwithstanding any other provision of this offer, we will not be required to accept any options tendered for exchange, and we may terminate the offer, or postpone our acceptance and cancellation of any options tendered for exchange, in each case, subject to Rule 13e-4(f)(5) under the Exchange Act, if at any time on or after the date this offer begins, and before the expiration date, any of the following events has occurred, or has been determined by us to have occurred:

                  there shall have been threatened or instituted or be pending any action, proceeding or litigation seeking to enjoin, make illegal or delay completion of the offer or otherwise relating in any manner to the offer,

                  any order, stay, judgment or decree is issued by any court, government, governmental authority or other regulatory or administrative authority and is in effect, or any statute, rule, regulation, governmental order or injunction shall have been proposed, enacted, enforced or deemed applicable to the offer, any of which might restrain, prohibit or delay completion of the offer or impair the contemplated benefits of the offer to us,

                  there shall have occurred:

                  any general suspension of trading in, or limitation on prices for, our securities on any national securities exchange or in the over-the-counter market in the United States,

                  the declaration of a banking moratorium or any suspension of payments in respect of banks in the United States,

                  any limitation, whether or not mandatory, by any governmental, regulatory or administrative agency or authority on, or any event that, in our reasonable judgment, might affect the extension of credit to us by banks or other lending institutions in the United States,

                  in our reasonable judgment, any extraordinary or material adverse change in U.S. financial markets generally, including a decline of at least 10% in either the Dow Jones Industrial Average, the Nasdaq Index or the Standard & Poor’s 500 Index from the date of commencement of the exchange offer,

                  the commencement of a war or other national or international calamity directly or indirectly involving the United States, which would reasonably be expected to affect materially or adversely, or to delay materially, the completion of the exchange offer, or

                  if any of the situations described above existed at the time of commencement of the exchange offer and that situation, in our reasonable judgment, deteriorates materially after commencement of the exchange offer,

                  as the term “group” is used in Section 13(d)(3) of the Exchange Act:

                  any person, entity or group acquires more than 5% of our outstanding shares of common stock, other than a person, entity or group which had publicly disclosed such ownership with the SEC prior to the date of commencement of the exchange offer,

 

-27-



 

                  any such person, entity or group which had publicly disclosed such ownership prior to such date shall acquire additional common stock constituting more than 1% of our outstanding shares, or

                  any new group shall have been formed that beneficially owns more than 5% of our outstanding shares of common stock that in our judgment in any such case, and regardless of the circumstances, makes it inadvisable to proceed with the exchange offer or with such acceptance for exchange of eligible options,

                  there shall have occurred any change, development, clarification or position taken in generally accepted accounting principles that could or would require us to record for financial reporting purposes compensation expense against our earnings in connection with the offer,

                  a tender or exchange offer, other than this exchange offer by us, for some or all of our shares of outstanding common stock, or a merger, acquisition or other business combination proposal involving us, shall have been proposed, announced or made by another person or entity or shall have been publicly disclosed,

                  any event or events occur that have resulted or may result, in our reasonable judgment, in an actual or threatened material adverse change in our business or financial condition,

                  any event or events occur that have resulted or may result, in our reasonable judgment, in a material impairment of the contemplated benefits of the offer to us (see Section 3 of this offer to exchange for a description of the contemplated benefits of the offer to us), or

                  any rules or regulations by any governmental authority, the National Association of Securities Dealers, the Nasdaq National Market, or other regulatory or administrative authority or any national securities exchange have been enacted, enforced or deemed applicable to us.

 

                If any of the above events occur, we may:

                  terminate the exchange offer and promptly return all tendered eligible options to tendering holders,

                  complete and/or extend the exchange offer and, subject to your withdrawal rights, retain all tendered eligible options until the extended exchange offer expires,

                  amend the terms of the exchange offer, or

                  waive any unsatisfied condition and, subject to any requirement to extend the period of time during which the exchange offer is open, complete the exchange offer.

 

                The conditions to this offer are for our benefit.  We may assert them in our discretion regardless of the circumstances giving rise to them before the expiration date.  We may waive any condition, in whole or in part, at any time and from time to time before the expiration date, in our discretion, whether or not we waive any other condition to the offer.  Our failure at any time to exercise any of these rights will not be deemed a waiver of any such rights.  The waiver of any of these rights with respect to particular facts and circumstances will not be deemed a waiver with respect to any other facts and circumstances.  Any determination we make concerning the events described in this Section 7 will be final and binding upon all persons.

 

 

-28-



 

8.             Price range of shares underlying the options.

 

                The Lattice common stock that underlies your options is traded on the Nasdaq National Market under the symbol “LSCC.”  The following table shows, for the periods indicated, the high and low bid information per share of our common stock as reported by the Nasdaq National Market.

 

 

 

High

 

Low

 

Fiscal Year 2003

 

 

 

 

 

1st Quarter (through February 12, 2003)

 

$

10.30

 

$

6.82

 

Fiscal Year 2002

 

 

 

 

 

1st Quarter

 

$

24.14

 

$

17.06

 

2nd Quarter

 

$

18.49

 

$

6.94

 

3rd Quarter

 

$

9.36

 

$

5.35

 

4th Quarter

 

$

10.79

 

$

4.08

 

Fiscal Year 2001

 

 

 

 

 

1st Quarter

 

$

27.25

 

$

16.75

 

2nd Quarter

 

$

27.64

 

$

15.88

 

3rd Quarter

 

$

25.85

 

$

14.04

 

4th Quarter

 

$

22.65

 

$

14.36

 

 

                On February 12, 2003, the last reported sale price of our common stock, as reported by the Nasdaq National Market, was $6.91 per share.

 

                You should evaluate current market quotes for our common stock, among other factors, before deciding whether or not to accept this offer.

9.             Source and amount of consideration; terms of new options.

Consideration.

 

                We will issue new options in exchange for eligible outstanding options properly elected to be exchanged by you and accepted by us for such exchange.  Each new option will be granted under our 1996 Stock Incentive Plan.  All new options will be subject to a new stock option agreement between you and us.  Subject to any adjustments for changes in our capitalization, such as stock splits, combinations, subdivisions, stock dividends, reclassifications or other similar events, that occur after the cancellation date and before the new option grant date and subject to the other terms and conditions of this offer, upon our acceptance of your properly tendered options, you will be entitled to receive new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.  Fractional options shall be rounded up to the nearest whole option.

 

                If we receive and accept tenders from eligible employees of all options eligible to be tendered, subject to the terms and conditions of this offer, we will grant new options to purchase a total of approximately 7,272,850 million shares of our common stock, or approximately 6.5% of the total shares of our common stock outstanding as of February 11, 2003.

General Terms of New Options.

 

                New options will be granted under our 1996 Stock Incentive Plan.  All new options will be subject to the terms of the plan and to a new option agreement between you and us.  The terms and conditions of the new options may vary from the terms and conditions of the options that you tendered for exchange, but,

 

 

-29-



 

 

except as described in this offer, such changes generally will not be substantially different from your existing rights.

 

                New options will be nonstatutory stock options regardless of whether the exchanged options were incentive stock options or nonstatutory stock options.

 

                In addition, because we will not grant new options until the first business day that is at least six months and one day after the cancellation date, your new option may have a higher exercise price than some or all of the options that you elect to exchange.

 

                The following description summarizes the material terms of our 1996 Stock Incentive Plan and the new options we plan to grant under this offer.  Our statements in this offer to exchange concerning the plan and the new options are merely summaries and do not purport to be complete.  The statements are subject to, and are qualified in their entirety by reference to, the plan, and the form of option agreement under the plan, which have been filed as exhibits to the Schedule TO of which this offer is a part.  Please contact us at Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, Attention: Stock Option Administrator  (telephone: (503) 268-8382), to receive a copy of the plan, and the form of option agreement thereunder.  We will promptly furnish you copies of these documents upon request at our expense.

1996 Stock Incentive Plan.

 

                The maximum number of common shares subject to options currently outstanding under our 1996 Stock Incentive Plan is approximately 12,915,093 shares.  The 1996 Stock Incentive Plan permits the granting of incentive stock options and non-statutory stock options to employees.  All new options granted pursuant to this offer will be non-statutory stock options.

General Terms of the Plan.

 

                The plan is administered by our board of directors or a committee appointed by our board of directors, which we refer to as the administrator.  Subject to the other provisions of the plan, the administrator has the power to determine the terms and conditions of the options granted, including the exercise price, the number of shares subject to the option and the exercisability of the options.

Term.

 

                All new options will have a term of 10 years from the new option grant date.

Termination of Employment Before the New Option Grant Date.

 

                If, for any reason, you are not an employee of Lattice or one of our subsidiaries from the date on which you elect to exchange your options through the new option grant date, you will not receive any new options or any other compensation in exchange for your options that have been accepted for exchange.  This means that if you quit with or without good reason, or die, or we terminate your employment with or without cause, before the new option grant date, you will receive nothing for the options that you tendered and which we cancelled.

 

 

-30-



 

Termination of Employment After the New Option Grant Date.

 

                The plan generally provides that if your employment terminates, other than as a result of your permanent and total disability or your death, you may exercise your option prior to the earlier of its expiration date or the date specified in your option agreement, but only to the extent that your option is vested at termination.

 

                The plan generally provides that if your employment terminates because of your permanent and total disability or death, you or your personal representatives, heirs or legatees may exercise any option held by you, including portions not yet vested, prior to the earlier of twelve (12) months from the date of termination or the expiration of the option.

 

                If you are a non-U.S. resident, certain other restrictions may apply.  Please refer to Schedules D through Q for details regarding your specific country.

Exercise Price.

 

                The administrator generally determines the exercise price at the time the option is granted.  The exercise price per share of the new options will be the closing price of Lattice common stock reported by the Nasdaq National Market on the new option grant date.  Notwithstanding the foregoing, if you are a resident of Italy, your exercise price will be determined as described in Schedule K.  Accordingly, we cannot predict the market price of the new options.  Your new options may have a higher exercise price than some or all of your current options.

Vesting and Exercise.

 

                Each stock option agreement specifies the term of the option and the date on which the option becomes exercisable.  The administrator determines the terms of vesting.  Each new option will have a new two year vesting schedule that will begin on the new option grant date.  Pursuant to the new vesting schedule, 12.5% of the shares subject to the new option will vest and become exercisable on the date three months from the new option grant date and 12.5% of the shares subject to the new option will vest and become exercisable every three months thereafter, subject to your continued employment with Lattice or one of our subsidiaries through each relevant vesting date.

Adjustments Upon Certain Events.

 

                Events Occurring before the New Option Grant Date.  Although we are not anticipating any acquisition, if Lattice is acquired between the cancellation date and the new option grant date, then the acquiror must grant the new options under the same terms as provided in this offer, unless the laws in foreign jurisdictions make the grant unlawful.  However, the type of stock and the number of shares covered by each new option will be determined in the same way as the consideration received by outstanding option holders is determined at the time of the acquisition.  Such new option would generally have an exercise price equal to the fair market value of the acquiror’s stock on the new option grant date.  As a result of this adjustment, you may receive options for more or fewer shares of the acquiror’s common stock than the number of options you would have received if no acquisition had occurred.

 

                The new options for the purchase of an acquiror’s stock will have an exercise price equal to the fair market value of the acquiror’s stock on the new option grant date.  If the acquiror’s stock was not traded on a public market, the fair market value of the acquiror’s stock may be determined in good faith by the acquiror’s board of directors, and the exercise price of the new options would reflect that determination.  If we are

 

 

-31-



 

 

acquired by another entity, options that are not tendered for exchange may receive a lower or higher exercise price, depending on the terms of the transaction, than those options that are tendered for exchange.

 

                Regardless of any such acquisition, the new option grant date will be the first business day that is at least six months and one day after the cancellation date.  Consequently, you may not be able to exercise your new options until after the effective date of the acquisition.  If you participate in the offer and the acquisition occurs after the expiration date but before the new option grant date, you will not be able to exercise your option to purchase Lattice common stock before the effective date of the acquisition.

 

                If you are located in a foreign jurisdiction, the terms and conditions of the new grant by the acquiror may be governed by local law, and therefore these terms may not apply to you.  In addition, you may not be able to receive the new option grant, depending on the local laws applicable to the acquiror.

 

                You should be aware that these types of transactions could significantly affect our stock price, including potentially substantially increasing the price of our shares.  Depending on the timing and structure of a transaction of this type, you might lose the benefit of any price appreciation in our common stock resulting from an acquisition.  The exercise price of new options granted to you after the announcement of an acquisition of Lattice would reflect any appreciation in our stock price resulting from the announcement, and could therefore exceed the exercise price of your current options.  This could result in option holders who do not participate in this offer receiving a greater financial benefit than option holders who do participate.  In addition, your new options may be exercisable for stock of the acquiror, not Lattice common stock, while option holders who decide not to participate in this offer could exercise their options before the effective date of the acquisition and sell their Lattice common stock before the effective date.

 

                Finally, if we are acquired, the acquiror may, as part of the transaction or otherwise, decide to terminate some or all of our employees before the new option grant date.  Termination of your employment for this or any other reason before the new option grant date means that you will not receive any new options, and will not receive any other compensation for your exchanged options.

 

                If a change in our capitalization, such as a stock split, combination, subdivision, stock dividend, reclassification or other similar event, occurs after the cancellation date but before the new option grant date, an appropriate adjustment will be made to the number of shares subject to each option, without any change in the aggregate purchase price.

 

                Events Occurring after the New Option Grant Date.  If a change in our capitalization, such as a stock split, combination, subdivision, stock dividend, reclassification or other similar event, occurs after the new option grant date, an appropriate adjustment will be made to the number of shares subject to each option, without any change in the aggregate purchase price.

 

                If we liquidate or dissolve, your outstanding options will terminate immediately before the consummation of the liquidation or dissolution.  The administrator may, however, provide for the acceleration of the exercisability of any option.

 

                The plan provides that if we merge or are consolidated with another corporation, or if our property or stock is acquired by another corporation, each option may be appropriately adjusted by the administrator.  However, in lieu of such adjustment, the administrator may, in its discretion, provide that the options accelerate and become fully exercisable for a period of thirty (30) days prior to the date of such event.

 

 

-32-



 

Transferability of Options.

 

                New options may not be transferred, other than by will or the laws of descent and distribution, as determined under local law, unless the administrator or its appointee indicates otherwise in a writing to the optionee.  In the event of your death, any person who acquires the right to exercise the option by bequest or inheritance may exercise issued options.

Registration of Shares Underlying Options.

 

                All of the shares of Lattice common stock issuable upon exercise of new options are registered under the Securities Act of 1933, as amended (the Securities Act) on registration statements on Form S-8 filed with the SEC.  Unless you are one of our affiliates, you will be able to sell the shares issuable upon exercise of your new options free of any transfer restrictions under applicable U.S. securities laws.

U.S. Federal Income Tax Consequences.

 

                You should refer to Section 14 of this offer for a discussion of the U.S. federal income tax consequences of the new options and the exchanged options, as well as the consequences of accepting or rejecting this offer.  If you are a resident of the United States, but are also subject to the tax laws of another non-U.S. jurisdiction, you should be aware that there might be other tax and social insurance contribution consequences that may apply to you.  Please refer to Schedules D through Q for more information.  We strongly recommend that you consult with your own advisors to discuss the consequences to you of this transaction.

Tax Consequences In Other Countries.

 

                You should refer to Schedules D through Q of this offer to exchange for a discussion of the tax consequences in your country of the new options and the options tendered for exchange, as well as the consequences of accepting or rejecting this offer.  If you are a resident of more than one country, you should be aware that there might be other tax and social insurance contribution consequences that may apply to you.  We strongly recommend that you consult with your own advisors to discuss the consequences to you of this transaction.

10.          Information concerning Lattice.

 

                Our principal executive offices are located at 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, and our telephone number is (503) 268-8000.  Questions regarding this option exchange should be directed to Bob Adam, Manager — Payroll and Benefits, at telephone number (503) 268-8675, or to Terry Dols, Vice President — Human Resources, at telephone number (503) 268-8120.

 

                Lattice Semiconductor Corporation designs, develops and markets high performance programmable logic devices, or PLDs, and related software. Programmable logic devices are widely-used semiconductor components that can be configured by the end customer as specific logic circuits, and enable the end customer to shorten design cycle times and reduce development costs.  Our end customers are primarily original equipment manufacturers in the communications, computing, industrial, military and consumer end markets.

 

                The financial information included in our annual report on Form 10-K for the fiscal year ended December 31, 2001 and our quarterly report on Form 10-Q for the quarter ended September 30, 2002 is incorporated herein by reference.  Please see Section 18 of this offer to exchange entitled, “Additional

 

 

-33-



 

 

Information,” for instructions on how you can obtain copies of our SEC filings, including filings that contain our financial statements.

 

                We had a book value per share of $7.05 at September 30, 2002.

 

                The following table sets forth our ratio of earnings to fixed charges for the periods specified:

 

 

 

Fiscal Year Ended

 

Nine Months Ended

 

 

 

December 31,
2000

 

December 31,
2001

 

September 30,
2002

 

Ratio of earnings to fixed charges

 

17.7x

 

N/A

 

N/A

 

 

                The ratio of earnings to fixed charges is computed by dividing earnings by fixed charges.  For the purposes of computing the ratio of earnings to fixed charges, earnings consist of income before provision for income taxes plus fixed charges.  Fixed charges consist of interest expense, amortization of debt discount and issuance costs on all indebtedness, and the estimated portion of rental expense deemed by Lattice to be representative of the interest factor of rental payments under operating leases.  Earnings from continuing operations were not sufficient to cover fixed charges by $174 million for the year ended December 31, 2001, and by $77 million for the nine months ended September 30, 2002.

11.                               Interests of directors and executive officers; transactions and arrangements concerning the options.

 

                A list of our directors and executive officers is attached to this offer to exchange as Schedule A.  Non-employee directors may not participate in this offer.  As of February 11, 2003, our executive officers and directors (15 persons) as a group beneficially owned options outstanding under the 1996 Stock Incentive Plan to purchase a total of 5,430,000 of our shares, which represented approximately 42.0% of the shares subject to all options outstanding under the 1996 Stock Incentive Plan as of that date.  As of the same date, our executive officers and directors as a group beneficially owned options outstanding under our 2001 Stock Plan to purchase a total of 3,448,956 of our shares, which represented approximately 43.6% of the shares subject to all options outstanding under the 2001 Stock Plan.  Executive officers and directors as a group beneficially owned options outstanding under all of the above-referenced plans to purchase a total of 8,878,956 of our shares, which represented approximately 42.6% of the shares subject to all options outstanding under these plans as of that date.  Of the options owned by executive officers, 5,367,706 are eligible to be tendered in the offer.

 

                The following table below sets forth the beneficial ownership of each of our executive officers and directors of options under the eligible plans outstanding as of February 11, 2003.  The percentages in the table below are based on the total number of outstanding options (i.e., whether or not eligible for exchange) to purchase shares of our common stock under the eligible plans and eligible agreements, which was 20,833,314 as of February 11, 2003.  Executive officers are eligible to participate in the offer.  As noted on the table, non-employee directors are not eligible to participate in the offer.

 

 

-34-



 

 

Name

 

Position

 

Number of Shares Covered by Outstanding Options Granted Under the Eligible Plans

 

Percentage of Total Outstanding
Options Under the Eligible Plans

 

 

 

 

 

 

 

 

 

Cyrus Y. Tsui

 

Chief Executive Officer and Chairman of the Board

 

3,918,375

 

18.8

%

Steven A. Laub

 

President and Director

 

1,448,084

 

7.0

%

Stephen A. Skaggs

 

Senior Vice President, Chief Financial Officer and Secretary

 

1,014,900

 

4.9

%

Frank J. Barone

 

Corporate Vice President, Product Operations

 

492,432

 

2.4

%

Stephen M. Donovan

 

Corporate Vice President, Sales

 

535,712

 

2.6

%

Jonathan K. Yu

 

Corporate Vice President, Business Development

 

433,780

 

2.1

%

Martin R. Baker

 

Vice President and General Counsel

 

426,543

 

2.0

%

Jan Johannessen

 

Vice President, Investments

 

190,000

 

*

 

Rodney F. Sloss

 

Vice President, Finance

 

350,519

 

1.7

%

Kenneth K. Yu

 

Vice President and Managing Director, Lattice Asia

 

353,995

 

1.7

%

Mark O. Hatfield**

 

Director

 

0

 

0

%

Daniel S. Hauer**

 

Director

 

0

 

0

%

Soo Boon Koh**

 

Director

 

0

 

0

%

Harry A. Merlo**

 

Director

 

0

 

0

%

Larry W. Sonsini**

 

Director

 

0

 

0

%


*                 Less than 1%

**        Not eligible to participate in the offer.

 

                Except as described below, neither we, nor, to the best of our knowledge, any of our directors or executive officers, nor any affiliates of ours, engaged in transactions involving options to purchase our common stock under the plans, or in transactions involving our common stock, during the 60 days before and including February 13, 2003:

                  On December 18, 2002, Harry A. Merlo gifted 3,000 shares of our common stock to his children, and 3,000 shares of our common stock to educational trusts for three of his grandchildren.

                  We granted options under our 2001 Stock Plan to purchase an aggregate of 27,900 shares of our common stock with an exercise price of $7.57.

                  Individuals exercised options under our 1996 Stock Incentive Plan and our 2001 Stock Plan to acquire an aggregate of 10,671 shares of our common stock with exercise prices ranging from $5.92 to $7.875.

                  We cancelled options under our 1996 Stock Incentive Plan and our 2001 Stock Plan to purchase an aggregate of 93,569 shares of our common stock.

12.                               Status of options acquired by us in the offer; accounting consequences of the offer.

 

                Options that we acquire through the offer will be cancelled and the shares subject to those options will be returned to the pool of shares available for grants of new awards under the plan pursuant to which they were granted.  To the extent shares returning to the plans are not fully reserved for issuance upon exercise of the new options to be granted in connection with the offer, the shares will be available for future awards to employees and other eligible plan participants, respectively, without further stockholder action, except as required by applicable law or the rules of the Nasdaq National Market or any other securities quotation system or any stock exchange on which our shares are then quoted or listed.

 

                If we were to grant the new options under a traditional stock option repricing, in which an employee’s current options would be immediately repriced, or on any date that is earlier than six months and one day after the date on which we cancel the options accepted for exchange, we would be required for financial reporting purposes to treat the new options as variable awards.  This means that we would be required to record the non-cash accounting impact of increases in our stock price as a compensation expense for the new options

 

 

-35-



 

 

issued under this offer.  We would have to continue this variable accounting for these new options until they were exercised, forfeited or terminated.  The higher the market value of our shares, the greater the compensation expense we would have to record.  By deferring the grant of the new options for at least six months and one day, we believe that we will not have to treat the new options as variable awards and will avoid these accounting charges.  As a result, we believe that we will not incur any compensation expense solely as a result of the transactions contemplated by the offer.

13.          Legal matters; regulatory approvals.

 

                We are not aware of any license or regulatory permit that appears to be material to our business that might be adversely affected by our exchange of options and issuance of new options as contemplated by the offer, or of any approval or other action by any government or governmental, administrative or regulatory authority or agency or any Nasdaq listing requirements that would be required for the acquisition or ownership of our options as contemplated herein.  Should any additional approval or other action be required, we presently contemplate that we will seek such approval or take such other action.  We cannot assure you that any such approval or other action, if needed, could be obtained or what the conditions imposed in connection with such approvals would entail or whether the failure to obtain any such approval or other action would result in adverse consequences to our business.  Our obligation under the offer to accept tendered options for exchange and to issue new options for tendered options is subject to the conditions described in Section 7 of this offer to exchange.

 

                If we are prohibited by applicable laws or regulations from granting new options on the new option grant date, we will not grant any new options.  We are unaware of any such prohibition at this time, and we will use reasonable efforts to effect the grant, but if the grant is prohibited on the new option grant date we will not grant any new options and you will not receive any other compensation for the options you tendered.

14.          Material U.S. federal income tax consequences.

 

                The following is a general summary of the material U.S. federal income tax consequences of the exchange of options pursuant to the offer.  This discussion is based on the Internal Revenue Code, its legislative history, treasury regulations thereunder and administrative and judicial interpretations as of the date of this offering circular, all of which are subject to change, possibly on a retroactive basis.  This summary does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances, nor is it intended to be applicable in all respects to all categories of option holders.  If you are a resident of the United States, but are also subject to the tax laws of another country, you should be aware that there might be other tax and social security consequences that may apply to you.

 

                Option holders who exchange outstanding options for new options should not be required to recognize income for U.S. federal income tax purposes at the time of the exchange.  We believe that the exchange will be treated as a non-taxable exchange.

 

                If you are a tax resident or citizen of a foreign jurisdiction, you should refer to Schedules D through Q for a discussion of some of the tax and legal consequences that may apply to you.

 

                We strongly recommend that you consult your own tax advisor with respect to the federal, state and local tax consequences of participating in the offer, as the tax consequences to you are dependent on your individual tax situation.

 

 

-36-



 

Nonstatutory Stock Options.

 

                All exchanged options will be replaced with options that are nonstatutory stock options for purposes of the Internal Revenue Code, regardless of whether the exchanged options are incentive stock options or nonstatutory stock options.

 

                Under current law, an option holder will not realize taxable income upon the grant of a nonstatutory stock option.  However, when an option holder exercises the option, the difference between the exercise price of the option and the fair market value of the shares subject to the option on the date of exercise will be compensation income taxable to the option holder.

 

                We will be entitled to an income tax deduction equal to the amount of compensation income taxable to the option holder if we comply with eligible reporting requirements.

15.          Terms of the offer specific to participants residing in foreign jurisdictions.

 

                If you are a tax resident or citizen of a foreign jurisdiction or are otherwise subject to a tax liability of a foreign jurisdiction, your tax consequences with respect to the exchange will vary from those tax consequences described above for United States citizens or permanent residents.  Employees in foreign jurisdictions should refer to Schedules D through Q for a discussion of the tax and legal consequences of electing to participate in the offer.

 

                We recommend that you consult your own tax advisor to determine the tax and social insurance contribution consequences of this offer, as the tax consequences to you are dependent on your individual tax situation.

 

                In addition, if you are a resident of more than one country, you should be aware that there might be other tax and social insurance contribution consequences that may apply to you in more than one jurisdiction.  We strongly recommend that you consult with your own advisors to discuss the consequences to you of this transaction.

16.          Extension of offer; termination; amendment.

 

                We reserve the right, in our discretion, at any time and regardless of whether or not any event listed in Section 7 of this offer to exchange has occurred or is deemed by us to have occurred, to extend the period of time during which the offer is open and delay the acceptance for exchange of any options.  If we elect to extend the period of time during which this offer is open, we will give you oral or written notice of the extension and delay, as described below.  If we extend the expiration date, we will also extend your right to withdraw tenders of eligible options until such extended expiration date.  In the case of an extension, we will issue a press release or other public announcement no later than 6:00 a.m., Pacific Time, on the next business day after the previously scheduled expiration date.

 

                We also reserve the right, in our reasonable judgment, before the expiration date to terminate or amend the offer and to postpone our acceptance and cancellation of any options elected to be exchanged if any of the events listed in Section 7 of this offer to exchange occurs, by giving oral or written notice of the termination or postponement to you or by making a public announcement of the termination.  Our reservation of the right to delay our acceptance and cancellation of options elected to be exchanged is limited by Rule 13e-4(f)(5) under the Exchange Act, which requires that we must pay the consideration offered or return the options promptly after termination or withdrawal of a tender offer.

 

 

-37-



 

 

                Subject to compliance with applicable law, we further reserve the right, before the expiration date, in our discretion, and regardless of whether any event listed in Section 7 of this offer to exchange has occurred or is deemed by us to have occurred, to amend the offer in any respect, including by decreasing or increasing the consideration offered in this offer to option holders or by decreasing or increasing the number of options being sought in this offer.

 

                The minimum period during which the offer will remain open following material changes in the terms of the offer or in the information concerning the offer, other than a change in the consideration being offered by us or a change in amount of existing options sought, will depend on the facts and circumstances of such change, including the relative materiality of the terms or information changes.  If we modify the number of eligible options being sought in this offer or the consideration being offered by us for the eligible options in this offer, the offer will remain open for at least 10 business days from the date of notice of such modification.  If any term of the offer is amended in a manner that we determine constitutes a material change adversely affecting any holder of eligible options, we will promptly disclose the amendments in a manner reasonably calculated to inform holders of eligible options of such amendment, and we will extend the offer’s period so that at least five business days, or such longer period as may be required by the tender offer rules, remain after such change.

 

                For purposes of the offer, a “business day” means any day other than a Saturday, Sunday or a U.S. federal holiday and consists of the time period from 12:01 a.m. through 12:00 midnight, Eastern Time.

17.          Fees and expenses.

 

                We will not pay any fees or commissions to any broker, dealer or other person for soliciting options to be exchanged through this offer.

18.          Additional information.

 

                This offer to exchange is part of a Tender Offer Statement on Schedule TO that we have filed with the SEC.  This offer to exchange does not contain all of the information contained in the Schedule TO and the exhibits to the Schedule TO.  We recommend that you review the Schedule TO, including its exhibits, and the following materials that we have filed with the SEC before making a decision on whether to elect to exchange your options:

 

1.                                      The description of our common stock contained in our registration statement on Form 8-A, filed on September 27, 1989, including any amendments or reports filed for the purpose of updating such description;

 

2.                                      Our annual report on Form 10-K for the year ended December 31, 2001, filed on March 26, 2002;

 

3.                                      Our proxy statement for our 2002 Annual Meeting of Stockholders, filed on April 4, 2002;

 

4.                                      Our current report on Form 8-K, filed on February 4, 2002, as amended on April 2, 2002 and December 19, 2002;

 

5.                                      Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2002, filed on May 10, 2002;

 

 

-38-



 

 

6.                                      Our Quarterly Report on Form 10-Q for the quarter ended June 30, 2002, filed on August 12, 2002; and

 

7.                                      Our Quarterly Report on Form 10-Q for the quarter ended September 30, 2002, filed on November 12, 2002.

 

                These filings, our other annual, quarterly and current reports, our proxy statements and our other SEC filings may be examined, and copies may be obtained, at the SEC’s public reference room at 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549.  You may obtain information on the operation of the public reference room by calling the SEC at 1-800-SEC-0330.  Our SEC filings are also available to the public on the SEC’s Internet site at http://www.sec.gov.

 

                Each person to whom a copy of this offer to exchange is delivered may obtain a copy of any or all of the documents to which we have referred you, other than exhibits to such documents, unless such exhibits are specifically incorporated by reference into such documents, at no cost to you, by writing to us at Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, Attention: the Stock Option Administrator, or by telephoning the Stock Option Administrator at (503) 268-8382.

 

                As you read the documents listed above, you may find some inconsistencies in information from one document to another.  If you find inconsistencies between the documents, or between a document and this offer to exchange, you should rely on the statements made in the most recent document.

 

                The information contained in this offer about us should be read together with the information contained in the documents to which we have referred you, in making your decision as to whether or not to participate in this offer.

19.          Financial statements.

 

                Attached as Schedule B and Schedule C to this offer are our financial statements that are included in our annual report on Form 10-K for our fiscal year ended December 31, 2001, and our quarterly report on Form 10-Q for our fiscal quarter ended September 30, 2002.  More complete financial information may be obtained by accessing our public filings with the SEC by following the instructions in Section 18 of this offer to exchange.

20.          Miscellaneous.

 

                We are not aware of any jurisdiction where the making of the offer is not in compliance with applicable law.  If we become aware of any jurisdiction where the making of the offer is not in compliance with any valid applicable law, we will make a good faith effort to comply with such law.  If, after such good faith effort, we cannot comply with such law, the offer will not be made to, nor will options be accepted from the option holders residing in such jurisdiction.

 

                We have not authorized any person to make any recommendation on our behalf as to whether you should elect to exchange your options through the offer.  You should rely only on the information in this document or documents to which we have referred you.  We have not authorized anyone to give you any information or to make any representations in connection with the offer other than the information and representations contained in this offer to exchange and in the related option exchange program documents.  If anyone makes any recommendation or representation to you or gives you any information, you must not rely upon that recommendation, representation or information as having been authorized by us.

 

 

Lattice Semiconductor Corporation

February 13, 2003

 

 

-39-



SCHEDULE A

INFORMATION CONCERNING THE EXECUTIVE OFFICERS
AND DIRECTORS OF LATTICE SEMICONDUCTOR CORPORATION

 

                The executive officers and directors of Lattice Semiconductor Corporation are set forth in the following table:

 

Name

 

Position and Offices Held

 

 

 

 

 

Cyrus Y. Tsui

 

Chief Executive Officer and Chairman of the Board

 

Steven A. Laub

 

President and Director

 

Stephen A. Skaggs

 

Senior Vice President, Chief Financial Officer and Secretary

 

Frank J. Barone

 

Corporate Vice President, Product Operations

 

Stephen M. Donovan

 

Corporate Vice President, Sales

 

Jonathan K. Yu

 

Corporate Vice President, Business Development

 

Martin R. Baker

 

Vice President and General Counsel

 

Jan Johannessen

 

Vice President, Investments

 

Rodney F. Sloss

 

Vice President, Finance

 

Kenneth K. Yu

 

Vice President and Managing Director, Lattice Asia

 

Mark O. Hatfield

 

Director

 

Daniel S. Hauer

 

Director

 

Soo Boon Koh

 

Director

 

Harry A. Merlo

 

Director

 

Larry W. Sonsini

 

Director

 

 

                The address of each executive officer and director is: c/o Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421.

 

 

A-1



 

 

SCHEDULE B

FINANCIAL STATEMENTS
OF LATTICE SEMICONDUCTOR CORPORATION
INCLUDED IN ITS QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2002

 

LATTICE SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(In thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

Sept. 30,

2002

 

Sept. 30,

2001

 

Sept. 30,

2002

 

Sept. 30,

2001

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

56,072

 

$

58,038

 

$

171,416

 

$

243,218

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of products sold

 

22,429

 

21,995

 

68,527

 

91,676

 

Research and development

 

21,523

 

17,946

 

63,986

 

54,261

 

Selling, general and administrative

 

11,712

 

11,297

 

35,790

 

42,064

 

In-process research and development

 

5,653

 

 

29,853

 

 

Amortization of intangible assets (1)

 

18,070

 

21,127

 

54,616

 

63,024

 

Total costs and expenses

 

79,387

 

72,365

 

252,772

 

251,025

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(23,315

)

(14,327

)

(81,356

)

(7,807

)

 

 

 

 

 

 

 

 

 

 

Loss on depreciation of foundry investments

 

 

(152,795

)

 

(152,795

)

Other income, net

 

2,764

 

403

 

3,941

 

4,737

 

 

 

 

 

 

 

 

 

 

 

Loss before benefit for income taxes

 

(20,551

)

(166,719

)

(77,415

)

(155,865

)

 

 

 

 

 

 

 

 

 

 

Benefit for income taxes

 

(6,180

)

(62,118

)

(29,280

)

(58,863

)

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(14,371

)

$

(104,601

)

$

(48,135

)

$

(97,002

)

 

 

 

 

 

 

 

 

 

 

Basic net loss per share

 

$

(0.13

)

$

(0.96

)

$

(0.44

)

$

(0.89

)

 

 

 

 

 

 

 

 

 

 

Diluted net loss per share

 

$

(0.13

)

$

(0.96

)

$

(0.44

)

$

(0.89

)

 

 

 

 

 

 

 

 

 

 

Shares used in per share calculations:

 

 

 

 

 

 

 

 

 

Basic

 

110,232

 

109,155

 

109,855

 

108,635

 

Diluted

 

110,232

 

109,155

 

109,855

 

108,635

 

 

(1) Includes $760 and $168 of amortization of deferred stock compensation expense for the three months ended September 30, 2002 and September 30, 2001, respectively, and $1,887 and $336 for the nine months ended September 30, 2002 and September 30, 2001, respectively, attributable to Research and Development activities.

 

See Accompanying Notes to Condensed Consolidated Financial Statements

 

 

B-1



 

 

LATTICE SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEET

(In thousands, except share and par value data)

(unaudited)

 

 

 

September 30,

 

December 31,

 

 

 

2002

 

2001

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

154,641

 

$

250,203

 

Short-term investments

 

135,574

 

281,363

 

Accounts receivable, net

 

27,699

 

19,452

 

Inventories

 

60,864

 

64,926

 

Other current assets

 

14,512

 

28,747

 

Deferred income taxes

 

27,941

 

31,591

 

Total current assets

 

421,231

 

676,282

 

 

 

 

 

 

 

Property and equipment, net

 

63,877

 

63,222

 

Foundry investments, advances and other assets

 

112,132

 

162,418

 

Intangible assets, net

 

173,427

 

125,081

 

Goodwill

 

222,931

 

81,387

 

Deferred income taxes

 

91,957

 

65,590

 

 

 

$

1,085,555

 

$

1,173,980

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

38,160

 

$

38,255

 

Deferred income on sales to distributors

 

14,402

 

18,103

 

Income taxes payable

 

 

2,751

 

Total current liabilities

 

52,562

 

59,109

 

 

 

 

 

 

 

4 3/4% Convertible notes due in 2006

 

226,501

 

260,000

 

Other long-term liabilities

 

15,271

 

15,101

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value,10,000,000 shares authorized; none issued or outstanding

 

 

 

Common stock, $.01 par value, 300,000,000 shares authorized, 112,308,169 and 109,428,061 shares issued and outstanding

 

1,123

 

1,094

 

Paid-in capital

 

580,811

 

548,053

 

Deferred stock compensation

 

(12,797

)

(2,739

)

Accumulated other comprehensive (loss) income

 

(211

)

22,932

 

Retained earnings

 

222,295

 

270,430

 

Total stockholders’ equity

 

791,221

 

839,770

 

 

 

$

1,085,555

 

$

1,173,980

 

 

See Accompanying Notes to Condensed Consolidated Financial Statements.

 

 

B-2



 

 

LATTICE SEMICONDUCTOR CORPORATION

 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(In thousands)

(unaudited)

 

 

 

 

Nine Months Ended September 30,

 

 

 

2002

 

2001

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

 

$

(48,135

)

$

(97,002

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

70,205

 

79,918

 

Gain on sale of equity securities

 

(4,017

)

 

Gain on extinguishment of convertible notes

 

(5,710

)

 

In-process research and development

 

29,853

 

 

Loss on foundry investments

 

 

152,795

 

Tax benefit of option exercises

 

797

 

12,220

 

 

 

 

 

 

 

Changes in assets and liabilities (net of effect of business combinations):

 

 

 

 

 

Accounts receivable

 

(8,247

)

30,437

 

Inventories

 

7,534

 

(5,555

)

Foundry investments, advances and other assets

 

27,337

 

(19,325

)

Deferred income taxes

 

1,369

 

(54,296

)

Accounts payable and accrued expenses

 

3,006

 

(44,949

)

Deferred income

 

(3,701

)

(34,842

)

Income taxes payable

 

(22,513

)

(8,136

)

Other liabilities

 

(1,406

)

2,323

 

Total adjustments

 

94,507

 

110,590

 

Net cash provided by operating activities

 

46,372

 

13,588

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Proceeds from short-term investments

 

249,048

 

229,210

 

Purchase of short-term investments

 

(103,259

)

(229,121

)

Acquisition of Agere FPGA

 

(254,232

)

 

Acquisition of Cerdelinx

 

(2,530

)

 

Other intangible assets acquired

 

 

(5,475

)

Proceeds from sale of equity securities

 

9,930

 

 

Capital expenditures

 

(15,314

)

(12,130

)

Net cash used by investing activities

 

(116,357

)

(17,516

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Repurchases of common stock, net

 

 

(10,614

)

Extinguishment of convertible debt, net

 

(27,441

)

 

Net proceeds from issuance of common stock

 

1,864

 

19,343

 

Net cash (used in) provided by financing activities

 

(25,577

)

8,729

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

(95,562

)

4,801

 

Beginning cash and cash equivalents

 

250,203

 

235,900

 

Ending cash and cash equivalents

 

$

154,641

 

$

240,701

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

Cash (received) paid for income taxes, net

 

$

(35,083

)

$

13,588

 

Cash paid for interest

 

$

6,527

 

$

6,175

 

Supplemental disclosures of non-cash investing and financing activities:

 

 

 

 

 

Unrealized loss on appreciation of foundry investments included in other comprehensive income

 

$

(23,776

)

 

Stock issued in Cerdelinx acquisition

 

$

21,643

 

 

 

See Accompanying Notes to Condensed Consolidated Financial Statements.

 

 

B-3



 

 

LATTICE SEMICONDUCTOR CORPORATION

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1 - Basis of Presentation:

The accompanying consolidated financial statements are unaudited and have been prepared by Lattice Semiconductor Corporation (“the Company”) pursuant to the rules and regulations of the Securities and Exchange Commission and in our opinion include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2001.

On August 26, 2002, we completed the stock for stock acquisition of Cerdelinx Technologies, Inc. (“Cerdelinx”) for 2.6 million shares valued at $8.30 per share. This transaction was accounted for as an asset purchase, and accordingly, the results of operations for Cerdelinx and estimated fair value of assets acquired and liabilities assumed were included in our condensed consolidated financial statements beginning August 26, 2002. This acquisition is discussed further in Note 4.

On January 18, 2002, we completed the acquisition of the field-programmable gate array (“FPGA”) business (“Agere FPGA”) of Agere Systems Inc. (“Agere”) for $250 million in cash. This transaction was accounted for as a purchase, and accordingly, the results of operations for Agere FPGA and estimated fair value of assets acquired and liabilities assumed were included in our condensed consolidated financial statements beginning January 18, 2002. This acquisition is discussed further in Note 5.

The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the fiscal periods presented. Actual results could differ from these estimates.

We report based on a 52 or 53 week year ending on the Saturday closest to December 31. For ease of presentation, we have adopted the convention of using March 31, June 30, September 30 and December 31 as period end dates for all financial statement captions.

This Quarterly Report on Form 10-Q contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Actual results could differ materially from those projected in the forward-looking statements as a result of the factors, set forth in the section entitled “Factors Affecting Future Results” and elsewhere in this report.

Note 2 - Revenue Recognition:

Revenue from direct customers is recognized upon shipment provided that persuasive evidence of a sales arrangement exists, the price is fixed, title has transferred, collection of resulting receivables is reasonably assured, there are no customer acceptance requirements and no remaining significant obligations.  Certain of our sales are made to distributors under agreements providing price protection and right of return on unsold merchandise.  Revenue and cost relating to such distributor sales are deferred until the product is sold by the distributor and related revenue and costs are then reflected in income.  Revenue from software sales is not material.

 

B-4



 

Note 3 — Net Income Per Share:

Net income per share is computed based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of stock options, warrants to purchase common stock and convertible subordinated notes.

The most significant difference between the computation of basic and diluted net income per share is that basic net income per share does not treat potentially dilutive securities such as stock options, warrants and convertible subordinated notes as outstanding. For all periods presented, the computation of net loss per share excludes the effect of our stock options, warrants and convertible notes as they were antidilutive. A reconciliation of basic and diluted net income per share is presented below (in thousands, except for per share data):

 

 

 

Three months ended

 

Nine months ended

 

 

 

Sept. 30,

 

Sept. 30,

 

Sept. 30,

 

Sept. 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(14,371

)

$

(104,601

)

$

(48,135

)

$

(97,002

)

Shares used in basic net loss per share calculations

 

110,232

 

109,155

 

109,855

 

108,635

 

 

 

 

 

 

 

 

 

 

 

Dilutive effect of stock options and  warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in diluted net loss per share

 

110,232

 

109,155

 

109,855

 

108,635

 

Basic net loss per share

 

$

(0.13

)

$

(0.96

)

$

(0.44

)

$

(0.89

)

Diluted net loss per share

 

$

(0.13

)

$

(0.96

)

$

(0.44

)

$

(0.89

)

 

Note 4 — Acquisition of Cerdelinx:

 

                On August 26, 2002, we completed the stock for stock acquisition of Cerdelinx for 2.6 million shares valued at $8.30 per share. Cerdelinx was an early stage fabless semiconductor company focused on the design of application specific standard products targeted towards emerging high-speed communications and storage applications. Cerdelinx had a team of engineers who were developing a portfolio of low-power CMOS transceivers and backplane interfaces with embedded high-speed SERDES I/O to support 10 gigabit-per-second applications. The acquisition will serve to enhance our silicon development efforts and our ability to deliver leading-edge programmable solutions within the ten-gigabyte, networking and storage market segments. This acquisition principally comprises intellectual property and a work force.  The core technology portion of the intellectual property is valued using a royalty savings methodology which discounts estimated royalties that would be paid on an after tax basis. The in-process technology portion of the intellectual property is valued using a discounted cash flow methodology described in detail below.  Work force is valued using a replacement cost methodology which discounts costs to an after tax amount.  The transaction was completed pursuant to an Agreement and Plan of Reorganization entered into on July 15, 2002, as amended on July 24, 2002, among Lattice, Cerdelinx and affiliated parties.  The components of the purchase price were as follows (in millions):

 

 

Stock issued and liabilities assumed

$

22.8

 

 

Estimated direct acquisition costs

1.1

 

 

Total

$

23.9

 

 

B-5



 

In conformity with Financial Accounting Standard (SFAS) No. 142, “Goodwill and Other Intangible Assets,” the total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed.  As Cerdelinx was not considered a business under SFAS 141, “Business Combinations,” no goodwill was recognized.  In estimating the fair value of the assets acquired, management considered various factors, including an appraisal.  The purchase price allocation is subject to further refinement and change over the four quarters subsequent to the acquisition. We are in the process of completing our integration of Cerdelinx and accordingly, the amounts recorded are based on our current estimates of these costs. The total purchase price was allocated as follows (in millions):

 

 

Core technology

$

7.2

 

 

Deferred stock compensation

5.8

 

 

In process research and development costs

5.7

 

 

Work force

4.7

 

 

Liabilities assumed

(1.2

)

 

Equipment

1.1

 

 

Non-compete agreement

0.3

 

 

Cash

0.3

 

 

Total

$

23.9

 

There were no significant exit costs incurred or accrued in connection with this transaction. Management does not expect intangible assets acquired to be deductible for income tax purposes.

Employees who joined Lattice as a result of this acquisition held Cerdelinx shares and options which were converted into 0.9 million Lattice shares and options which were either unvested or otherwise restricted from sale over terms up to four years at a grant price from $0.41 per share to $2.54 per share. The spread which is the difference between grant price and market value of our common stock on the Closing Date, aggregating $5.8 million on these shares and options, was recorded as paid-in capital and deferred stock compensation and is being amortized to operations equally over the vesting (or restriction lapsing) period as part of Amortization of Intangible Assets.

In-Process Research and Development (“IPR&D”)

IPR&D consists of those products obtained through acquisition that are not yet proven to be technologically feasible but have been developed to a point where there is value associated with them in relation to potential future revenue. Because technological feasibility was not yet proven and no alternative future uses are believed to exist for the in-process technologies, the assigned value was expensed immediately after the closing of the acquisition.

The fair value underlying the $5.7 million assigned to acquired IPR&D was determined by identifying research projects in areas for which technological feasibility had not been established and there were no alternative future uses. The acquired IPR&D consists of low-power CMOS transceivers and backplane interfaces with embedded high-speed SERDES I/O. These products are approximately 60% complete and are estimated to be completed in 2003 at an estimated cost of approximately $2 million.

The fair value was determined by an income approach where fair value is the present value of projected free cash flows that will be generated by the products incorporating the acquired technologies under development, assuming they are successfully completed. The estimated net free cash flows generated by the products over six year periods were discounted at rates ranging from 15 to 17 percent in relation to the stage of completion and the technical risks associated with achieving technological feasibility. The net cash flows for such projects were based on management’s estimates of revenue, expenses and asset requirements.

 

B-6



 

All of these projects have completion risks related to silicon functionality, architecture performance, process technology availability, packaging technology, continued availability of key technical personnel and product reliability. To the extent that estimated completion dates are not met, the risk of competitive product introduction is greater and revenue opportunity may be permanently lost.

The core technology included in the acquisition of Cerdelinx has an estimated weighted average useful life of approximately six years, and the work force and non-compete agreements included in the Cerdelinx acquisition have estimated useful lives of approximately four years resulting in a weighted average useful life of approximately five years.

Note 5 — Acquisition of Agere FPGA:

On January 18, 2002, we completed the acquisition of Agere FPGA for $250 million in cash. This acquisition increased our share of the PLD market, accelerated our entry into the FPGA portion of the market and provided us with additional technical employees and intellectual property. This acquisition principally comprises intellectual property, which was valued using a discounted cash flow methodology of which goodwill was a by-product. The transaction was completed pursuant to an Asset Purchase Agreement dated as of December 7, 2001 between Lattice and Agere.  The components of  the purchase price were as follows (in millions):

 

 

Cash

$

250.0

 

 

Estimated direct acquisition costs

6.3

 

 

Total

$

256.3

 

In accordance with Financial Accounting Standard (SFAS) No. 141, “Business Combinations,” the total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed. In estimating the fair value of the assets acquired, management considered various factors, including an appraisal. The purchase price allocation is subject to further refinement and change over the next two quarters. We are in the process of completing our integration of Agere FPGA, and accordingly, the amounts recorded are based on our current estimates of these costs. The total purchase price was allocated as follows (in millions):

 

 

Excess of purchase price over net assets acquired

$

142.0

 

 

Current technology

63.3

 

 

In process research and development

24.2

 

 

Fair value of non-compete agreement

13.8

 

 

Licensed technology

10.2

 

 

Inventory

2.6

 

 

Backlog

1.6

 

 

Property, plant and equipment

0.2

 

 

Accrued liabilities

(1.6

)

 

Total

$

256.3

 

There were no significant exit costs incurred or accrued in connection with this transaction. Management expects the costs of this acquisition, including goodwill, to be deductible for income tax purposes.

Employees joining us from Agere during the first quarter of 2002 were awarded approximately 1.1 million stock options which vest equally over four years at a grant price of $14.76 per share. The difference between grant price and market value of our common stock on the grant date, aggregating approximately $7.0 million, was recorded as paid-in capital and deferred stock compensation and is being amortized to operations ratably over the vesting period as part of Amortization of Intangible Assets.

 

B-7



 

In-Process Research and Development (“IPR&D”)

IPR&D consists of those products obtained through acquisition that are not yet proven to be technologically feasible but have been developed to a point where there is value associated with them in relation to potential future revenue. Because technological feasibility was not yet proven and no alternative future uses are believed to exist for the in-process technologies, the assigned value was expensed immediately upon the closing date of the acquisition.

The value of $24.2 million assigned to acquired IPR&D was determined by identifying research projects in areas for which technological feasibility had not been established and there was no alternative future use. Projects in the IPR&D category are the ORCA 4 FPGA family, the next generation ORCA 5 FPGA family and the FPSC field-programmable system chips. The following is a brief description of these projects. The ORCA 4 FPGA family project, increasing speed and density and enhancing yields, was approximately 85% complete and estimated to be completed by 2003 at an estimated cost of $1.5 million. This project is currently expected to be completed during the fourth quarter of 2002 with no material change in cost. The next generation ORCA 5 FPGA family project, increasing speed and density while reducing die size, was approximately 50% complete and estimated to be completed by 2004 at an estimated cost of $2 million. There has been no material change in the schedule or estimated cost of this project. The future development of FPSC field-programmable system chips (field-programmable system chips which combine embedded pre-defined logic circuits with the ORCA 4 and ORCA 5 FPGA platforms) was approximately 25% to 90% complete, and  estimated to be completed by 2004 at an estimated cost of $2 million. There has been no material change in the schedule or estimated cost of this project. The IPR&D value of $24.2 million was determined by an income approach where fair value is the present value of projected free cash flows that will be generated by the products incorporating the acquired technologies under development, assuming they are successfully completed. The estimated net free cash flows generated by the products over 5-7 year periods were discounted at rates ranging from 23 to 25 percent in relation to the stage of completion and the technical risks associated with achieving technological feasibility. The net cash flows for such projects were based on management’s estimates of revenue, expenses and asset requirements. Any delays or failures in the completion of these projects could impact our expected return on investment and future results. In addition, our financial condition would be adversely affected if the value of other intangible assets acquired became impaired.

All of these projects have completion risks related to silicon functionality, architecture performance, process technology availability, packaging technology, continued availability of key technical personnel, product reliability and availability of software support. To the extent that estimated completion dates are not met, the risk of competitors’ product introductions is greater and revenue opportunity may be permanently lost.

The non-compete agreement from Agere and the current and licensed technology included in the acquisition of Agere FPGA have an estimated weighted average useful life of approximately 6.3 years.  In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” the excess of purchase price over net assets acquired, or Goodwill, will be subject to an impairment test at least annually and will not be amortized (see Note 8).

Pro forma results

The following pro forma results of operations information are provided for illustrative purposes only and do not purport to be indicative of the consolidated results of operations for future periods or that actually would have been realized had Lattice and Agere FPGA been a consolidated entity during the periods presented. The pro forma results combine the results of operations as if Agere FPGA had been acquired as of the beginning of the periods presented. The results include the impact of certain adjustments such as intangible asset amortization, estimated changes in interest income (expense) related to cash outlays associated with the transaction and income tax benefits related to the aforementioned adjustments. Additionally, the in-process research and development charge of $24.2 million discussed above has been excluded from the periods presented due to its non-recurring nature.

 

B-8



 

(in thousands, except per share amounts)

(unaudited)

 

 

 

 

Nine months ended

 

 

 

 

Sept. 30,
2002

 

Sept. 30,
2001

 

 

 

 

 

 

 

 

 

Revenue

 

$

176,808

 

$

300,218

 

 

Net loss

 

$

(32,607

)

$

(107,665

)

 

Basic net loss per share

 

$

(.30

)

$

(.99

)

 

Diluted net loss per share

 

$

(.30

)

$

(.99

)

 

Note 6Inventories (in thousands):

 

 

 

 

Sept. 30,
2002

 

Dec. 31,
2001

 

 

 

 

 

 

 

 

 

Work in progress

 

$

41,926

 

$

44,460

 

 

Finished goods

 

18,938

 

20,466

 

 

 

 

 

$

60,864

 

$

64,926

 

 

Note 7 — Changes in Stockholders’ Equity (in thousands):

 

 

 

Common Stock

 

Paid-in Capital

 

Deferred Stock Comp.

 

Accumulated Other Comprehensive  Income

 

Retained Earnings

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, December 31, 2001

 

$1,094

 

$548,053

 

$(2,739

)

$22,932

 

$270,430

 

$839,770

 

Common stock issued

 

29

 

20,016

 

 

 

 

20,045

 

Tax benefit of option exercises

 

 

797

 

 

 

 

797

 

Unrealized loss on foundry investments (Note 10)

 

 

 

 

(20,378

)

 

(20,378

)

Reclassify gain on sale of foundry investments previously unrealized (Note 10)

 

 

 

 

(3,398

)

 

(3,398

)

Deferred stock compensation

 

 

11,945

 

(11,945

)

 

 

 

Amortization of deferred stock compensation

 

 

 

1,887

 

 

 

1,887

 

Translation adjustment

 

 

 

 

633

 

 

633

 

Net loss for the nine-month period

 

 

 

 

 

 

(48,135

)

(48,135

Balances, September 30, 2002

 

$1,123

 

$580,811

 

$(12,797

)

$(211

)

$222,295

 

$791,221

 

Total comprehensive loss for the first nine-month period of 2002 was approximately $71.3 million and comprises $48.1 million net loss from operations, $23.8 million in unrealized loss and reclassifications related to foundry investments, offset by $0.6 million of translation adjustments.

Note 8New Accounting Pronouncements:

 

In June 2001, the FASB issued SFAS 142, which supersedes APB Opinion No. 17, “Intangible Assets.” SFAS 142, among other things, establishes new standards for intangible assets acquired in a business combination, eliminates amortization of goodwill and sets forth requirements to periodically evaluate goodwill for impairment. We adopted this statement during the first quarter of 2002 and thus goodwill and certain intangibles with indefinite lives are no longer being amortized. Accordingly, approximately $8 million of previous quarterly amortization is no longer being recorded. To apply SFAS 142, a company is divided into separate “reporting units,” each representing groups of products that are separately managed.  For this purpose, we have one reporting unit.  To determine whether or not goodwill may be impaired, a test is required

 

 

B-9



 

 

comparing the book value of the “reporting unit” to its trading price. Similar tests are required in the future, at least annually, and more often where there is a change in circumstances that could result in an impairment of goodwill.  If the trading price of our common stock is below the book value for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value (trading price plus a control premium).  The excess of book value over estimated market value will then be subtracted from the goodwill account with a resulting charge to operations. Subsequent unrealized recoveries in market value, if any, will not be recorded. We have completed an initial goodwill impairment assessment as of January 1, 2002 to determine if a transition impairment charge should be recognized under SFAS 142. Upon assessment, no transition impairment charge was recorded.

The following table presents the impact of SFAS 142 on our net income and our net income per share had the new standard been in effect for the nine months ended September 30, 2002 and 2001, the years ended December 31, 2001 and 2000, respectively, and the nine months ended December 31, 1999:

(in thousands, except per share amounts)

(unaudited)

 

 

 

Nine months ended

 

Year ended

 

Nine months ended

 

 

 

Sept. 30,
2002

 

Sept. 30,
2001

 

Dec. 31,
2001

 

Dec. 31,
2000

 

Dec. 31,
1999

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income — as reported

 

$

(48,135

)

$

(97,002

)

$

(109,519

)

$

167,887

 

$

(48,146

)

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Amortization of goodwill

 

 

23,965

 

32,949

 

30,997

 

18,222

 

Income tax effect

 

 

(9,050

)

(12,206

)

(11,140

)

(6,848

)

Net adjustments

 

 

14,915

 

20,743

 

19,857

 

11,374

 

Net (loss) income — as adjusted

 

$

(48,135

)

$

(82,087

)

$

(88,776

)

$

187,744

 

$

(36,772

)

Basic net (loss) income per share — as reported

 

$

(.44

)

$

(.89

)

$

(1.01

)

$

1.65

 

$

(.50

)

Basic net (loss) income per share — adjusted

 

$

(.44

)

$

(.76

)

$

(.82

)

$

1.85

 

$

(.39

)

Diluted net (loss) income per share — as reported

 

$

(.44

)

$

(.89

)

$

(1.01

)

$

1.47

 

$

(.50

)

Diluted net (loss) income per share — adjusted

 

$

(.44

)

$

(.76

)

$

(.82

)

$

1.64

 

$

(.39

)

 

The following tables present details of the Company’s total purchased intangible assets (in millions):

 

Sept. 30, 2002

 

Gross

 

Accumulated amortization

 

Net

 

 

 

 

 

 

 

 

 

Current technology

 

$

273.6

 

$

(147.0

)

$

126.6

 

Core technology

 

7.2

 

(0.1

)

7.1

 

Licenses

 

10.2

 

(1.0

)

9.2

 

Non-compete agreements

 

14.1

 

(3.2

)

10.9

 

Workforce

 

4.7

 

(0.1

)

4.6

 

Customer list

 

17.4

 

(11.5

)

5.9

 

Patents and trademarks

 

26.8

 

(17.7

)

9.1

 

Total

 

$

354.0

 

$

(180.6

)

$

173.4

 

 

 

B-10



 

 

December 31, 2001

 

Gross

 

Accumulated amortization

 

Net

 

 

 

 

 

 

 

 

 

Current technology

 

$

210.2

 

$

(106.8

)

$

103.4

 

Customer list

 

17.4

 

(8.9

)

8.5

 

Patents and trademarks

 

26.8

 

(13.6

)

13.2

 

Total

 

$

254.4

 

$

(129.3

)

$

125.1

 

 

The estimated future amortization expense of purchased intangible assets as of September 30, 2002 is as follows (in millions):

 

 

Fiscal Year:

 

Amount

 

 

 

 

 

 

 

2002 (remaining three months)

 

$

17.7

 

 

2003

 

71.3

 

 

2004

 

43.7

 

 

2005

 

14.3

 

 

2006

 

10.8

 

 

2007

 

9.8

 

 

Later years

 

5.8

 

 

 

 

$

173.4

 

 

The estimated future amortization expense of deferred stock compensation attributable to Research and Development activities as of September 30, 2002 is approximately $1.1 million for the remaining three months of 2002, $4.2 million annually for 2003 and 2004, and $3.1 million for 2005.

In October 2001, the FASB issued SFAS 144, “Accounting for the Disposal of Long-Lived Assets,” which supersedes SFAS 121, “Accounting for the Impairment Of Long-Lived Assets and for Long-Lived Assets to be Disposed of.” SFAS 144 retains the fundamental provisions of SFAS 121 regarding the recognition and measurement of the impairment of long-lived assets to be held and used and the measurement of long-lived assets to be disposed of by sale, but provides additional definition and measurement criteria for determining when an impairment has occurred. Goodwill and financial instruments are excluded from the scope of SFAS 144, however amortizable intangible assets fall within its scope. The adoption of this statement in the first quarter of 2002 did not have a material impact on our results of operations, financial position or cash flows.

In May 2002, the FASB issued SFAS 145, “Rescission of FAS Nos. 4, 44, and 64, Amendment of FAS 13, and Technical Corrections.” Among other things, SFAS 145 rescinds various pronouncements regarding early extinguishment of debt and allows extraordinary accounting treatment for early extinguishment only when the provisions of Accounting Principles Board Opinion No. 30, “Reporting the Results of Operations — Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions” are met. SFAS 145 provisions regarding early extinguishment of debt are generally effective for fiscal years beginning after May 15, 2002. Management adopted this pronouncement during the second quarter of 2002.

During the second and third quarter of 2002, we extinguished approximately $9.2 million and $24.3 million, respectively, face value of our 4¾% convertible notes for approximately $8.0 million and $19.8 million in cash, respectively, including accrued interest. We recognized gains of approximately $1.2 million and $4.5 million,

 

B-11



 

respectively, in connection with these transactions. As specified in SFAS 145, these gains were recorded in “Other income, net” in the accompanying Condensed Consolidated Statement of Operations.

In July 2002, the FASB issued SFAS 146, “Accounting for Costs Associated with Exit or Disposal Activities.” SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred. SFAS 146 eliminates the definition and requirement for recognition of exit costs in Emerging Issues Task Force (EITF) Issue No. 94-3 where a liability for an exit cost was recognized at the date of an entity’s commitment to an exit plan. This statement is effective for exit or disposal activities initiated after December 31, 2002. We do not believe that the adoption of this statement will have a material impact on our results of operations, financial position or cash flows.

Note 9 — Legal Matters:

We are not currently a party to any material legal proceedings.

Note 10 — Unrealized Loss on Foundry Investments:

In 1995, we entered into a series of agreements with United Microelectronics Corporation (“UMC”), a public Taiwanese company, pursuant to which we agreed to join UMC and several other companies to form a separate Taiwanese corporation, (“UICC”), for the purpose of building and operating an advanced semiconductor manufacturing facility in Taiwan, Republic of China.  Under the terms of the agreements, we invested approximately $49.7 million for an approximate 10% equity interest in the corporation and the right to receive a percentage of the facility’s wafer production at market prices.

In 1996, we entered into an agreement with Utek Corporation (“Utek”), a public Taiwanese company in the wafer foundry business that became affiliated with the UMC group in 1998, pursuant to which we agreed to make a series of equity investments in Utek under specific terms. In exchange for these investments, we received the right to purchase a percentage of Utek’s wafer production. Under this agreement, we invested approximately $17.5 million. On January 3, 2000, UICC and Utek merged into UMC.

We own 88,151,430 shares of UMC at September 30, 2002 of which 23,259,813 are restricted from sale for more than one year by the terms of our agreement with UMC.  Under the terms of the UMC agreement, if we sell any of these shares, our rights to guaranteed wafer capacity at UMC may be reduced on a pro-rata basis based on the number of shares that we sell.  If we sell over 10,057,351 of these shares, we may lose all of our rights to guaranteed wafer capacity at UMC.  The restricted shares are carried at cost on our Consolidated Balance Sheet until they are sold, or become Available for Sale, or the value suffers an other than temporary impairment.  Available for Sale shares are marked to market in our Consolidated Balance Sheet until they are sold at which time a gain or loss is recognized in our Consolidated Statement of Operations.  Unrealized gains and losses from Available for Sale shares are included in Accumulated Other Comprehensive Income (Loss) within Stockholders’ Equity.  An other than temporary impairment of UMC share value could result in a reduction of the Balance Sheet carrying value and would result in a charge to our Consolidated Statement of Operations.

In the September 2001 quarter, the carrying value of the UMC shares was reduced as we recorded a $152.8 million loss representing a decline in the market value of our UMC shares.  In each quarter that the market value of the UMC investment is below carrying value, we evaluate whether the investment is other than temporarily impaired.  We recorded the unrealized loss on our UMC investment in the September 30, 2001 Statement of Operations.  At that time, we believed the investment was other than temporarily impaired for the following reasons:

1)              It was becoming increasingly likely that the stock price would not recover based on the increasing size of the unrealized loss, the extended time period during which the stock price had continued to

 

B-12



 


decline without a trend reversal, and the dampening volatility, which indicated to us that the stock price was becoming more stable;

2)              UMC’s financial performance had weakened relative to earlier quarters;

3)              The opinion of many industry observers and analysts regarding the semiconductor downturn had become significantly more negative;

4)              The events of September 11 further exacerbated market conditions;

5)              We had previously believed that UMC would initiate an ADR conversion program that would enable us to sell our shares at a premium on the New York Stock Exchange, but such a program was never initiated; and

6)              Although we still had the intent and ability to hold the shares for an indefinite period, we concluded this fact did not overcome the negative factors associated with the shares.

 

The carrying value of our investment in UMC was approximately $103.1 million at December 31, 2001. During the first nine months of 2002, we recorded a $31.4 million unrealized loss ($20.4 million net of tax and reflected in Accumulated Other Comprehensive Income) related to changes in the market value of our unrestricted UMC shares. In connection with the sale of certain unrestricted UMC shares discussed below, approximately $3.4 million of previously unrealized gain (net of tax) on these shares was realized. During the second quarter of 2002, we sold approximately 7.6 million of our unrestricted UMC shares for approximately $9.9 million cash. The resultant $4.0 million pre-tax gain associated with these sales was recorded in “Other income, net” in the accompanying Condensed Consolidated Statement of Operations and represents the difference between market value on the date of sale and the carrying value at September 30, 2001. The resultant carrying value of our UMC shares was approximately $61.0 million at September 30, 2002 and this balance is classified as part of Foundry investments, advances and other assets.

If we liquidate our UMC shares, it is likely that the amount of any future realized gain or loss will be different from the accounting gain or loss reported in prior periods.

Note 11 — Segment and Geographic Information:

We operate in one industry segment comprising the design, development, manufacture and marketing of high performance programmable logic devices. Our sales by major geographic area were as follows (in thousands):

 

 

 

Three months ended

 

Nine months ended

 

 

 

Sept. 30,
2002

 

Sept. 30,
2001

 

Sept. 30,
2002

 

Sept. 30,
2001

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

21,906

 

$

26,103

 

$

70,617

 

$

114,469

 

Export Sales:

 

 

 

 

 

 

 

 

 

Europe

 

14,825

 

16,416

 

45,272

 

64,076

 

Asia

 

17,133

 

12,840

 

47,247

 

51,430

 

Other

 

2,208

 

2,679

 

8,280

 

13,243

 

 

 

34,166

 

31,935

 

100,799

 

128,749

 

 

 

$

56,072

 

$

58,038

 

$

171,416

 

$

243,218

 

Resale of product through two distributors accounted for approximately 23% and 19% of revenue in the first nine months of 2002, and 30% and 20%, respectively, for the first nine months of 2001. More than 90% of our

 

B-13



 

property and equipment is located in the United States. Other long-lived assets located outside the United States consist primarily of foundry investments and advances (see Note 10).

Note 12 — Subsequent Events:

To date in the fourth quarter of 2002, we extinguished an additional $18.4 million of our convertible subordinated notes for approximately $15.0 million in cash, resulting in a gain of approximately $3.6 million.

 

 

 

 

 

B-14



SCHEDULE C

 

FINANCIAL STATEMENTS
OF LATTICE SEMICONDUCTOR CORPORATION
INCLUDED IN ITS ANNUAL REPORT ON FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2001

 

CONSOLIDATED BALANCE SHEET

(in thousands, except share and par value amounts)

 

 

 

December 31,
2001

 

December 31,
2000

 

 

 

(note 1)

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

250,203

 

$

235,900

 

Short-term investments

 

281,363

 

299,508

 

Accounts receivable, net

 

19,452

 

49,688

 

Inventories (note 2)

 

64,926

 

59,493

 

Prepaid expenses and other current assets

 

28,747

 

23,249

 

Deferred income taxes (note 7)

 

31,591

 

49,093

 

Total current assets

 

676,282

 

716,931

 

Foundry investments, advances and other assets (note 5)

 

162,418

 

189,407

 

Property and equipment, less accumulated depreciation (note 3)

 

63,222

 

68,554

 

Intangible assets, less accumulated amortization of $212,002 and $127,653 (note 4)

 

206,468

 

286,358

 

Deferred income taxes (note 7)

 

65,590

 

34,634

 

 

 

$

1,173,980

 

$

1,295,884

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

20,201

 

$

74,160

 

Accrued payroll obligations

 

18,054

 

22,876

 

Income taxes payable (note 7)

 

2,751

 

9,484

 

Deferred income

 

18,103

 

58,184

 

Total current liabilities

 

59,109

 

164,704

 

4¾% Convertible notes due in 2006 (note 8)

 

260,000

 

260,000

 

Other long-term liabilities

 

15,101

 

15,525

 

Commitments and contingencies (notes 5, 6, 10 and 11)

 

 

 

Stockholders’ equity (note 9):

 

 

 

 

 

Preferred stock, $.01 par value, 10,000,000 shares authorized; none issued and outstanding

 

 

 

Common stock, $.01 par value, 300,000,000 shares authorized; 109,428,061 and 107,533,379 shares issued and outstanding

 

1,094

 

1,075

 

Paid-in capital

 

548,053

 

522,492

 

Deferred stock compensation

 

(2,739

)

 

Other comprehensive income (loss)

 

22,932

 

(47,861

)

Retained earnings

 

270,430

 

379,949

 

 

 

839,770

 

855,655

 

 

 

$

1,173,980

 

$

1,295,884

 

 

The Accompanying Notes are an Integral Part of this Statement

 

 

C-1



 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS

(in thousands, except per share data)

 

 

 

Year Ended December 31,

 

Nine Months
Ended
December 31,

 

 

 

2001

 

2000

 

1999

 

Revenue (note 13)

 

$

295,326

 

$

567,759

 

$

269,699

 

Costs and expenses:

 

 

 

 

 

 

 

Cost of products sold

 

111,498

 

217,830

 

108,687

 

Research and development

 

71,679

 

77,057

 

45,903

 

Selling, general and administrative (note 12)

 

53,027

 

81,082

 

50,676

 

In-process research and development (note 4)

 

 

 

89,003

 

Amortization of intangible assets(1) (note 4)

 

84,349

 

81,873

 

45,780

 

 

 

320,553

 

457,842

 

340,049

 

(Loss) income from operations

 

(25,227

)

109,917

 

(70,350

)

Other (expense) income, net:

 

 

 

 

 

 

 

Interest income

 

17,733

 

16,202

 

6,057

 

Interest expense (note 8)

 

(13,962

)

(14,036

)

(9,732

)

(Loss) gain on foundry investments (note 5)

 

(152,795

)

149,960

 

 

Other income (expense), net

 

285

 

28

 

(445

)

 

 

(148,739)

 

152,154

 

(4,120

)

(Loss) income before (benefit) provision for income taxes

 

(173,966

)

262,071

 

(74,470

)

(Benefit) provision for income taxes (note 7)

 

(64,447

)

94,184

 

(27,989

)

(Loss) income before extraordinary item

 

(109,519

)

167,887

 

(46,481

)

Extraordinary item, net of income taxes (note 8)

 

 

 

(1,665

)

Net (loss) income

 

$

(109,519

)

$

167,887

 

$

(48,146

)

Basic (loss) income per share, before extraordinary item

 

$

(1.01

)

$

1.65

 

$

(0.49

)

Diluted (loss) income per share, before extraordinary item

 

$

(1.01

)

$

1.47

 

$

(0.49

)

Basic net (loss) income per share

 

$

(1.01

)

$

1.65

 

$

(0.50

)

Diluted net (loss) income per share

 

$

(1.01

)

$

1.47

 

$

(0.50

)

Shares used in per share calculations:

 

 

 

 

 

 

 

Basic

 

108,814

 

101,716

 

95,428

 

Diluted

 

108,814

 

120,321

 

95,428

 


(1)          Includes $397 of amortization of deferred stock compensation expense for the year ended December 31, 2001 attributable to Research and Development activities.

 

The Accompanying Notes are an Integral Part of this Statement

 

 

C-2



 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, except par value)

 

 

 

Common Stock

 

Paid-in Capital

 

Deferred
Stock
Compensation

 

Accumulated
Other
Comprehensive
Income (Loss)

 

Retained
Earnings

 

 

 

 

 

($0.01 Par Value)

 

 

Shares

 

Amount

Total

 

Balances, March 31, 1999

 

94,388

 

$

944

 

222,582

 

$

 

 

260,208

 

$

483,734

 

Common stock issued

 

2,183

 

22

 

14,187

 

 

 

 

14,209

 

Fair value of options issued to Vantis employees

 

 

 

23,982

 

 

 

 

23,982

 

Tax benefit of option exercises

 

 

 

8,937

 

 

 

 

8,937

 

Other

 

 

 

57

 

 

 

 

57

 

Net loss for fiscal period 1999

 

 

 

 

 

 

(48,146

)

 

Total comprehensive loss

 

 

 

 

 

 

 

(48,146

)

Balances, December 31, 1999

 

96,571

 

966

 

269,745

 

 

 

212,062

 

482,773

 

Common stock issued

 

11,502

 

114

 

237,266

 

 

 

 

237,380

 

Repurchase of common stock

 

(540

)

(5

)

(9,375

)

 

 

 

(9,380

)

Tax benefit of option exercises

 

 

 

24,856

 

 

 

 

24,856

 

Unrealized loss on foundry investments (net of tax of $30.0 million—note 5)

 

 

 

 

 

(47,861

)

 

 

Net income for 2000

 

 

 

 

 

 

167,887

 

 

Total comprehensive income

 

 

 

 

 

 

 

120,026

 

Balances, December  31, 2000

 

107,533

 

1,075

 

522,492

 

 

(47,861

)

379,949

 

855,655

 

Common stock issued

 

2,491

 

25

 

20,491

 

 

 

 

20,516

 

Repurchase of common stock

 

(596

)

(6

)

(10,608

)

 

 

 

(10,614

)

Tax benefit of option exercises

 

 

 

12,542

 

 

 

 

12,542

 

Impairment loss on foundry investments (note 5)

 

 

 

 

 

47,861

 

 

 

Unrealized gain on foundry investments (net of tax of $13.3 million—note 5)

 

 

 

 

 

24,106

 

 

 

Deferred stock compensation

 

 

 

3,136

 

(3,136

)

 

 

 

Amortization of deferred stock compensation

 

 

 

 

397

 

 

 

397

 

Translation adjustments

 

 

 

 

 

(1,174

)

 

 

Net loss for 2001

 

 

 

 

 

 

(109,519

)

 

Total comprehensive loss

 

 

 

 

 

 

 

(38,726

)

Balances, December  31, 2001

 

109,428

 

$

1,094

 

$

548,053

 

$

(2,739

)

$

22,932

 

$

270,430

 

$

839,770

 

 

 

The Accompanying Notes are an Integral Part of this Statement

 

 

C-3



 

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

(in thousands)

 

 

 

Year Ended
December 31,

 

Nine Months
Ended December 31,

 

 

 

2001

 

2000

 

1999

 

Cash flow from operating activities:

 

 

 

 

 

 

 

Net (loss) income

 

$

(109,519

)

$

167,887

 

$

(48,146

)

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

106,539

 

102,213

 

57,842

 

Loss (gain) on value of foundry investments

 

152,795

 

(149,960

)

 

In-process research and development costs

 

 

 

89,003

 

Tax benefit of option exercises

 

12,542

 

24,856

 

8,937

 

Extraordinary item, net of income taxes

 

 

 

(1,665

)

Changes in assets and liabilities (net of purchase accounting adjustments):

 

 

 

 

 

 

 

Accounts receivable

 

30,236

 

(16,012

)

(5,206

)

Inventories

 

(5,433

)

(33,457

)

(884

)

Prepaid expenses and other current assets

 

(7,327

)

(2,842

)

(387

)

Deferred income taxes

 

(55,369

)

15,092

 

(53,011

)

Foundry investments, advances and other assets

 

(11,478

)

(359

)

769

 

Accounts payable and accrued expenses

 

(53,959

)

(10,515

)

2,054

 

Accrued payroll obligations

 

(4,822

)

3,970

 

443

 

Income taxes payable

 

(6,733

)

(2,975

)

7,474

 

Deferred income

 

(40,081

)

12,996

 

25,195

 

Other liabilities

 

(424

)

3,371

 

7,443

 

Net cash provided by operating activities

 

6,967

 

114,265

 

89,861

 

Cash flow from investing activities:

 

 

 

 

 

 

 

Proceeds from (purchase of) short-term investments, net

 

18,145

 

(199,192

)

139,817

 

Acquisition of Vantis Corporation, net of cash acquired

 

 

 

(439,258

)

Other acquisition costs

 

(2,233

)

 

 

Intangible assets

 

(5,189

)

4,886

 

 

Foundry investments

 

 

 

(4,593

)

Capital expenditures

 

(13,751

)

(25,883

)

(15,675

)

Net cash used by investing activities

 

(3,028

)

(220,189

)

(319,709

)

Cash flow from financing activities:

 

 

 

 

 

 

 

Proceeds from bank borrowings and convertible notes

 

 

 

513,000

 

Payments on bank borrowings

 

 

 

(253,000

)

Debt issuance costs

 

 

 

(9,895

)

Repurchase of common stock

 

(10,614

)

(9,380

)

 

Net proceeds from issuance of common stock

 

20,978

 

237,380

 

14,266

 

Net cash provided by financing activities

 

10,364

 

228,000

 

264,371

 

Net increase in cash and cash equivalents

 

14,303

 

122,076

 

34,523

 

Beginning cash and cash equivalents

 

235,900

 

113,824

 

79,301

 

Ending cash and cash equivalents

 

$

250,203

 

$

235,900

 

$

113,824

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

 

Fair value of options issued to Vantis employees (note 4)

 

$

 

$

 

$

23,982

 

Unrealized gain (loss) on appreciation of foundry investments included in other comprehensive income (loss)

 

$

24,106

 

$

(47,861

)

$

 

 

 

C-4



 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1.  NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations.  Lattice Semiconductor Corporation designs, develops and markets high performance programmable logic devices, or PLDs, and related software.  Programmable logic devices are widely-used semiconductor components that can be configured by the end customer as specific logic circuits, and enable the end customer to shorten design cycle times and reduce development costs.  Our end customers are primarily original equipment manufacturers in the communications, computing, industrial, military and consumer end markets.

Fiscal Reporting Period.  We report based on a 52 or 53 week year ending on the Saturday closest to December 31.  For ease of presentation, we have adopted the convention of using March 31, June 30, September 30 and December 31 as period end dates for all financial statement captions.  In the fourth quarter of 1999, we changed our fiscal year end from March 31 to December 31.  The nine month fiscal period ended January 1, 2000 is referred to as “the nine months ended December 31, 1999” or “fiscal period 1999.”

Principles of Consolidation.  On June 15, 1999, we completed the acquisition of all of the outstanding capital stock of Vantis Corporation (“Vantis”) from Advanced Micro Devices, Inc. (“AMD”).  The transaction was accounted for as a purchase, and accordingly, the results of operations of Vantis and estimated fair value of assets acquired and liabilities assumed were included in our consolidated financial statements beginning June 16, 1999 (see note 4).  The accompanying consolidated financial statements include the accounts of Lattice Semiconductor Corporation and its subsidiaries, all wholly-owned, after the elimination of all significant intercompany balances and transactions.

Cash Equivalents and Short-Term Investments.  We consider all highly liquid investments, which are readily convertible into cash and have original maturities of three months or less, to be cash equivalents.  Short-term investments, which are relatively less liquid and have maturities of less than one year, were composed of corporate auction preferred stocks ($160.0 million), municipal and local government obligations ($102.1 million), and time deposits ($19.2 million) at December 31, 2001.

We account for our short-term investments as held-to-maturity, and state them at amortized cost with corresponding premiums or discounts amortized over the life of the investment as interest income.  Amortized cost approximated fair value at December 31, 2001.

Financial Instruments.  The carrying value of our financial instruments approximates fair value except the restricted portion of our foundry investment in Taiwan, which is carried at cost (see note 5).  We estimate the fair value of cash and cash equivalents, short-term investments, accounts receivable, other current assets and current liabilities based upon existing interest rates related to such assets and liabilities compared to the current market rates of interest for instruments of similar nature and degree of risk.

Derivative Financial Instruments.  As of December 31, 2001, 2000 and 1999 and for the fiscal periods then ended, we had no outstanding derivatives, including foreign exchange contracts for the purchase or sale of foreign currencies.  We do not enter into derivative financial instruments for trading purposes.

Foreign Exchange.  A portion of our silicon wafer purchases are denominated in Japanese yen.  We maintain yen-denominated bank accounts and bill our Japanese customers in yen.  The yen bank deposits utilized to hedge yen-denominated wafer purchases are accounted for as identifiable hedges against specific and firm wafer purchases.  Gains or losses from foreign exchange rate fluctuations on unhedged balances denominated in foreign currencies are reflected in Other Income.  Realized and unrealized gains or losses were not significant for the fiscal periods presented.

 

C-5



 

Concentrations of Credit Risk.  Financial instruments which potentially expose us to concentrations of credit risk consist primarily of short-term investments and trade receivables.  We place our investments through several financial institutions and mitigate the concentration of credit risk by placing percentage limits on the maximum portion of the investment portfolio which may be invested in any one investment instrument.  Investments consist primarily of A1 and P1 or better rated U.S. commercial paper, U.S. government agency obligations and other money market instruments, “AA” or better rated municipal obligations, money market preferred stocks and other time deposits.  Concentrations of credit risk with respect to trade receivables are mitigated by a geographically diverse customer base and our credit and collection process.  Accounts receivable are shown net of allowances for doubtful accounts of $1,475,000 and $1,700,000 at December 31, 2001 and 2000, respectively.  We perform credit evaluations for all customers and secure transactions with letters of credit or advance payments where necessary.  Write-offs for uncollected trade receivables have not been significant to date.

Revenue Recognition.  Revenue from direct customers is recognized upon shipment provided that persuasive evidence of a sales arrangement exists, the price is fixed, title has transferred, collection of resulting receivables is probable, there are no customer acceptance requirements and no remaining significant obligations.  Certain of our sales are made to distributors under agreements providing price protection and right of return on unsold merchandise.  Revenue and cost relating to such distributor sales are deferred until the product is sold by the distributor and related revenue and costs are then reflected in income.

Inventories and Inventory Valuation Allowances.  Inventories are stated at the lower of first-in, first-out cost or market on a quarterly basis.  In addition, we establish reserves for unproven, excess and obsolete inventories.

Long-Lived Assets.  We account for our long-lived assets, primarily Property and equipment and Intangible assets, in accordance with Statement of Financial Accounting Standards No. 121 (SFAS 121), “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of,” which requires us to review the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Impairment is measured by comparing the estimated undiscounted cash flows to the carrying amount.  A loss is recorded if the carrying amount of the asset exceeds the estimated undiscounted cash flows.

Property and Equipment.  Property and equipment are stated at cost.  Depreciation is computed using the straight-line method for financial reporting purposes over the estimated useful lives of the related assets, generally three to five years for equipment and software and thirty years for buildings.  Accelerated methods of computing depreciation are generally used for income tax purposes.

Intangible Assets.  Intangible assets consist of goodwill and other intangibles related to our acquisition of Vantis Corporation (see note 4) and the acquisition of Integrated Intellectual Property, Inc. (“I2P”) on March 16, 2001.  These assets are generally being amortized over five years, and fifteen years for income tax purposes, on a straight-line basis.  The undiscounted cash flows method is used to assess the carrying value of goodwill (see note 5 and New Accounting Pronouncements in this footnote).

Translation of Foreign Currencies.  We translate accounts denominated in foreign currencies in accordance with SFAS 52, “Foreign Currency Translation.”  Translation adjustments related to the consolidation of foreign subsidiary financial statements are reflected in other comprehensive income (loss) in Stockholders’ Equity.  Foreign currency transaction gains and losses, which were insignificant for the fiscal periods presented, are included in other income.

Research and Development.  Research and development costs are expensed as incurred.

Stock-Based Compensation.  We account for our employee and director stock options and employee stock purchase plan in accordance with provisions of Accounting Principles Board Opinion No. 25 (“APB 25”),

 

C-6



 

“Accounting for Stock Issued to Employees.”  Additional pro forma disclosures as required under SFAS 123, “Accounting for Stock-Based Compensation,” are presented in note 9.  Pursuant to FASB Interpretation No. 44, “Accounting for Certain Transactions Involving Stock Based Compensation — an interpretation of APB Opinion No. 25,” effective July 1, 2000, the “in-the-money” portion of stock options granted to employees in connection with acquisitions is accounted for as Deferred stock compensation in Stockholders’ Equity and amortized to operations over the vesting periods of the options.

Net Income Per Share.  Net income per share is computed based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method.  Potentially dilutive securities consist of stock options, warrants to purchase common stock and convertible subordinated notes.

The most significant difference between basic and diluted net income per share is that basic net income per share does not treat potentially dilutive securities such as convertible subordinated notes, options and warrants as outstanding.  Diluted loss per common share for 2001 and fiscal period 1999 is based only on the weighted average number of common shares outstanding during these periods, as the inclusion of options, warrants and convertible subordinated notes would have been antidilutive.  For 2000, diluted weighted-average shares outstanding include the effect of stock options, warrants and approximately 12.5 million shares issuable on the assumed conversion of our $260 million of convertible subordinated notes (see note 8).  For 2000, diluted net income per share is adjusted to exclude interest expense and debt issuance cost amortization (net of tax) of approximately $8.3 million and $1.2 million, respectively.  A reconciliation of the numerators and denominators of basic and diluted net income per share is presented below:

 

 

 

Year Ended
Dec. 31, 2001

 

Year Ended
Dec. 31, 2000

 

Nine Months
Ended
Dec. 31, 1999

 

 

 

(in thousands, except for per share data)

 

Basic and diluted net (loss) income

 

$

(109,519

)

$

167,887

 

$

(48,146

)

Shares used in basic net income per share calculations

 

108,814

 

101,716

 

95,428

 

Dilutive effect of stock options, warrants and convertible notes

 

 

18,605

 

 

Shares used in diluted net income per share calculations

 

108,814

 

120,321

 

95,428

 

Basic net (loss) income per share

 

$

(1.01

)

$

1.65

 

$

(0.50

)

Diluted net (loss) income per share

 

$

(1.01

)

$

1.47

 

$

(0.50

)

On August 31, 2000 our Board of Directors approved a two-for-one stock split of our common stock to be effected in the form of a stock dividend of one share of common stock for each share of our outstanding common stock.  This dividend was paid on October 11, 2000 to stockholders of record on September 20, 2000.  On August 11, 1999 our Board of Directors approved a two-for-one stock split of our common stock to be effected in the form of a stock dividend of one share of common stock for each share of our outstanding common stock.  All share and per share amounts presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively to reflect these two-for-one splits.

In July 2000, we completed a follow-on public stock offering, consisting of 8,000,000 shares of our common stock at a price of $27.44 per share.  Our net proceeds were approximately $210 million after deducting underwriting discounts and offering expenses.

Comprehensive Income (Loss).  Comprehensive income (loss) approximated net income (loss) for fiscal period 1999.  For 2000, comprehensive income consists primarily of net income of $167.9 million and an unrealized loss on depreciation of unrestricted foundry investments (net of tax) of approximately $47.9 million (see note 5).  For 2001, comprehensive income consists primarily of net loss of  $109.5 million offset by an unrealized gain recorded related to the market value appreciation of our unrestricted foundry investments (net of tax) of approximately $72.0 million (see note 5).

 

C-7



 

Statement of Cash Flows.  Income taxes paid approximated $7.3 million, $55.9 million and $10.1 million in 2001, 2000, and fiscal period 1999, respectively.  Interest paid aggregated approximately $12.4 million, $12.3 million and $6.9 million in 2001, 2000, and fiscal period 1999, respectively.

Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, such as accounts receivable, inventory and deferred income taxes and liabilities, such as accrued liabilities, income taxes and deferred income, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the fiscal periods presented. Actual results could differ from those estimates.

New Accounting Pronouncements.  In June 1998, the FASB issued SFAS 133, “Accounting for Derivative Instruments and Hedging Activities.”  SFAS 133 establishes new accounting treatment for derivatives and hedging activities and supersedes and amends a number of existing accounting standards.  We adopted this pronouncement in the first quarter of 2001; such adoption did not and has not had a material effect on the consolidated financial statements.

In June 2001, the FASB issued SFAS 142, “Goodwill and Other Intangible Assets,” which supersedes APB Opinion No. 17, “Intangible Assets.”  SFAS 142, among other things, establishes new standards for intangible assets acquired in a business combination, eliminates amortization of goodwill and sets forth requirements to periodically evaluate goodwill for impairment.  We will adopt this statement during the first quarter of 2002, at which time goodwill and certain intangibles with indefinite lives will no longer be amortized, eliminating approximately $8 million of existing quarterly amortization.  Amortization expense for the fourth quarter of 2001 and for the year ended December 31, 2001 was approximately $21.3 million and $84.3 million, respectively.  As of December 31, 2001, the consolidated balance sheet caption “Intangible Assets” included approximately $81.4 million of goodwill and $125.1 million of other intangible assets.  We will complete an initial goodwill impairment assessment in 2002 to determine if a transition impairment charge should be recognized under SFAS 142.  We do not anticipate a material impairment charge upon the completion of the initial impairment review.

In October 2001, the FASB issued SFAS 144, “Accounting for the Disposal of Long-Lived Assets,” which supersedes SFAS 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of.”  SFAS 144 retains the fundamental provisions of SFAS 121 regarding the recognition and measurement of the impairment of long-lived assets to be held and used and the measurement of long-lived assets to be disposed by sale, but provides additional definition and measurement criteria for determining when an impairment has occurred.  Goodwill and financial assets are excluded from the scope of SFAS 144, however, amortizable intangible assets fall within its scope.  We do not expect this pronouncement to materially affect our financial statements when we adopt it during the first quarter of 2002.

Financial Presentation.  Reclassifications of prior year balances included in our consolidated financial statements have been made to conform to the 2001 presentation.  Such reclassifications had no effect on the results of operations or on Stockholders’ Equity.

NOTE 2.  INVENTORIES

 

 

 

December 31,

 

 

 

2001

 

2000

 

 

 

(in thousands)

 

Work in progress

 

$

44,460

 

$

37,718

 

Finished goods

 

20,466

 

21,775

 

 

 

$

64,926

 

$

59,493

 

 

 

C-8



 

NOTE 3.  PROPERTY AND EQUIPMENT

 

 

 

December 31,

 

 

 

2001

 

2000

 

 

 

(in thousands)

 

Land

 

$

2,099

 

$

2,099

 

Buildings

 

24,703

 

24,703

 

Computer and test equipment

 

109,606

 

103,454

 

Office furniture and equipment

 

9,452

 

8,750

 

Leasehold and building improvements

 

13,513

 

12,823

 

 

 

159,373

 

151,829

 

Accumulated depreciation and amortization

 

(96,151

)

(83,275

)

 

 

$

63,222

 

$

68,554

 

Depreciation expense was approximately $19.1 million, $17.1 million and $10.4 million for 2001, 2000 and fiscal period 1999, respectively.

NOTE 4.  ACQUISITION OF VANTIS

On June 15, 1999, we paid approximately $500.1 million in cash to AMD for all of the outstanding capital stock of Vantis Corporation.  Additionally, we paid approximately $10.8 million in direct acquisition costs, accrued an additional $5.4 million of pre-acquisition contingencies, accrued $8.3 million in exit costs and assumed certain liabilities of $34.5 million related to the Vantis business.  This purchase was financed using a combination of cash reserves and a credit facility bearing interest at adjustable rates (see note 8).  In addition, we exchanged Lattice stock options for all of the options outstanding under the former Vantis employee stock plans with a calculated Black-Scholes value of approximately $24.0 million.  The total purchase price of Vantis was $583.1 million.  The purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed based on an independent appraisal and management estimates.  The total purchase price was allocated as follows:

 

 

 

(in millions)

 

Current technology

 

$

210.3

 

Excess of purchase price over net assets assumed

 

158.8

 

In-process research and development

 

89.0

 

Fair value of other tangible net assets

 

61.3

 

Assembled workforce, customer list, patents and trademarks

 

53.5

 

Fair value of property, plant and equipment

 

10.2

 

Total

 

$

583.1

 

Accrued exit costs recorded at June 15, 1999 in conjunction with the acquisition aggregated approximately $8.3 million.  We recorded $4.2 million in accrued costs related to Vantis office closures, primarily for the planned closure of the main Vantis facilities in Sunnyvale, California.  These closures were consummated in accordance with plans in June 2000.  We also recorded $2.5 million related to separation benefits for Vantis employees.  Payments of approximately $1.4 million were made to Vantis employees who terminated for merger related reasons and have been charged to this accrued liability.  If these employees had not terminated, substantially all of the related costs would have been charged to selling, general and administrative expenses.  We reversed the remaining portion of this accrued liability during the June 2000 quarter, with an offsetting credit to Intangible Assets (Goodwill).  Additionally, we recorded and incurred $1.6 million in other exit costs primarily relating to the termination of Vantis distributors and independent sales representative firms.  Approximately $1.2 million of such costs had been charged to this accrued liability as of December 31, 2000.  These accruals are based upon our current estimates and are in accordance with Emerging Issues Task Force (“EITF”) No. 95-3, “Recognition of Liabilities in Connection with a Purchase Business Combination.”  There are no significant remaining exit cost liabilities at December 31, 2001.

 

C-9



 

In-Process Research and Development (“IPR&D”).  The value assigned to IPR&D was determined by identifying individual research projects for which technological feasibility had not been established.  These included semiconductor projects with a value after application of the SEC’s IPR&D valuation methodology of $77.2 million and a process technology project with a value of $11.8 million.  The value of each project was determined by estimating the expected cash flows from the projects once commercially viable, applying a factor based on the stage of completion of each project so as to include only those cash flows that relate to development efforts prior to the acquisition date, and discounting the resulting net cash flows back to their present value.  The percentage of completion for each project was determined using proportionate cost incurred and technical milestones achieved to date.  The percentage of completion varied by individual project ranging from 50% to 69% for semiconductors on June 15, 1999.  The process technology project was estimated to be 90% complete on June 15, 1999.  Since June 15, 1999, there have been no significant changes in the assumptions underlying these valuations.

The semiconductor projects were related to new PLD products (requiring new architectures and process technologies) and had the attendant risks associated with development of advanced semiconductor circuit designs such as achievement of speed, power, density, reliability and cost goals.  All of the semiconductor projects had remaining risks related to achievement of these design goals and effective software integration.  In addition, certain projects had basic circuit design and layout activities, which had not been completed as of June 15, 1999.  These semiconductor projects were released to market beginning in the first half of 2000 and continuing through 2001.  Estimated costs to complete all in-process semiconductor projects at June 15, 1999 totaled $19.0 million and ranged from $0.2 million to $16.5 million.

The process technology project was related to the development of a new advanced manufacturing process to reduce transistor size, improve speed and lower power consumption.  Through June 15, 1999, transistor design, lithography and metalization process development, process integration and certain transistor size reduction plans had been achieved.  Development of packaging integration technology, achievement of manufacturability yield objectives, satisfaction of reliability standards and qualification testing had not been accomplished at June 15, 1999.  The process was qualified for initial production in the first quarter of 2000 with approximately $450,000 of costs incurred after June 15, 1999 out of a total of $4 million of estimated costs.  This process technology is expected to remain in production through 2004.

The estimated costs to develop the in-process research and development into commercially viable products at June 15, 1999 were approximately $19.4 million in aggregate—$4.7 million in 1999 subsequent to our acquisition, $10.0 million in 2000, and $4.7 million in 2001.

Useful Lives of Intangible Assets.  The estimated weighted average useful life of the intangible assets for current technology, assembled workforce, customer lists, trademarks, patents and residual goodwill, created as a result of the acquisition, is approximately five years (see note 1—New Accounting Pronouncements).

Pro forma Results.  The following pro forma results of operations information is provided for illustrative purposes only and do not purport to be indicative of the consolidated results of operations for future periods or that actually would have been realized had Lattice and Vantis been a consolidated entity during the periods presented.  These pro forma results do not include the effect of non-recurring purchase accounting adjustments.  The pro forma results combine the results of operations as if Vantis had been acquired as of the beginning of the periods presented.  The results include the impact of certain adjustments such as goodwill amortization, estimated changes in interest income (expense) related to cash outlays and borrowings associated with the transaction (see note 8) and income tax benefits related to the aforementioned adjustments.  Additionally, the in-process research and development charge of $89.0 million discussed above has been excluded from the periods presented due to its non-recurring nature:

 

C-10



 

 

 

Pro forma Results
(Unaudited)
Nine Months Ended
December 31,1999

 

 

 

(in thousands, except

per-share amounts)

 

Revenue

 

$

314,394

 

 

Income before extraordinary item

 

$

2,017

 

 

Net income

 

$

352

 

 

Basic net income per share

 

$

0.00

 

 

Diluted net income per share

 

$

0.00

 

 

NOTE 5.  FOUNDRY INVESTMENTS, ADVANCES AND OTHER ASSETS

 

 

 

December 31,

 

 

 

2001

 

2000

 

 

 

(in thousands)

 

Foundry investments and other assets

 

$

124,870

 

$

153,665

 

Wafer supply advances

 

37,548

 

35,742

 

 

 

$

162,418

 

$

189,407

 

In 1995, we entered into a series of agreements with United Microelectronics Corporation (“UMC”), a public Taiwanese company, pursuant to which we agreed to join UMC and several other companies to form a separate Taiwanese corporation, (“UICC”), for the purpose of building and operating an advanced semiconductor manufacturing facility in Taiwan, Republic of China.  Under the terms of the agreements, we invested approximately $49.7 million for an approximate 10% equity interest in the corporation and the right to receive a percentage of the facility’s wafer production at market prices.

In 1996, we entered into an agreement with Utek Corporation (“Utek”), a public Taiwanese company in the wafer foundry business that became affiliated with the UMC group in 1998, pursuant to which we agreed to make a series of equity investments in Utek under specific terms.  In exchange for these investments, we received the right to purchase a percentage of Utek’s wafer production.  Under this agreement, we invested approximately $17.5 million.

On January 3, 2000, UICC and Utek merged into UMC.  As a result, during the first quarter of 2000, we recognized a $150.0 million gain ($92.1 million after-tax) in income representing the equity market appreciation of our foundry investment in UICC and Utek.  During 2000, we subsequently recorded unrealized gains and losses related to this investment due to changes in the market value of our unrestricted UMC shares, to equity as Accumulated Other Comprehensive Loss.  These unrealized losses in 2000 totaled $77.9 million ($47.9 million net of tax).

During the quarter ended September 30, 2001, we recorded a $152.8 million charge to our Consolidated Statement of Operations ($94.9 million net of tax) representing what we believe to be an other than temporary decline in the market value of this investment since the recording of the $150.0 million gain in the first quarter of 2000.  The charge includes the $77.9 million in unrealized losses ($47.9 million after tax) previously reflected in Accumulated Other Comprehensive Loss.  During the quarter ended December 31, 2001, we recorded a $37.4 million unrealized gain ($24.1 million net of tax), representing the appreciation of the unrestricted UMC shares during the quarter, as Accumulated Other Comprehensive Income.

We currently own approximately 84 million shares of UMC common stock.  Restrictions by UMC and the Taiwan government apply to approximately 28% of these shares.  If we liquidate our UMC shares, it is likely that the amount of any future realized gain or loss will be different from the accounting gain or loss reported in prior periods.

 

C-11



 

In March 1997, and as subsequently amended in January 2002, we entered into an advance payment production agreement with Seiko Epson and Epson Electronics America, Inc. (“EEA”) under which we agreed to advance approximately $69 million, payable upon completion of specific milestones, to Seiko Epson to finance construction of an eight-inch sub-micron semiconductor wafer manufacturing facility.  Under the terms of the agreement, the advance is to be repaid with semiconductor wafers over a multi-year period.  No interest income is recorded.  The agreement calls for wafers to be supplied by Seiko Epson through EEA pursuant to purchase agreements with EEA.  Payments of approximately $51.2 million have been made under this agreement.  Approximately $3.4 million of these advances are expected to be repaid with semiconductor wafers during fiscal year 2002 and are thus reflected as part of “Prepaid expenses and other current assets” in our accompanying Consolidated Balance Sheet.

NOTE 6.  LEASE OBLIGATIONS

Certain of our facilities and equipment are leased under operating leases, which expire at various times through 2008.  Rental expense under the operating leases was approximately $5,078,000, $5,469,000 and $2,822,000 for 2001, 2000 and fiscal period 1999, respectively.  Future minimum lease commitments at December 31, 2001 are as follows:

 

Fiscal year

 

(in thousands)

 

2002

 

$

7,418

 

2003

 

6,903

 

2004

 

6,509

 

2005

 

5,903

 

2006

 

4,628

 

Later years

 

8,111

 

 

 

$

39,472

 

Included in these amounts are certain properties which are currently subleased.  A portion of this sublease income is payable to the property owner.  Future minimum sublease receipts based on agreements in place at December 31, 2001, net of such payments are as follows:

 

Fiscal year

 

(in thousands)

 

2002

 

$

2,623

 

2003

 

2,473

 

2004

 

2,555

 

2005

 

2,622

 

2006

 

886

 

 

 

$

11,159

 

 

 

C-12



 

NOTE 7.  INCOME TAXES

The components of the (benefit) provision for income taxes for 2001, 2000, and fiscal period 1999 are presented in the following table:

 

 

 

Year Ended
December 31,
2001

 

Year Ended
December 31,
2000

 

Nine Months
Ended
December 31,
1999

 

 

 

(in thousands)

 

Current:

 

 

 

 

 

 

 

Federal

 

$

(7,018

)

$

68,791

 

$

24,721

 

State

 

(2,087

)

8,414

 

1,706

 

 

 

(9,105

)

77,205

 

26,427

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(47,482

)

14,925

 

(50,967

)

State

 

(7,860

)

2,054

 

(3,449

)

 

 

(55,342

)

16,979

 

(54,416

)

 

 

$

(64,447

)

$

94,184

 

$

(27,989

)

Foreign income taxes were not significant for the fiscal periods presented.

The (benefit) provision for income taxes differs from the amount of income tax determined by applying the applicable U.S. statutory federal income tax rate to pretax income as a result of the following differences:

 

 

 

Year Ended
December 31,
2001

 

Year Ended
December 31,
2000

 

Nine Months
Ended
December 31,
1999

 

 

 

(in thousands)

 

Computed income tax (benefit) expense at the statutory rate

 

$

(60,886

)

$

91,725

 

$

(26,064

)

Adjustments for tax effects of:

 

 

 

 

 

 

 

State taxes, net

 

(6,466

)

6,805

 

(1,133

)

Research and development credits

 

(1,175

)

(808

)

(400

)

Nontaxable investment items

 

4,177

 

(3,976

)

(1,113

)

Other

 

(97

)

438

 

721

 

 

 

$

(64,447

)

$

94,184

 

$

(27,989

)

The components of our net deferred tax assets are as follow:

 

 

 

December 31,

 

 

 

2001

 

2000

 

 

 

(in thousands)

 

Current deferred tax assets:

 

 

 

 

 

Deferred income

 

$

5,929

 

$

22,110

 

Expenses and allowances not currently deductible

 

25,662

 

26,983

 

 

 

$

31,591

 

$

49,093

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2001

 

2000

 

 

 

(in thousands)

 

Non-current deferred tax assets:

 

 

 

 

 

Intangible asset charges not currently deductible

 

$

70,011

 

$

56,708

 

Expenses and allowances not currently deductible

 

5,576

 

3,920

 

Other

 

3,333

 

1,910

 

Total deferred tax assets

 

78,920

 

62,538

 

Non-current deferred tax liabilities:

 

 

 

 

 

Tax effect on net unrealized gain on market value of foundry investments

 

(13,330

)

(27,904

)

Net non-current deferred tax assets

 

$

65,590

 

$

34,634

 

 

 

C-13



 

In conjunction with the $150.0 million pre-tax gain on our foundry investments as discussed in note 5, we recorded a deferred tax liability of approximately $57.9 million.  This deferred tax liability has been adjusted for subsequent recorded gains and losses related to these investments.  The remaining deferred tax liability related to our foundry investments, aggregating approximately $13.3 million, is netted against non-current deferred tax assets as summarized above.

Prior to fiscal period 1999, we recorded valuation allowances to reduce deferred tax assets which could only be realized by earning taxable income in distant future years.  We established the valuation allowances because we could not determine if it was more likely than not that such income would be earned.  Management now believes that it is more likely than not that such taxable income will be earned, and therefore, no valuation allowance has been provided.  The effect of this change in estimate was recorded in the first quarter of fiscal period 1999, and is included in the deferred tax benefit of $54.4 million for fiscal period 1999.

NOTE 8.  LONG-TERM DEBT

On October 28, 1999, we issued $260 million in 4 ¾% convertible subordinated notes due on November 1, 2006.  These notes pay interest semi-annually on May 1 and November 1.  Holders of these notes may convert them into shares of our common stock at any time on or before November 1, 2006, at a conversion price of $20.72 per share, subject to adjustment in certain events.  Beginning on November 6, 2002 and ending on October 31, 2003, we may redeem the notes in whole or in part at a redemption price of 102.71% of the principal amount.  In the subsequent three twelve-month periods, the redemption price declines to 102.04%, 101.36% and 100.68% of principal, respectively.  The notes are subordinated in right of payment to all of our senior indebtedness, and are subordinated by operation of law to all liabilities of our subsidiaries.  At December 31, 2001, we had no senior indebtedness and our subsidiaries had $2.5 million of debt and other liabilities outstanding.  Issuance costs relative to the convertible subordinated notes are included in Other Assets and aggregated approximately $6.9 million and are being amortized to expense over the lives of the notes.  Accumulated amortization of these issuance costs amounted to approximately $3.6 million at December 31, 2001.  The estimated fair value of the convertible subordinated notes, based on quoted market prices, was approximately $315.9 million and $285.7 million at December 31, 2001 and December 31, 2000, respectively.

On June 15, 1999, we entered into a credit agreement with a group of lenders and ABN AMRO Bank N.V. as administrative agent for the lender group.  The credit agreement consisted of two credit facilities: a $60 million unsecured revolving credit facility (“Revolver”), and a $220 million unsecured reducing term loan (“Term Loan”), both expiring and due on June 30, 2002.  On June 15, 1999, we borrowed $220 million under the Term Loan and approximately $33 million under the Revolver.  The $33 million Revolver was repaid in full during the third calendar quarter of 1999.

In conjunction with the issuance of the convertible subordinated notes, we repaid the $220 million Term Loan in full during the fourth calendar quarter of 1999.  Remaining unamortized loan fees at the time of repayment, aggregating approximately $2.6 million ($1.665 million net of income taxes or a charge of $0.02 for basic and diluted earnings per share), were written off and are reflected in the accompanying Consolidated Statement of Operations as an Extraordinary Item, Net of Income Taxes.

 

C-14



 

NOTE 9.  STOCKHOLDERS’ EQUITY

Common Stock.  In December 2000, our Board of Directors authorized management to repurchase up to five million shares of our common stock.  As of December 31, 2001, we had repurchased 1,136,000 shares (596,000 in 2001) at an aggregate cost of approximately $20.0 million ($10.6 million in 2001).

Stock Warrants.  As of December 31, 2001, we have issued warrants to purchase 2,922,531 shares of common stock to a vendor.  Of this amount, 2,532,768 warrants were issued and 1,856,500 exercised prior to fiscal period 1999.  During fiscal period 1999, a warrant was issued to purchase 220,200 shares of common stock, earned ratably from March 1999 to February 2000.  Additionally, the vendor exercised warrants for 269,716 shares at $8.50 per share.  During 2000, a warrant was issued to purchase 74,000 shares of common stock, earned ratably from March 2000 to February 2001.  During 2001, a warrant was issued to purchase 95,563 shares of common stock, earned ratably from March 2001 to February 2002.  Expense recorded in conjunction with the vesting of warrants by this vendor was not material.

Stock Option Plans.  As of December 31, 2001, we had reserved 9,000,000 and 17,200,000 shares of common stock for issuance to officers and key employees under our 2001 Stock Option Plan and 1996 Stock Option Plan, respectively.  The 2001 Plan options are granted at fair value at the date of grant, generally vest over four years in increments as determined by the Board of Directors and have terms up to ten years.  The 1996 Plan options are typically granted at fair value at the date of grant, generally vest over four years in increments as determined by the Board of Directors and have terms up to ten years.

In conjunction with the acquisition of I2P on March 16, 2001, we exchanged 223,276 Lattice stock options for all of the options outstanding under the I2P stock option plans.  These options generally vest over four years and have terms of 10 years.  Additionally, on June 16, 1999, we exchanged 4,720,544 Lattice stock options for all of the options outstanding under the former Vantis stock option plans.  These options generally vest over four years and have terms of ten years.

The 2001 Directors’ Stock Option Plan, which replaced the 1993 Directors’ Stock Option Plan, provides for the issuance of stock options to members of our Board of Directors who are not employees of Lattice; 1,000,000 shares of our Common Stock are reserved for issuance thereunder.  These options are granted at fair value at the date of grant and become exercisable quarterly over a one year period beginning three years after the date of grant and expire ten years from the date of grant.

The following table summarizes our stock option activity and related information for the past three fiscal periods:

 

 

 

Year Ended
December 31, 2001

 

Year Ended
December 31, 2000

 

Nine Months Ended
December 31, 1999

 

 

 

Number of
Shares
Under
Option

 

Weighted-
Average
Exercise
Price

 

Number of
Shares
Under
Option

 

Weighted-
Average
Exercise
Price

 

Number of
Shares
Under
Option

 

Weighted
Average
Exercise
Price

 

 

 

(number of shares in thousands)

 

Options outstanding at beginning of fiscal period

 

17,008

 

$

14.95

 

16,444

 

$

9.80

 

11,748

 

$

7.86

 

Options granted

 

5,713

 

22.16

 

5,170

 

27.31

 

7,704

 

12.04

 

Options canceled

 

(399

)

17.81

 

(1,306

)

13.22

 

(1,072

)

9.94

 

Options exercised

 

(2,247

)

8.15

 

(3,300

)

9.32

 

(1,936

)

6.87

 

Options outstanding at end of fiscal period

 

20,075

 

$

17.71

 

17,008

 

$

14.95

 

16,444

 

$

9.80

 

 

 

C-15



 

The following table summarizes information about stock options outstanding at December 31, 2001:

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Number
of
Shares

 

Weighted-
Average
Remaining
Contract Life
(in Years)

 

Weighted-
Average
Exercise Price

 

Number
of
Shares

 

Weighted-
Average
Exercise Price

 

 

 

(number of shares in thousands)

 

$

1.88  —

$

7.88

 

 

4,701

 

0.78

 

$

7.75

 

3,468

 

$

7.79

 

$

7.89  —

$

13.32

 

 

2,800

 

1.42

 

10.44

 

1,795

 

10.16

 

$

13.33  —

$

21.38

 

 

3,925

 

2.41

 

15.99

 

1,370

 

15.33

 

$

21.39  —

$

24.91

 

 

3,914

 

3.57

 

24.86

 

222

 

24.83

 

$

24.92  —

$

32.25

 

 

4,735

 

2.52

 

27.40

 

1,566

 

27.62

 

 

 

20,075

 

2.14

 

$

17.71

 

8,421

 

$

13.66

 

Stock Purchase Plan.  Our employee stock purchase plan, most recently approved by the stockholders in August 1997, permits eligible employees to purchase shares of common stock through payroll deductions, not to exceed 10% of the employee’s compensation.  The purchase price of the shares is the lower of 85% of the fair market value of the stock at the beginning of each six-month period or 85% of the fair market value at the end of such period, but in no event less than the book value per share at the mid-point of each offering period.  Amounts accumulated through payroll deductions during the offering period are used to purchase shares on the last day of the offering period.  Of the 2,800,000 shares authorized to be issued under the plan, 203,049, 200,072, and 78,580 shares were issued during 2001, 2000 and fiscal period 1999, respectively, and 353,719 shares were available for issuance at December 31, 2001.

Pro forma Disclosures.  We account for our stock options and employee stock purchase plan in conformity with APB 25 and have adopted the additional pro forma disclosure provisions of SFAS 123.  The fair value, as defined by SFAS 123, for stock options and employee stock plan purchase rights was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

 

 

Grants for Periods Ended

 

 

 

Dec. 31,
2001

 

Dec. 31,
2000

 

Dec. 31,
1999

 

Stock options:

 

 

 

 

 

 

 

Expected volatility

 

56.1

%

53.9

%

41.4

%

Risk-free interest rate

 

3.9

%

6.3

%

5.9

%

Expected life from vesting date

 

1.9 years

 

1.8 years

 

1.6 years

 

Dividend yield

 

0

%

0

%

0

%

Stock purchase rights:

 

 

 

 

 

 

 

Expected volatility

 

53.3

%

46.6

%

52.8

%

Risk-free interest rate

 

4.65

%

6.3

%

5.3

%

Expected life

 

6 months

 

6 months

 

6 months

 

Dividend yield

 

0

%

0

%

0

%

The Black-Scholes option pricing model was developed for use in estimating the fair value of freely tradable, fully transferable options without vesting restrictions.  Our stock options have characteristics which differ significantly from those of freely tradable, fully transferable options.  The Black-Scholes option pricing model also requires highly subjective assumptions, including expected stock price volatility and expected stock option term which greatly affect the calculated fair value of an option.  Our actual stock price volatility and option term may be materially different from the assumptions used herein.

The resultant grant date weighted-average fair values calculated using the Black-Scholes option pricing model and the noted assumptions for stock options granted was $10.29, $13.13 and $5.71, and for stock

 

C-16



 

purchase rights $5.92, $7.79 and $3.87, for 2001, 2000, and fiscal period 1999, respectively.  For purposes of pro forma disclosures, the estimated fair value of the options is amortized to expense over the options’ vesting period.

Our pro forma information is as follows:

 

(In Thousands, Except Per Share Data)

 

Year
Ended
Dec. 31,
2001

 

Year
Ended
Dec. 31,
2000

 

Nine Months
Ended
Dec. 31,
1999

 

Pro forma net (loss) income

 

$

(132,133

)

$

147,884

 

$

(56,337

)

Pro forma basic (loss) earnings per share

 

$

(1.22

)

$

1.46

 

$

(0.59

)

Pro forma diluted (loss) earnings per share

 

$

(1.22

$

1.31

 

$

(0.59

Because the SFAS 123 pro forma disclosure applies only to options granted subsequent to April 1, 1995, its pro forma effect was not fully reflected until 2000.

NOTE 10.  EMPLOYEE BENEFIT PLANS

Profit Sharing Plan.  We initiated a profit sharing plan effective April 1, 1990.  Under the provisions of this plan, as approved by the Board of Directors, a percentage of our operating income, as defined and calculated at the end of March and September for the prior six-month period, is paid to qualified employees.  In 2001, 2000, and fiscal period 1999, approximately $2.1 million, $6.7 million, and $2.6 million, respectively, was charged against operations in connection with the plan.

Qualified Investment Plan.  In 1990, we adopted a 401(k) plan, which provides participants with an opportunity to accumulate funds for retirement.  Under the terms of the plan, eligible participants may contribute up to 15% of their eligible earnings to the plan Trust.  The plan allows for us to make discretionary matching contributions.  For the fiscal periods presented, matching contributions of up to 5% of base pay, vesting over four years, were made through the second quarter of 2001.  Expense related to our matching contributions was approximately $1.0 million, $1.8 million and $0.9 million, respectively, for 2001, 2000 and fiscal period 1999.

NOTE 11.  COMMITMENTS AND CONTINGENCIES

We are exposed to certain asserted and unasserted potential claims.  Patent and other proprietary rights infringement claims are common in the semiconductor industry.  There can be no assurance that, with respect to potential claims made against us, that we could obtain a license on terms or under conditions that would not have a material adverse effect on our financial position, cash flows or results of operations.

In connection with our 1999 acquisition of Vantis, we agreed to assume both the claims against Altera and the claims by Altera against AMD in the case captioned Advanced Micro Devices, Inc. V. Altera Corporation (Case No. C-94-20567-RMW) proceeding in the United States District Court for the Northern District of California.  This litigation, which began in 1994, involved multiple claims and counterclaims for patent infringement relating to Vantis and Altera programmable logic devices and both parties were seeking damages and injunctive relief.

On July 23, 2001, we and Altera announced a comprehensive, royalty-free patent cross-license agreement and a multi-year patent peace agreement.  In addition, we and Altera each agreed to dismiss all patent infringement suits against each other without any admission of liability.  No payments were exchanged as part of the settlement.

 

C-17



 

NOTE 12.  RELATED PARTY

Larry W. Sonsini is a member of our Board of Directors and is presently the Chairman and CEO of Wilson Sonsini Goodrich & Rosati, Professional Corporation, a law firm that provides us with corporate legal services.  Legal services billed to Lattice aggregated approximately $1,314,000, $373,000, and $1,086,000, respectively, for 2001, 2000 and fiscal period 1999.  Amounts payable to the law firm were not significant at December 31, 2001 or 2000, respectively.

NOTE 13.  SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one industry segment comprising the design, development, manufacture and marketing of high performance programmable logic devices.  Our sales by major geographic area were as follows:

 

(In Thousands)

 

Year
Ended
Dec. 31,
2001

 

Year
Ended
Dec. 31,
2000

 

Nine Months
Ended
Dec. 31,
2001

 

United States

 

$

135,832

 

$

245,882

 

$

126,333

 

Export sales:

 

 

 

 

 

 

 

Europe

 

81,177

 

158,591

 

70,641

 

Asia

 

62,582

 

120,285

 

55,003

 

Other

 

15,735

 

43,001

 

17,722

 

 

 

159,494

 

321,877

 

143,366

 

 

 

$

295,326

 

$

567,759

 

$

269,699

 

Resale of product through two distributors accounted for approximately 29% and 20%, 23% and 18%, and 20% and 15%, for 2001, 2000, and fiscal period 1999, respectively.  No individual customer accounted for more than 10% of revenue for any of the fiscal periods presented.  More than 90% of our property and equipment is located in the United States.  Other long-lived assets located outside the United States consist primarily of foundry investments and advances (see note 5).

NOTE 14.  ACQUISITION

On December 10, 2001, we announced a definitive agreement to acquire the FPGA business of Agere Systems, Inc. for $250 million in cash.  This acquisition was completed on January 18, 2002 and financed with cash on hand.  The transaction will be accounted for as a purchase.

The acquisition includes a general purpose ORCA® FPGA product portfolio, a field programmable system chip (FPSC) product portfolio and all related software design tools.  In addition, we acquired certain intellectual property cores and patents unique to Agere’s FPGA business and also entered into a cross-license agreement with Agere covering certain FPGA and FPSC patents, intellectual property and technology.  As part of the transaction, we also hired approximately 100 Agere product development, marketing and technical sales employees.

The $250 million purchase price, associated costs and assumed liabilities are tax deductible (over 15 years for substantially all of the sum).  Management, with the assistance of a third party valuation of intangible assets, attributed $65 million to purchased technology, $24 million to in-process research and development costs, and $24 million to a non-compete agreement and to licensed technology.  Value attributed to acquired tangible assets and assumed liabilities is not material to our financial statements.  Goodwill is the difference between a) the sum of the purchase price, associated costs and assumed liabilities, and b) the fair value of acquired assets.  Purchased and licensed (non-goodwill) intangible assets will be amortized over approximately 7 years on a straight line basis except in-process research and development costs which will be charged to operations in the March 2002 quarter.

 

C-18



 

REPORT OF INDEPENDENT ACCOUNTANTS

 

To the Board of Directors and Stockholders of Lattice Semiconductor Corporation

In our opinion, the accompanying consolidated balance sheet and the related consolidated statements of operations, of changes in stockholders’ equity, and of cash flows present fairly, in all material respects, the financial position of Lattice Semiconductor Corporation and its subsidiaries (the Company) at December 31, 2001 and 2000, and the results of their operations and their cash flows for the years ended December 31, 2001 and December 31, 2000, and for the nine months ended December 31, 1999 in conformity with accounting principles generally accepted in the United States of America.  These financial statements are the responsibility of the Company’s management; our responsibility is to express an opinion on these financial statements based on our audits.  We conducted our audits of these statements in accordance with auditing standards generally accepted in the United States of America, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.

 

/s/ PricewaterhouseCoopers LLP

 

Portland, Oregon

January 30, 2002

 

C-19



SCHEDULE D

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN CANADA

 

This supplement has been prepared to provide employees in Canada with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

The tax treatment as a result of the exchange of an eligible option for a new option is uncertain.  It is possible that the Canada Customs and Revenue Agency (the “CCRA”) will treat the exchange as: (i) a tax-neutral exchange of options; (ii) a taxable exchange of employee stock options; or (iii) two separate transactions (i.e., a tender of eligible options for cancellation, followed by a grant of new and unrelated options), whereby the tender is viewed as a disposition for no consideration and no taxable income arises.  We believe that the tax authorities would view the transaction as described in (iii), but no definitive guidance has been issued in that regard.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

Subject to the potential deferral provisions discussed in the paragraph below, when you exercise your new options you must include the difference between the fair market value of the shares on the date of exercise and the exercise price in your income.  Only one-half of this “gain” is subject to tax; that is, you can permanently exclude one-half of this “gain” from the taxable amount.  You will be subject to tax on the remaining one-half of the gain at your applicable marginal tax rate.

You may be able to defer taxation of the taxable portion of the gain arising upon exercise (i.e., the remaining one-half of the difference between the fair market value of the shares on the date of exercise and the exercise price) until the earliest of: (i) when you sell the shares purchased upon exercise; (ii) when you die; or (iii) when you become a non-resident of Canada.  In order to be eligible for this deferral, you must file an election with your employer by January 15 of the year following the year in which shares are purchased upon exercise.

You may only defer the tax on the spread at exercise on up to C$100,000 worth of options that vest in any one year.  For the purpose of calculating this limit, the value of an option equals the fair market value of the shares subject to the option at the time the option was granted.

 

D-1



 

If CCRA successfully treats the transaction as a continuation of the existing option (i.e., a tax-neutral exchange described in alternative (i) in the section above), the one-half deduction and the deferral will not be available.  However, proposed legislation may permit the one-half deduction and the deferral for option exchanges after 1998.

You will not be subject to social insurance contributions.

Sale of Shares

If you acquire shares upon exercise, you will be subject to tax when you subsequently sell the shares.  The taxable amount will be one-half of the difference between the sale proceeds and the adjusted cost basis of the shares (generally, the fair market value on the date of exercise), less any brokerage fees.  In addition, any amount on which taxation was deferred at exercise, if applicable, will become taxable at the time the shares are sold.  Income tax will be assessed on the taxable income at your marginal income tax rate.

If you own other shares of Lattice which you have acquired upon exercise of other options or otherwise, your adjusted cost basis may be different than described above.  In order to preserve the cost basis of shares sold in a cashless exercise, you will have to specifically identify any such shares in your annual tax return.  Shares acquired upon the exercise of options for which a tax deferral election has been filed will also retain their own cost basis.  You are strongly advised to consult your tax advisor in any of these situations.

One-half of any loss arising on the sale of the shares (including any brokerage fees) may be deducted from any taxable capital gain for the year, the previous three taxation years, or any subsequent year.

Withholding and Reporting

Your employer will report the income recognized at exercise, any amount excluded under the one-half exemption rule and the value of any deferred stock option benefit, if applicable, to the CCRA.  A copy of the T4 form containing this information will be delivered to you prior to the last day of February in the year following the year in which you exercise your new option.

Your employer is not required to withhold income tax or social insurance contributions on any portion of the taxable benefit from the exchange, grant, exercise of new option or the sale of shares.  You will be responsible for paying all applicable taxes.  For each year that you defer taxation, if any, you must file a Form T1212 with the CCRA with your annual tax return.

Securities Information

You are permitted to sell shares acquired upon exercise of the new option through the designated broker appointed by Lattice if any, provided the resale of shares takes place outside of Canada through the facilities of a stock exchange on which the shares are listed.

 

D-2



 

SCHEDULE E

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN CHINA

 

This supplement has been prepared to provide employees in China with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option and Sale of Shares

Due to legal restrictions in China, you will not be permitted to obtain shares upon exercise of your new options.  Instead, you must use the cashless-sell all method of exercise whereby all the shares you are entitled to at exercise are immediately sold and the proceeds less the exercise price, applicable taxes and brokers’ fees, if any, are remitted to you in cash.

When you exercise the new option, you will be subject to income tax on the difference between the fair market value of the shares on the date you exercise your option and the exercise price.  In addition, you may also be subject to social insurance contributions on this amount.

Withholding and Reporting

Your employer will be required to withhold and report for income tax and social insurance purposes when you exercise your new option.  You will be responsible for paying any difference between the actual tax liability and the amount withheld.

 

E-1



 

SCHEDULE F

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN FINLAND

 

This supplement has been prepared to provide employees in Finland with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise the new option, you will likely be subject to income tax at the normal marginal rates on the difference between the fair market value of the shares on the date of exercise and the exercise price.  In addition, you will be subject to social insurance contributions on the same amount.

Sale of Shares

If you acquire shares upon exercise, you will be subject to capital gains tax when you subsequently sell the shares.  The taxable amount will be the difference between the sale proceeds and the fair market value of the shares on the date of exercise.  When determining the applicable capital gain, you may deduct from the sale proceeds either: (1) the acquisition cost of the asset and other costs in connection with the gain; or (2) 20% of the sale proceeds (50% if the shares are held at least ten years).  If the sale proceeds are less than the fair market value of the shares at exercise, you will be entitled to claim a capital loss for this difference.

Wealth Tax

You may be subject to a wealth tax on your new option, if the amount of your wealth exceeds the annual threshold of €185,000.  The option value is calculated as the value of the underlying shares on the last day of the year minus the exercise price.  This amount is multiplied by 70% to determine the amount includable in your wealth calculation.

 

F-1



 

Withholding and Reporting

Your employer is required to report and withhold income tax and social insurance contributions at exercise.  You must report the exercise of the new option and the sale of shares on your tax return.  You will be responsible for paying any difference between the actual tax and the amount withheld.

 

 

F-2



 

SCHEDULE G

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN FRANCE

 

This supplement has been prepared to provide employees in France with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of eligible options for new options.

Nature of New Option

Your new options will be non-French qualified, just like your outstanding options.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

You will be subject to income tax and social insurance contributions on the difference between the fair market value of the underlying shares at exercise and the exercise price when you exercise your new option.

Sale of Shares

When you sell your shares acquired at exercise, if any, you will be subject to capital gains tax, which current is charged at the rate of 26% (i.e., 16% income tax, a 7.5% CSG contribution (the general social insurance obligation), a 0.5% CRDS contribution (the contribution for the reimbursement of social insurance debt) and a 2% special tax).  The gain subject to tax will be calculated as the difference between the sale proceeds and the fair market value of the shares at exercise.  These taxes apply only if the aggregate gross proceeds from the sale of shares that you receive during a calendar year period exceed an indexed amount, which is set at €7,650 for 2002.

If the sale proceeds are less than the fair market value of the shares at the date of exercise, you will be permitted to recognize a capital loss in the amount of this difference.  This capital loss can be offset against

 

G-1



 

the spread at exercise and the excess against the capital gain of same nature realized during the same year or during the five following year.  This capital loss cannot be offset against other kinds of income.

Withholding and Reporting

Your employer is not required to withhold for income taxes at the time of exercise nor at the time the shares are sold.  Your employer will report the spread at exercise on your pay slip for the month in which the exercise occurs.  Your employer will withhold for social insurance contributions at the time of exercise.  It is your responsibility to report and pay all other applicable taxes.

Exchange Control Information

You may hold shares acquired at exercise, if any, outside France provided you declare all foreign accounts, whether open, current, or closed, in your income tax return.  Furthermore, you must declare to the customs and excise authorities any cash or securities you import or export without the use of a financial institution when the value of the cash or securities is equal to or exceeds a specified level, currently €7,600.

 

G-2



 

SCHEDULE H

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN GERMANY

 

This supplement has been prepared to provide employees in Germany with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise your new option, you will be subject to income tax on the difference between the fair market value of the shares on the date of exercise and the exercise price.  You also will be subject to social insurance contributions to the extent you have not already exceeded the applicable contribution ceiling.

Pursuant to Section 19a of the German Income Tax Act (Einkommensteuergesetz), you may be able to deduct €154 per calendar year from the taxable amount because this income results from the purchase of stock in your employer’s parent company.  You should consult with your tax advisor to determine if this deduction applies to your specific situation.

Sale of Shares

You will not be subject to tax when you subsequently sell shares provided you own the shares for at least 12 months, do not own 1% or more of Lattice’s stated capital (and have not owned 1% or more at any time in the last five years) and the shares are not held as business assets (this requirement should be met since you purchased the shares as an employee).  However, for sales after 2002, proposed legislation in Germany may require you to pay tax upon any gain realized from the sale of shares (calculated as the sale proceeds less the fair market value of the underlying shares at exercise), regardless of your ownership of Lattice’s stated capital, of how long the shares are held and of the capacity in which they are held.  The proposed legislation provides for a special flat tax rate of 15% for such capital gains.

 

H-1



 

If you are subject to tax upon sale, you will be subject to tax on one-half of the gain as capital gain (less one-half of the sales related expenses).  Furthermore, you will only be subject to tax if your total capital gain exceeds €512 in the relevant tax year.  If this threshold is exceeded, you will be taxed on the full gain (and not only the gain in excess of €512).

Withholding and Reporting

Your employer is required to withhold and report income tax and social insurance contributions (to the extent that you have not exceeded the applicable contribution ceiling) when you exercise the new options.  If your actual tax liability differs from the amount withheld, it is your responsibility to pay the additional tax.  It is your responsibility to report and pay any taxes due as a result of the sale of shares.

Exchange Control Information

Cross-border payments in excess of €12,500 must be reported monthly.  If you use a German bank to carry out the cross-border payment in excess of €12,500 in connection with the purchase or sale of Lattice shares, the bank will make the report.  In addition, you must report any receivables or payables or debts in foreign currency exceeding an amount of €5,000,000 on a monthly basis.  Finally, you must also report your holdings in a foreign company (e.g., Lattice) on an annual basis, in the unlikely event that you hold shares representing 10% or more of the total or voting capital of Lattice.

 

H-2



 

SCHEDULE I

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN HONG KONG

 

This supplement has been prepared to provide employees in Hong Kong with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to income tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise the new option, you will be subject to income tax on the difference between the fair market value of the shares on the date of exercise and the exercise price.  Mandatory Provident Fund contributions will not likely be due.

Sale of Shares

You will not be subject to tax when you subsequently sell your shares.

Withholding and Reporting

Your employer is not required to withhold salaries tax when you exercise the new option or when you subsequently sell the shares.  However, your employer will report your taxable benefits resulting from the exercise of your option as part of its normal annual return.  It is your responsibility to report and pay all applicable taxes.

Terms of New Option

If the applicable plan is deemed to constitute an occupational retirement scheme for the purposes of the Occupational Retirement Schemes Ordinance (“ORSO”), then all your outstanding options (both outstanding options that were not cancelled in the exchange and the new options) granted under the applicable plan will not provide for accelerated vesting upon termination of employment.

 

I-1



 

Securities Information

This document is private and confidential and has been printed in limited numbers and distributed to selected employees of Lattice.  It is for the exclusive use of the person to whom it is addressed and should be returned if such person decides not to participate in the exchange program.

 

I-2



 

SCHEDULE J

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN ISRAEL

 

This supplement has been prepared to provide employees in Israel with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

You will not be subject to tax when you exercise your new options.

Sale of Shares

If you acquire shares at exercise, you will be subject to income tax and social insurance contributions when you subsequently sell the shares.  The taxable amount is the difference between the sale proceeds and the exercise price.

Withholding and Reporting

Your employer is required to withhold and report income tax and social insurance contributions when you sell shares.  You will be responsible for reporting and paying any difference between the actual tax liability and the amount withheld.  You may also be required to report any options and/or shares you hold on your annual tax return.

 

J-1



 

SCHEDULE K

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN ITALY

 

This supplement has been prepared to provide employees in Italy with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

You should not be subject to tax when you exercise the new option because the exercise price will be the higher of: (1) the fair market value at the time of the new grant as defined by the applicable plan; and (2) the Italian Fair Market Value (i.e., the average of the official prices over the month preceding the new grant date) at the time of the new grant.

Sale of Shares

If you acquire shares at exercise, you will be subject to capital gains tax when you subsequently sell the shares.  The taxable amount will likely be the difference between the sale proceeds and the exercise price.  Capital gains are currently taxed at a flat rate of 12.5%.

You may also elect to be taxed under one of two alternative tax regimes.  To be eligible for either of these methods, you must transfer your stock certificates to the custody of a broker authorized by the Italian Ministry of Finance.

Administered Savings Method

Under the administered savings method, you deposit shares with an authorized broker, but you retain the right to make investment decisions.  Under this method, a 12.5% flat withholding tax is levied on the capital gains for each transaction.  Your broker pays the tax from the sale proceeds at the time of the sale of the shares, so that capital gain is not included on your annual tax return.  The advantage of this tax regime is

 

K-1



 

that it preserves the anonymity of the owner of the shares.  The tax effect, however, is the same as described above in the Sale of Shares.

Managed Savings Method

Under the managed savings method, you deposit shares with an authorized broker and leave the administration and investment decisions to the broker.  In this case, the 12.5% flat withholding tax is levied not on the capital gain actually realized through the sale of the shares but on the net result of your entire investment portfolio with the broker, i.e., the difference between the value of your portfolio at the end of the year and the value of the portfolio at the beginning of the year, subject to some adjustment.  Once again, the broker pays the tax at the end of the year from your account and the gain is not included on your individual tax return.  The advantage of this method is that it preserves the anonymity of the owner of the shares.  The disadvantage is that your taxable amount is not equal to capital gains actually realized through the sale of the shares, but rather is based on the increased value of the shares held in your portfolio.

Withholding and Reporting

Your employer is not required to withhold income tax or social insurance contributions at the time of the exchange, the grant, the exercise of your option or the subsequent sale of shares.  It is your responsibility to report and pay all applicable taxes resulting from the sale of shares.

Exchange Control Information

Exchange control reporting is required if you transfer cash or shares to or from Italy in excess of €12,500 or the equivalent amount in U.S. dollars.  You may be exempt from this formality if the payments are made through an authorized broker resident in Italy, as that entity would comply with the reporting obligation.  Exchange control reporting is also required if you have any foreign investment (including stock) held outside Italy in excess of €12,500.  The reporting must be done on your individual tax return.

Terms of New Option

The exercise price for the new options will be determined in compliance with the rules for obtaining favorable tax treatment in Italy.  Specifically, the new exercise price will be the higher of (1) the fair market value at the time of the new grant as defined by the applicable plan; and (2) the Italian Fair Market Value (i.e., the average of the official prices over the month preceding the new grant date) at the time of the new grant.  Because the exercise price will be determined under this formula, the exercise price for new options may be higher for employees in Italy than for other employees.

 

 

K-2



 

SCHEDULE L

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN JAPAN

 

This supplement has been prepared to provide employees in Japan with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is possible that you will be subject to income tax as a result of the exchange of an eligible option for a new option, although this result is not certain.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise the new option, you will be subject to tax on the difference between the fair market value of the shares on the date of exercise and the exercise price.  This gain likely will be treated as “remuneration income” (although this currently is being debated in Japanese courts) and will be taxed at your marginal tax rate.  Social insurance contributions will not be due on gain at exercise.

Sale of Shares

If you acquire shares upon exercise, you will be subject to tax when you subsequently sell the shares.  You will be taxed on the difference between the sale proceeds and the fair market value of the shares on the date of exercise.  As of January 1, 2003, the tax rate on net capital gains for certain listed shares (including those listed on a foreign stock market) is 20% if they are sold through a securities broker licensed in Japan.  Additional favorable capital gain tax treatment may apply on a temporary basis for shares sold between 2003 and 2007.  This treatment will apply to shares of publicly listed companies (including foreign listed companies) that satisfy certain additional conditions.

Withholding and Reporting

Your employer is not required to withhold income tax or social insurance contributions when you exercise your option.  It is your responsibility to file a personal tax return and to report and pay any taxes resulting from the exchange, the exercise of your option and the sale of shares.

 

L-1



 

SCHEDULE M

LATTICE SEMICONDUCTOR CORPORATION
STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN KOREA

 

This supplement has been prepared to provide employees in the Korea with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

You will not be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise the new option, any gain realized on the difference between the fair market value of the shares at exercise and the exercise price will be subject to income tax at the rate applicable to salary income and social insurance contributions.

Sale of Shares

If you acquire shares upon exercise, you will be subject to capital gains tax when you subsequently sell the shares.  The taxable amount will be the difference between the sale proceeds and the fair market value of the shares on the date of exercise, unless the amount of shares (and any other company shares) sold in that year is less than the exempt amount, which is KRW2,500,000 per asset type.  Any gain you realize on stock assets that exceeds KRW2,500,000 will be subject to capital gains tax.

The securities transaction tax will not apply to the disposition of shares acquired pursuant to exercise of your options.

Withholding and Reporting

Your employer is not required to withhold income tax or social insurance contributions when you exercise the new options.  It is your responsibility to file a personal tax return and to report and pay any income tax and social insurance contributions due upon exercise of the options and sale of the shares.

 

M-1



 

Exchange Control Information

When you exercise your new option, your remittance of funds must be “confirmed” by a foreign exchange bank in Korea.  This procedure does not require approval of the remittance from the bank.  You must submit the following documents to the bank with a confirmation application available from the bank: (i) the notice of grant; (ii) the plan document; (iii) the stock option award letter or agreement indicating the type of shares to be acquired and the amount of shares; and (iv) a certificate of employment from your local employer.

Exchange control laws also require Korean residents who realize US$100,000 or more from the sale of shares to repatriate the proceeds back to Korea within six months of the sale.

 

M-2



 

SCHEDULE N

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN SINGAPORE

 

This supplement has been prepared to provide employees in Singapore with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

You may be subject to tax as a result of the exchange of an eligible option for the right to a new option (provided certain conditions are met) as the Inland Revenue Authority of Singapore (the “IRAS”) may view the exchange as a taxable “release.”  In practice, the IRAS is likely to disregard the “release” of the options and simply tax the new options when you exercise them.  However, this result is not certain.  Therefore, we advise you to consult with your tax advisor.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

Assuming you are not taxed when the eligible options are cancelled, when you exercise the new option, you will likely be subject to income tax on the difference between the fair market value of the shares on the date of exercise and the exercise price (the “Spread”) unless you are eligible for an exemption or deferral as discussed below.  Please note that the application of these exemption/deferrals are not clear with respect to option exchanges.  Therefore, you should consult your tax advisor regarding whether you will qualify.  You will not likely be subject to Central Provident Fund contributions.

Company Employee Equity-Based Remuneration Scheme (“CEEBR Scheme”)1

You may be able to claim a tax exemption on the first S$2,000 of Spread per year and 25% of the remaining Spread per year subject to a total exemption of S$1 million over a 10-year period beginning in the year you exercise your options.  To take advantage of this tax exemption, the vesting provisions of your options must be as follows:

 


1 Formerly called the “Company Stock Option Scheme”

 

N-1



 

(a)           where the exercise price is equal to at least the fair market value of the underlying shares on the date of grant (which will be the case for your new options), the option may not be exercised within one year of the grant of the option; and

(b)           where the exercise price is less than the fair market value of the underlying shares on the date of grant (i.e., discounted option), the option may not be exercised within two years of the grant of the option.

In addition, the CEEBR Scheme must be offered to at least 50% of the Singapore company’s employees.

You should consult your tax advisor to determine if you qualify for this exemption in whole or in part (i.e., the portion of the new option vesting one year or more after the new grant date).

Qualified Employee Equity-Based Remuneration (“QEEBR Scheme”)2

You may also be able, in certain circumstances, to defer the tax due at exercise under the QEEBR Scheme on the portion of the Spread that was not exempt, if any, from tax under the CEEBR Scheme.  You should consult with a tax advisor to determine if you qualify for this deferral.  If you think that you qualify, you should apply to the to the IRAS for a deferral.  If you qualify for deferral under the QEEBR Scheme, you will accrue interest on the deferred tax as explained below.

To qualify for tax deferral under the QEEBR Scheme, you would have to satisfy the following conditions:

(a)           you are employed in Singapore at the time the option is exercised;

(b)           the option was granted to you by the company for whom you are working at the time of exercise of the option or an associated company of that company;

(c)           the tax payable on the QEEBR gains is not borne by your employer; and

(d)           the minimum vesting periods that are applicable to CEEBR Schemes (discussed above) must be met.

You will not qualify for the QEEBR Scheme if:

(a)           you are an undischarged bankrupt;

(b)           IRAS records show that you are a delinquent taxpayer; or

(c)           the tax deferred under the QEEBR Scheme is less than S$200.

You should consult your tax advisor to determine if you qualify for the QEEBR Scheme in whole or in part (i.e., the portion of the new option vesting one year or more after the new grant date).

 


2 Formerly called the “Qualified Employee Stock Option Plan Scheme”

 

N-2



 

If you are a qualifying employee, you may apply to the IRAS for tax deferral at the time of filing your income tax return for the Year of Assessment (“YOA”) (i.e., the year in which option is exercised and the spread would be subject to tax unless deferred).  You would have to submit to the IRAS the Application Form for Deferment of Tax on Gains from the QEEBR, together with your employer’s certification on the Application Form that the QEEBR is properly qualified and your tax returns.

The maximum deferral period is five years starting from 1 January after the YOA.  Subject to the maximum of five years, an employee can choose to defer the payment of the tax on the QEEBR gains for any period of time.

The interest charge on the deferred tax will commence one month after the date of assessment (i.e., the date you exercise the option).  The interest rate chargeable will be pegged to the average prime rate of the Big Four Banks offered on 15 April of each year and interest will be computed annually based on said rate using the simple interest method.  The tax deferred and the corresponding amount of interest would be due on the expiration of the deferral period.  You may settle the deferred tax earlier in one lump sum.

Tax payment deferral will cease and payment of the tax plus the corresponding interest will become due immediately:

(a)           in the case of a foreign employee (including a Singapore PR), when you

(i)             terminate your employment in Singapore and leave Singapore;

(ii)            are posted overseas; or

(iii)           leave Singapore for any period exceeding three months;

(b)           when you become bankrupt; and

(c)           when you die (the deferred tax would be recovered from your estate).

Sale of Shares

If you acquire shares at exercise, you will not be subject to tax when you subsequently sell the shares provided you are not in the business of buying and selling securities.

Withholding and Reporting

Generally, your employer is not required to withhold income tax or Central Provident Fund contributions with respect to the exchange, grant of new options, exercise of new options or upon sale of shares.  However, if you are not a Singaporean citizen or permanent resident of Singapore and you are about to cease employment or leave Singapore, special withholding rules will apply to you.

Even though your employer is not generally required to withhold taxes, your employer will prepare a Form IR8A each year stating the salary or benefits paid to you during the year.  This will include the value of the shares which you acquire pursuant to exercise.  Your employer will provide this Form IR8A to you.  It is then your responsibility to report and pay all applicable taxes.

 

N-3



 

Additional Reporting Requirements

If you are a director, associate director or shadow director of a Singapore affiliate of Lattice, you are subject to certain notification requirements under the Singapore Companies Act.  Among these requirements is an obligation to notify the Singapore affiliate in writing when you receive an interest (e.g., options, shares) in Lattice or any related companies.  Please contact Lattice to obtain a copy of the notification form.  In addition, you must notify the Singapore affiliate when you sell shares of Lattice or any related company (including when you sell shares acquired under the exchange program).  These notifications must be made within two days of acquiring or disposing of any interest in Lattice or any related company.  In addition, a notification must be made of your interests in Lattice or any related company within two days of becoming a director.

 

N-4



 

SCHEDULE O

LATTICE SEMICONDUCTOR CORPORATION
STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN SWEDEN

 

This supplement has been prepared to provide employees in Sweden with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

You will not be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise the new option, you will be subject to income tax on the difference between the fair market value of the shares on the date of exercise and the exercise price.  Additionally, this amount will also be subject to social insurance contributions.  However, it is your employer’s responsibility to pay the social insurance contributions due on this amount.

Sale of Shares

If you acquire shares upon exercise, you will be subject to capital gains tax when you subsequently sell the shares.  The taxable amount will be the difference between the sale proceeds and the fair market value of shares at exercise.

Withholding and Reporting

Your employer is required to withhold and report income tax when you exercise your new option.  You will be responsible for reporting to your employer that you have exercised the option and the taxable amount.  You must make this report no later than the month after the exercise.  In addition, when you exercise your option, you must report the spread on your annual statement of earnings for that year.  This should match the amount reported by your employer on your income statement.  It is your responsibility to report and pay any taxes due as a result of the sale of the shares.

 

O-1



 

SCHEDULE P

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN TAIWAN

 

This supplement has been prepared to provide employees in Taiwan with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

You will not be subject to tax as a result of the exchange of an eligible option for a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

When you exercise the new option, you will not be subject to tax or social insurance contributions.

Sale of Shares

If you acquire shares upon exercise, you will not be subject to tax when you subsequently sell the shares.

Withholding and Reporting

Your employer is not required to withhold or report income tax or social insurance contributions at the time of exercise or sale of shares.  It is your responsibility to report any pay all applicable taxes.

 

P-1



SCHEDULE Q

LATTICE SEMICONDUCTOR CORPORATION
STOCK OPTION EXCHANGE PROGRAM: A GUIDE TO ISSUES IN THE UNITED KINGDOM

 

This supplement has been prepared to provide employees in the United Kingdom with a summary of the tax and certain legal consequences of the proposed option exchange; that is, the cancellation of eligible options to purchase shares of Lattice Semiconductor Corporation (“Lattice”) in exchange for the grant of new options six months and one day later.  This summary is general in nature and does not discuss all of the tax consequences that may be relevant to you in light of your particular circumstances.  Please note that tax laws change frequently and occasionally they change on a retroactive basis.  We advise all option holders considering participation in the exchange to consult with their own tax or financial advisors.

If you are a citizen or resident of another country for local law purposes, the information contained in this summary may not be applicable to you.  You are strongly advised to seek appropriate professional advice as to how the tax or other laws in your country apply to your specific situation.

Option Exchange

It is unlikely that you will be subject to tax as a result of the exchange of an eligible option for the grant of a new option.

Grant of New Option

You will not be subject to tax when the new option is granted to you.

Exercise of New Option

You will be subject to tax when you exercise your new option.  Income tax will be charged on the difference between the fair market value of the stock on the date of exercise and the exercise price (the “Spread”).  Your employer will be responsible for tax withholding under the Pay As You Earn system in relation to the tax due on the Spread and, therefore, for paying the income tax withheld to the UK Inland Revenue on your behalf.  Your employer will inform you of how it intends to recoup the income tax that it pays on your behalf.  If you fail to pay to your employer the income tax due within 30 days of the date of exercise of your option, you will be deemed to have received a further taxable benefit equal to the amount of income tax due.  This will give rise to a further income tax charge.

You will be liable to pay employees’ national insurance contributions (“NICs”) in relation to the Spread on exercise of your new option.  With effect from 6 April 2003, employees’ NICs are payable up to the maximum earnings limit set for employees’ NICs purposes and, in addition, 1% NICs will apply without limit.  Your employer will be responsible for withholding employees’ NICs and for paying the amount withheld to the UK Inland Revenue on your behalf.

In addition, you must execute a Joint Election Form as a condition to the grant of your new options whereby you agree to be responsible for the employer’s portion of NICs on the Spread at exercise.  For the UK tax year 6 April 2003 to 5 April 2004, the employer’s portion of NICs is scheduled to be charged at a rate of 12.8% on the Spread realized at exercise of your option.  This amount is deductible against your income

Q-1



 

tax liability due with respect to the exercise of your option.  If you do not execute a Joint Election Form with respect to your new options, your option will be cancelled and you will not be permitted to exercise it.

Sale of Shares

When you sell your shares, you will be subject to capital gains tax on the difference between: (1) the sale proceeds; and (2) and the sum of fair market value of the shares at exercise and the amount that was subject to tax at the time of exercise.

Please note that an annual exemption is available to set against total gains, up to a specified limit (£7,700 for the tax year 6 April 2002 to 5 April 2003) and you may also be able to benefit from taper relief to reduce your chargeable gain.  The rate of taper relief is dependant upon the number of years during which shares are held and whether the shares qualify as business assets.

Withholding and Reporting

Your employer is required to withhold and report income tax and NICs (both employee and employer portions) on the Spread at exercise.  If the amount withheld is not sufficient to cover your actual liability, you will be responsible for paying the deficiency.  In addition, you will be responsible for paying any taxes owed as a result of the sale of the shares.

Additional Reporting Requirements

If you are a director or shadow director of a UK subsidiary of Lattice and the UK subsidiary is not wholly owned by Lattice, you are subject to certain notification requirements under the Companies Act.  Specifically, you must notify the UK subsidiary in writing of your interest in Lattice and the number and class of shares or rights to which the interest relates.  You must also notify the UK subsidiary when you exercise your option or sell shares acquired through exercise or your new options.  This disclosure requirement also applies to any rights or shares acquired by your spouse or child (under the age of 18).

Terms of New Option

Your new options will be non-UK approved options.  For your new options, your employer will pass the cost of employer’s NICs to you and you will be required to sign a Joint Election Form agreeing to this pass-through.  If you do not sign the Joint Election Form, you will not be permitted to exercise your new option.  The eligible options that you currently hold are not subject to the requirement that you pay the employer’s portion of NICs with respect to your eligible options.  Therefore, you will not be liable for employer’s NICs to the extent you retain eligible options and they are subsequently exercised.

 

 

Q-2





Exhibit (a)(1)(b)

 

To:                                                       Worldwide Employee Stock Option Holders

 

From:                                        Cyrus Y. Tsui

 

Subject:                            Stock Option Exchange Program

 

Date:                                            February 13, 2003

 

Today, I am pleased to announce that our Board of Directors has decided to offer each of you the opportunity to participate in a Stock Option Exchange Program.

 

Employee stock options are a valuable motivation and retention tool and, as such, help to align the interests of our employees with our stockholders.  Unfortunately, at present, the majority of our currently outstanding employee stock options are “underwater,” meaning that the per share exercise prices of these stock options are greater than the current market price of our common stock.  The Stock Option Exchange Program, approved by our Board of Directors, has been structured to accomplish three important objectives:

 

                  Ensure that our employees are appropriately motivated to continue to work diligently to grow our business and meet our objectives; and

 

                  Reduce the number of outstanding employee stock options as a percentage of outstanding shares and thus reduce potential future stockholder dilution; and

 

                  Implement an exchange of the majority of our currently outstanding, underwater, employee stock options, without adverse accounting consequences.

 

Our Stock Option Exchange Program will provide each eligible employee with the opportunity to exchange certain eligible underwater stock options for new stock options.  These new stock options will be granted on the first business day that is at least six months and one day after the exchanged stock options are cancelled.  The price of these new options will be equal to the closing price of our common stock on the new option grant date.

 

Below is a summary of certain important aspects of our Stock Option Exchange Program.

 

Eligible Options:  All outstanding employee stock options with exercise prices equal to or greater than $12.00 per share that were granted under our 1996 Stock Incentive Plan or our 2001 Stock Plan are eligible for exchange.  Additionally, if you elect to participate in this offer, you must also exchange all options granted on or after August 13, 2002, regardless of the exercise price.

 

Exchange Ratio:  If you elect to participate in this offer, your exchanged options will be replaced with new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.

 

New Option Vesting:  Each new option will have a new two year vesting schedule that will begin on the new option grant date.  Under the new vesting schedule, 12.5% of the shares subject to the new option will vest and become exercisable on the date three months from the new option grant date and 12.5% of the shares subject to the new option will vest and become exercisable every three months thereafter, subject to your continued employment with Lattice or one of our subsidiaries through each relevant vesting date.

 

 

-1-



 

New Option Exercise Price:  The exercise price of the new options will be equal to the closing price of Lattice common stock on the Nasdaq National Market on the new option grant date.  Since the new option grant date is in the future, we cannot predict the exercise price of the new options.

 

Securities and Exchange Commission (SEC) regulations require that we have an offer period that gives you at least 20 business days to decide whether to participate in our Stock Option Exchange Program.  At the end of the 20 business days, we will close the offer period and the exchanged options that are accepted for inclusion in our Stock Option Exchange Program will be cancelled.  Accounting regulations require us to wait a minimum of six months and one day from the cancellation date before we grant the new options to avoid negative accounting treatment.

 

We expect the offer period to close on March 14, 2003 and the exchanged options to be cancelled on March 17, 2003.  Accordingly, we expect to grant new options on September 18, 2003.  Please note that the dates may change if we choose to extend the offer period. You must be an employee of Lattice continuously until the date we grant the new options in order to receive new options.

 

This Stock Option Exchange Program is being made under the terms and subject to the conditions of an Offer to Exchange, a list of Frequently Asked Questions, and the related Election Form and Withdrawal Form, all of which are available on our intranet site at http://intra.latticesemi.com/ and in the Schedule TO relating to this offer that we filed with the SEC, which can be accessed on the SEC’s web site at www.sec.gov.  Copies of the documents can also be obtained from our Stock Option Administrator and in the Human Resource Department at the following domestic locations: LHQ, LSV, LTX and LPA.  You should carefully read all of these documents before you decide whether to participate in the offer.

 

We have attempted to anticipate many of the questions you may have regarding the terms of the Stock Option Exchange Program and have included a list of Frequently Asked Questions as part of the Offer to Exchange, which you may view or download from the two web sites identified above.  Additionally, we will distribute to you a summary of your outstanding stock options with your next paycheck or direct deposit record on February 21, 2003.

 

Participation in our employee Stock Option Exchange Program is completely voluntary.  Participating in the offer involves risks that are discussed in the Offer to Exchange. Unfortunately, neither Lattice, nor any member of management, can advise you whether or not to participate in the Stock Option Exchange Program.  We recommend that you speak with your personal financial, legal and/or tax advisors to weigh the benefits and risks involved in participating in the Stock Option Exchange Program.  If you choose not to participate, you will retain your current options under their current terms and conditions.

 

To participate in the Stock Option Exchange Program, you must properly complete and sign the Election Form and return it to the Stock Option Administrator before the offer expires at 5:00 p.m., Pacific Time, on March 14, 2003, by facsimile at (503) 268-8116 or by hand to the Payroll and Stock Option Department in LHQ.  If the Stock Option Administrator has not received your properly completed and signed Election Form before the offer expires, you will have rejected this offer and you will keep your current options.  These forms are included in the Offer to Exchange, which is available on our intranet site listed above or outside the Stock Option Adminstrator’s office in LHQ and in the Human Resource Department at the following domestic locations: LHQ, LSV, LTX and LPA.

 

Please carefully read all of the offer documents.  This memorandum is an introduction to the offer, but does not detail all the terms and conditions that apply.  Please direct any questions you may have to Bob Adam,

 

 

-2-



 

Manager – Payroll and Benefits, at Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, telephone number (503) 268-8675, or to Terry Dols, Vice President — Human Resources, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8120.

 

NOTE:  Our Company meeting, scheduled for February 13, 2003, will address the Stock Option Exchange Program.  Please plan to attend this informative session.  Should you not be able to attend this meeting for some reason, the Human Resource Department will coordinate several informational meetings during February at LHQ, LSV, LTX and LPA to review the material covered during the February 13. 2003 meeting.

 

 

 

 

 

 

 

 

-3-





Exhibit (a)(1)(c)

FREQUENTLY ASKED QUESTIONS

The following are answers to some of the questions that you may have about the Stock Option Exchange Program.  You should carefully read the entire Offer to Exchange Certain Outstanding Options for new Options (the Offering Circular), the accompanying memorandum from our Chairman and Chief Executive Officer, Cyrus Y. Tsui, dated February 13, 2003, this list of frequently asked questions and the election and withdrawal forms together with their associated instructions.  The offer is made subject to the terms and conditions of these documents as they may be amended.  The information in this list of frequently asked questions is not complete.  Additional important information is contained in the Offering Circular and the remainder of the other offer documents.  We have included in this list of frequently asked questions references to other sections in the Offering Circular to help you find a more complete description of these topics.  References in this offer to “Lattice”, “we”, “us” or “our” refer to Lattice Semiconductor Corporation.

Q1. What is the offer?

A1.                                This offer is a voluntary opportunity for eligible employees to exchange outstanding options for new options.  The following is a brief summary of the terms of this offer:

Eligible Employees

                  Each person who is an employee of Lattice or one of our subsidiaries on the date of this offer who remains an employee through the cancellation date is eligible to exchange outstanding options for new options.

Eligible Options

                  All outstanding options with exercise prices equal to or greater than $12.00 per share that have been granted under our 1996 Stock Incentive Plan or our 2001 Stock Plan are eligible for exchange.

                  If you elect to exchange one or more of your eligible options, you must also exchange all options granted on or after August 13, 2002, regardless of the exercise price.  (Section 2)

Exchange Ratio

                  Exchanged options will be replaced with new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.  (Section 2)

For purposes of this offer, including the exchange ratios, the term “option” refers to an option to purchase one share of Lattice common stock.

New Options

                  New options will be granted on the first business day that is at least six months and one day after the cancellation date.  We refer to this date as the new option grant date.  We expect that the new option grant date will be September 18, 2003.

                  All new options will be nonstatutory stock options.

Exercise Price of the New Options

                  The exercise price of new options will be equal to the closing price of our common stock on the Nasdaq National Market on the new option grant date.  Notwithstanding the foregoing, if you are

 

 



 

                        a resident of Italy, your exercise price will be determined as described in Schedule K of the Offering Circular.  (Section 9)

Vesting and Exercisability of New Options

                  The vesting schedule of each new option will be as follows:  12.5% of the shares subject to the new option will vest every three months, with the vesting to commence on the new option grant date, subject to your continued employment with Lattice or one of our subsidiaries. (Section 9)

Terms Used in This Offer

                  offering period” refers to the period from the commencement of this offer to the expiration date.  The offering period will commence on February 13, 2003 and end on March 14, 2003, unless we extend the offering period.

                  exchanged options” refers to all options that you exchange pursuant to this offer.

                  new options” refers to the options issued pursuant to this offer that replace your exchanged options.

                  expiration date” refers to the time and date that this offer expires.  The expiration date will be March 14, 2003 at 5:00 p.m., Pacific Time, unless we extend the offering period.  If we extend the offering period, the term “expiration date” will refer to the time and date at which the extended offering period expires.

                  cancellation date” refers to the first business day after the expiration date.  This is the date when exchanged options will be cancelled.  The cancellation date will be March 17, 2003, unless we extend the offering period.  If we extend the offering period, then the cancellation date will be similarly extended.

                  new option grant date” refers to the first business day that is at least six months and one day after the cancellation date.  This is the date when new options will be granted.  We expect that the new option grant date will be September 18, 2003.  However, if we extend the offering period, then the new option grant date will be similarly extended.

Q2.                               How do I participate in this offer?

A2.                                If you choose to participate in this offer, you must do the following before 5:00 p.m., Pacific Time, on March 14, 2003:

1.                                       Properly complete and sign the election form provided by Lattice.

2.                                       Deliver the completed and signed election form, either via facsimile (fax number: (503) 268-8116) or by hand delivery, to the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421.

This is a one-time offer, and we will strictly enforce the offering period and expiration date.  We reserve the right to reject any options tendered for exchange that we determine are not in appropriate form or that we determine are unlawful to accept.  Subject to the terms and conditions of this offer, we will accept all properly tendered options promptly after the expiration of this offer.  (Section 4)

We may extend the offering period.  If we extend the offering period, we will issue a press release, e-mail or other communication disclosing the extension no later than 6:00 a.m., Pacific Time, on the business day following the previously scheduled expiration date.

 

-2-



 

The delivery of all documents, including election forms, is at your risk.  We intend to confirm the receipt of your election form and/or any withdrawal form within two (2) business days.  If you have not received a confirmation, you must confirm that we have received your election form and/or any withdrawal form.

Q3.                               Why is Lattice making this offer?

A3.                                We believe that this offer will foster retention of our valuable employees and better align the interests of our employees and stockholders to maximize stockholder value.  We issued the currently outstanding options to motivate our employees to perform at high levels and provide an effective means of recognizing employee contributions to our success.  Some of our outstanding options, whether or not they are currently exercisable, have exercise prices that are significantly higher than the current market price for our stock.  These options are commonly referred to as being “underwater.”  By making this offer, we intend to provide eligible employees with the opportunity to own options that over time may have a greater potential to increase in value.

This offer is also designed to decrease Lattice’s option overhang, which is the number of options outstanding as a percent of the total number of common shares outstanding.  The exchange ratio used in this offer is designed to help accomplish this goal.  (Section 3)

Q4.                               What securities are we offering to exchange?

A4.                                We are offering to exchange all outstanding, unexercised options with exercise prices equal to or greater than $12.00 per share held by eligible employees that have been granted under either our 1996 Stock Incentive Plan or our 2001 Stock Plan.  In exchange, we will grant new options under the 1996 Stock Incentive Plan.  Options to purchase our common stock granted under plans other than the 1996 Stock Incentive Plan and our 2001 Stock Plan are not eligible for exchange.  If you elect to participate in the offer, then you must ALSO exchange all options that we have granted to you on or after August 13, 2002, even if those options have exercise prices below $12.00 per share.  (Section 2)

Q5.                               Who may participate in this offer?

A5.                                You may participate in this offer if you are an employee of Lattice or one of our subsidiaries on the date this offer commences and you remain an employee through the cancellation date.  Non-employee members of our board of directors may not participate.  To receive a new option, you must remain an employee of Lattice or one of our subsidiaries through the new option grant date.  (Section 1)

Q6.                               If I am on an approved leave of absence or absent from work due to illness or disability am I still eligible to participate in this offer?

A6.                                If you are an employee of Lattice or one of our subsidiaries and you are on an approved leave of absence or you are absent from work due to an illness or disability, you will be eligible to participate in this offer as long as you remain an employee through the cancellation date.  To receive a new option, you must remain an employee of Lattice or one of our subsidiaries through the new option grant date.

Q7.                               Am I required to participate in this option exchange?

A7.                                No.  Participation in this offer is completely voluntary. (Section 2)

 

-3-



 

Q8.                               If I elect to exchange an eligible option grant do I have to elect to exchange all of the shares covered by that option grant?

A8.                                Yes.  We are not accepting partial tenders of individual option grants.  However, you may elect to exchange the remaining portion of any option that you have partially exercised.  Accordingly, you may elect to exchange one or more of your option grants, but you must elect to exchange all of the unexercised shares subject to a particular grant or none of the shares for that particular grant.  For example and except as otherwise described in the Offering Circular, if you hold (1) an eligible option to purchase 1,000 shares at an exercise price of $20.00 per share, 700 of which you have already exercised, (2) an eligible option to purchase 1,000 shares at an exercise price of $25.00 per share, and (3) an eligible option to purchase 2,000 shares at an exercise price of $30.00 per share, you may elect to exchange:

                  your first option covering 300 remaining unexercised shares,

                  your second option covering 1,000 shares,

                  your third option covering 2,000 shares,

                  two of your three options,

                  all three of your options, or

                  none of your options.

These are your only choices in this example.  You may not elect, for example, to exchange your first option with respect to only 150 shares (or any other partial amount) under that grant or less than all of the shares under the second and third option grants.  (Section 2)

Q9.                               How many new options will I receive for the options that I exchange?

A9.                                Exchanged options will be replaced with new options at an exchange ratio of four (4) new options for every seven (7) exchanged options.  Fractional options will be rounded up to the nearest whole option. (Section 2)

The number of new options that you receive will be adjusted if there are any changes in our capitalization, such as stock splits, combinations, subdivisions, stock dividends, reclassifications or other similar events, that occur after the cancellation date but before the new option grant date.  (Section 2)

All new options will be nonstatutory stock options.  (Sections 2 and 6)

Q10.                        Why isn’t the exchange ratio simply one-for-one?

A10.                          Our stock option exchange program must balance the interests of both employees and stockholders.  The exchange ratio selected for this offer will decrease the total number of options outstanding and will benefit stockholders by decreasing potential stockholder dilution.  (Section 3)

Q11.                        What will be the exercise price of my new options?

A11.                          The exercise price per share of the new options will be the closing price of our common stock on the  Nasdaq National Market on the new option grant date, which is expected to be September 18, 2003.

 

-4-



 

Notwithstanding the foregoing, if you are a resident of Italy, your exercise price will be determined as described in Schedule  K of the Offering Circular.

We cannot predict the exercise price of the new options.  Because we will grant new options on the first business day that is at least six months and one day after the cancellation date, the new options may have a higher exercise price than some or all of your current options.  (Section 9)

Q12.                        Are there any restrictions on when I can exercise any of the new options that are granted to me?

A12.                          Yes.  You cannot exercise your new options until they vest.  Also, if you are a non-U.S. resident, certain additional restrictions may apply.  Please refer to Schedules D through Q of the Offering Circular for details regarding your specific country.

Q13.                        When will my new options vest?

A13.                          Each new option will have a new two year vesting schedule that will begin on the new option grant date.  Pursuant to the new vesting schedule, 12.5% of the shares subject to the new option will vest and become exercisable on the date three months from the new option grant date and 12.5% of the shares subject to the new option will vest and become exercisable every three months thereafter, subject to your continued employment with Lattice or one of our subsidiaries through each relevant vesting date.  (Section 9)

Q14.                        Are there circumstances under which I would not be granted new options?

A14.                          Yes.  If, for any reason, you are no longer an employee of Lattice or one of our subsidiaries on the new option grant date, you will not receive any new options.  This means that if you quit, with or without a good reason, or die or we terminate your employment with or without cause, before the new option grant date, you will not receive anything for the options that you elected to exchange and that we cancelled.  Unless expressly provided otherwise by the applicable laws of a non-U.S. jurisdiction, your employment will remain “at-will” regardless of your participation in the offer and can be terminated by you or us at any time, with or without cause or notice.  (Section 1)

Moreover, even if we accept your options, we will not grant new options to you if we are prohibited from doing so by applicable laws.  For example, we could become prohibited from granting new options as a result of changes in SEC or Nasdaq rules or the laws of a non-U.S jurisdiction.  We do not anticipate any such prohibitions at this time.  (Section 13)

Q15.                        When will my exchanged options be cancelled?

A15.                          Your exchanged options will be cancelled on the first business day following the expiration date.  We refer to this date as the cancellation date.  We expect that the cancellation date will be March 17, 2003, unless the offering period is extended.  (Section 6)

Q16.                        Once I surrender my exchanged options, is there anything I must do to receive the new options?

A16.                          To receive new options, you must be employed by Lattice or one of our subsidiaries through the new option grant date.

As discussed above, we will grant new options on the first business day that is at least six months and one day after the cancellation date.  We expect that the new option grant date will be September 18, 2003.  If, for any reason, you do not remain employed by Lattice or one of our subsidiaries through

 

-5-



 

the new option grant date, you will not receive any new options or other compensation in exchange for your exchanged options.  Unless expressly provided otherwise by the applicable laws of a non-U.S. jurisdiction, your employment remains “at will” and can be terminated by you or us at any time, with or without cause or notice.  (Section 1)

Q17.                        When will I receive my new options?

A17.                          We will send you a promise to grant stock options promptly after the cancellation date.  The promise to grant stock options represents our commitment to grant you a new option on the new option grant date, provided that you remain employed by Lattice or one of our subsidiaries through the new option grant date.

We will grant the new options on the new option grant date.  The new option grant date will be the first business day that is at least six months and one day after the date on which we cancel the options accepted for exchange.  We will not grant the new options before the new option grant date.  We expect the new option grant date will be September 18, 2003.  If the offering period is extended, the new option grant date will be similarly extended.  (Section 6)

Q18.                        Why do I have to exchange options granted on or after August 13, 2002, if I choose to participate?

A18.                          Under current accounting rules, options that were granted during the six-month period before this offer commenced and the six-month period after the cancellation date could be viewed as “replacement” options for the exchanged options.  As such, accounting rules would require unfavorable accounting treatment for these replacement options.  (Section 12)

Q19.                        What evidence will I have of Lattice’s promise to grant new options to me on the new option grant date?

A19.                          Lattice will deliver to you a written promise to grant the new options to you on the new option grant date.  Lattice will deliver the written promise to you promptly after the cancellation date.  (Section 6)

Q20.                        Why won’t I receive my new options immediately after the expiration date of the offer?

A20.                          Accounting rules prohibit us from granting you new options for a period of six months and one day after the cancellation date, without significant adverse consequences to Lattice.  (Section 12)

Q21.                        Can I exchange shares of Lattice common stock that I acquired upon exercise of Lattice options or through the Lattice ESPP?

A21.                          No.  This offer relates only to outstanding Lattice options.  You may not exchange shares of Lattice common stock in this offer.  (Section 2)

Q22.                        If I participate in this offer, may I receive other option grants before I receive my new options?

A22.                          No.  If you participate in this offer, you will not receive any other option grants before the new option grant date.  Accounting rules prohibit us from granting additional options for a period of six months and one day after the cancellation date, without significant adverse consequences to Lattice.  (Sections 6 and 12)

 

-6-



 

Q23.                        If I do not participate in this offer, may I receive any option grants between now and the new option grant date?

A23.                          We have no current plans to grant options to employees except in connection with this offer and in connection with newly hired employees.  Therefore, you should not expect to receive any option grants between now and the new option grant date if you decide not to participate in this offer.  In addition, although we have made annual option grants to our existing employees in the past, we do not currently intend to grant additional options to our employees this year, other than in connection with this offer and to newly hired employees.  (Section 6)

Q24.                        Is this a repricing of options?

A24.                          No.  This is a stock option exchange offer.  The Financial Accounting Standards Board has issued rules that result in unfavorable accounting consequences for companies that reprice options.  If we repriced your options, our potential for profitability in the future would be significantly reduced because we would be required to record a charge against earnings with respect to any future appreciation of our common stock underlying the repriced options.  (Section 12)

Q25.                        Why can’t you just grant me additional options?

A25.                          Granting additional options covering the same aggregate number of shares of common stock as the outstanding eligible options would have a negative impact on our dilution.  Further, Lattice does not have authority to grant a sufficient number of stock options to make grants to employees that would achieve the same benefits to employees and stockholders that this program does, while allowing Lattice to maintain the flexibility it needs to provide ongoing grants, award additional options to recognize employee performance and grant options to newly hired employees.  We believe this program is in the best interests of our employees and stockholders to incent our employees with appropriate stock options, reduce the outstanding stock option overhang, and conserve options for future grants.  (Section 3)

Q26.                        Will I be required to give up all of my rights under the cancelled options?

A26.                          Yes.  Once we have accepted your exchanged options, your exchanged options will be cancelled and you will no longer have any rights under those options.  This means that if you quit, with or without a good reason, or die or we terminate your employment with or without cause, before the new option grant date, you will not receive anything for the options that you elected to exchange and that we cancelled.  We intend to cancel all exchanged options on the first business day following the expiration date.  We refer to this date as the cancellation date.  We expect that the cancellation date will be March 17, 2003.  (Section 6)

Q27.                        Will the terms and conditions of my new options be the same as my exchanged options?

A27.                          The terms and conditions of the new options may vary from the terms and conditions of the options that you tendered for exchange, but, except as described in the Offering Circular, such changes generally will not be substantially different from your existing rights. (Section 9)

Q28.                        What if Lattice is acquired by another company?

A28.                          At this time, we are not anticipating being acquired.  However, if Lattice were to be acquired between the time of the cancellation date and the new option grant date, then the acquiror must grant

 

-7-



 

the new option under the same terms as provided in this offer.  The type of stock and the number of shares covered by each new option would be determined in the same way as the consideration received by outstanding option holders would be determined at the time of the acquisition.  Such new option would generally have an exercise price equal to the fair market value of the acquiror’s stock on the new option grant date.  As a result of this adjustment, you could receive options for more or fewer shares of the acquiror’s common stock than the number of options you would have received if no acquisition had occurred.  In addition, if you are located outside of the U.S., the new grant may not be able to be made to you by the acquiror or the terms and conditions of the new option may vary from what is described in the Offering Circular.  (Section 9)

Q29.                        What happens to my options if I choose not to participate?

A29.                          If you choose not to participate, your existing options will remain outstanding until they expire by their terms, retain their current exercise price, and retain their current vesting schedule.  (Section 6)

Q30.                        How will Lattice determine whether an option has been properly tendered?

A30.                          We will determine, in our discretion, all questions about the validity, form, eligibility (including time of receipt), and acceptance of any options.  Our determination of these matters will be final and binding on all parties.  We reserve the right to reject any election form or any options tendered for exchange that we determine are not in appropriate form or that we determine are unlawful to accept.  We will accept all properly tendered options that are not validly withdrawn, subject to Section 7 of the Offering Circular.  No tender of options will be deemed to have been properly made until all defects or irregularities have been cured or waived by us.  We have no obligation to give notice of any defects or irregularities in any election form and we will not incur any liability for failure to give any notice.  (Section 4)

Q31.                        Will I have to pay taxes if I participate in the offer?

A31.                          If you participate in the offer, you should not be required under current U.S. law to recognize income for U.S. federal income tax purposes at the time of the exchange.  On the new option grant date, you will not be required under current law to recognize income for U.S. federal income tax purposes.  (Section 14)

If you are a tax resident or citizen of a foreign jurisdiction or are otherwise subject to a tax liability in a foreign jurisdiction, your tax consequences with respect to the exchange may vary from those tax consequences described above for United States citizens or permanent residents.  Employees in foreign jurisdictions should refer to Schedules D through Q of the Offering Circular for a discussion of the tax and legal consequences of electing to participate in the offer.  Tax consequences may also vary depending on each individual option holder’s circumstances.

You should consult with your own tax advisor to determine the personal tax consequences to you of participating in this offer.  If you are a resident of, or subject to the tax laws in, more than one country, you should be aware that there might be additional tax and social insurance consequences that may apply to you.

Q32.                        Will my new options be incentive stock options or nonstatutory stock options?

A32.                          All new options will be nonstatutory stock options for U.S. federal income tax purposes.

 

-8-



 

We recommend that you read the tax discussion in the Offering Circular and discuss the personal tax consequences of nonstatutory stock options with your financial, legal and/or tax advisors.  (Sections 9 and 14)

Q33.                        When will my new options expire?

A33.                          Your new options will expire 10 years from the new option grant date, or earlier if your employment with Lattice or one of our subsidiaries terminates.  (Section 9)

Q34.                        Will I receive a new option agreement?

A34.                          Yes.  All new options will be subject to a new option agreement between you and Lattice. (Section 9)

Q35.                        Is there any chance Lattice will not proceed with the option exchange?

A35.                          The completion of this offer is subject to a number of customary conditions that are described in Section 7 of the Offering Circular.  If any of these conditions are not satisfied, we will not be obligated to exchange properly tendered eligible options, though we may do so at our discretion.

In addition, prior to the expiration date, we may change the offer for any or no reason.  (Section 7)

Q36.                        If you extend the offering period, how will you notify me?

A36.                          If we extend the offering period, we will issue a press release or other public announcement disclosing the extension no later than 6:00 a.m., Pacific Time, on the next business day following the previously scheduled expiration date.  We will also send an e-mail to all eligible employees.  (Sections 2 and 16)

Q37.                        How will you notify me if the offer is changed?

A37.                          If we change the offer, we will issue a press release or other public announcement disclosing the change no later than 6:00 a.m., Pacific Time, on the next business day following the day we change the offer.  We will also send an e-mail to all eligible employees.  (Sections 2 and 16)

Q38.                        Can I change my mind and withdraw from this offer?

A38.                          Yes.  You may change your mind after you have submitted an election form and withdraw from the offer at any time before the offer expires at 5:00 p.m., Pacific Time, on March 14, 2003.  If we extend the offering period beyond that time, you may withdraw your election at any time until the extended offering period expires.  You may change your mind as many times as you wish, but you will be bound by the last properly submitted election or withdrawal form we receive before the offer expires.  (Section 5)

Q39.                        How do I withdraw my election?

A39.                          To withdraw your election, you must do the following before the expiration date:

1.               Properly complete and sign the withdrawal form provided by Lattice.

2.               Deliver the completed and signed withdrawal form to the Stock Option Administrator either by facsimile at (503) 268-8116 or by hand delivery to the Payroll and Stock Option

 

-9-



Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421.  (Section 5)

Q40.                        What if I withdraw my election and then decide again that I want to participate in this offer?

A40.                          If you have withdrawn your election to participate and then decide again that you would like to participate in this offer, you may re-elect to participate by submitting a new properly completed election form that is signed and dated after the date of your withdrawal form.  The new election form must be submitted before the offer expires.  (Section 5)

Q41.                        Are you making any recommendation as to whether I should exchange my eligible options?

A41.                          No.  We are not making any recommendation as to whether you should accept this offer.  You must make your own decision as to whether or not to participate in this offer.  For questions regarding personal tax implications or other investment-related questions, you should talk to your own legal counsel, accountant and/or financial advisor.  (Section 3)

Q42.                        Who can I talk to if I have questions about the offer, or if I need additional copies of the offer documents?

A42.                          If you have questions about this offer, you should contact:

 

 

Bob Adam

 

Terry Dols

 

Manager – Payroll and Benefits

 

Vice President – Human Resources

 

Lattice Semiconductor Corporation

 

Lattice Semiconductor Corporation

 

5555 N.E. Moore Court

 

5555 N.E. Moore Court

 

Hillsboro, OR 97124-6421

 

Hillsboro, OR 97124-6421

 

(503) 268-8675

 

(503) 268-8120

If you need additional copies of the offer documents, you should contact:

 

 

Stock Option Administrator

 

Payroll and Stock Option Department

 

Lattice Semiconductor Corporation

 

5555 N.E. Moore Court

 

Hillsboro, OR 97124-6421

 

(503) 268-8382

 

The offer documents are also available in the Human Resource Department at the following domestic locations: LHQ, LSV, LTX and LPA; on our intranet site at http://intra.latticesemi.com/; and in the Schedule TO relating to this offer that we filed with the SEC, which can be accessed on the SEC’s web site at www.sec.gov.  (Section 10)

 

 

 

 

-10-





Exhibit (a)(1)(d)

 

LATTICE SEMICONDUCTOR CORPORATION
OFFER TO EXCHANGE OPTIONS

 

ELECTION FORM

Before signing this election form, please make sure you have received, read and understand the documents that make up this offer, including: (1) the Offer to Exchange Certain Outstanding Options for New Options (referred to as the offer to exchange); (2) the memorandum from Cyrus Y. Tsui, dated February 13, 2003; (3) the list of Frequently Asked Questions; (4) this election form; and (5) the withdrawal form.  The offer is subject to the terms of these documents as they may be amended.  The offer provides eligible employees who hold eligible stock options the opportunity to exchange these options for new options covering a smaller number of shares, with exercise prices as set forth in Section 9 of the offer.  In accordance with the terms outlined in the offer documents, the number of new options you receive will be based on the exchange ratio set forth in Section 2 of the offer.  This offer expires at 5:00 p.m., Pacific Time, on March 14, 2003, unless we extend the offering period. PLEASE FOLLOW THE INSTRUCTIONS ATTACHED TO THIS FORM.

If you elect to exchange any eligible options, you will also have to exchange all options granted to you on or after August 13, 2002, regardless of the exercise price.  Each new option will have a new two year vesting schedule:  12.5% of the shares subject to the new option will vest and become exercisable on the date three months from the new option grant date and 12.5% of the shares subject to the new option will vest and become exercisable every three months thereafter, subject to your continued employment with Lattice or one of our subsidiaries through each relevant vesting date.  You will lose your rights to all exchanged options that are cancelled under the offer.  Your cancelled options will not be reinstated and you will not receive new options if your employment with Lattice ends for any reason before the new option grant date.

BY PARTICIPATING IN THE OFFER, YOU AGREE TO ALL TERMS OF THE OFFER AS SET FORTH IN THE OFFER DOCUMENTS.

 

-1-



 

If you would like to participate in this offer, please indicate your election by checking the box below, listing the option grants you would like to have exchanged, and completing and signing this election form.  Please be sure to follow the instructions, which are attached.

You may withdraw this election by submitting a properly completed and signed withdrawal form prior to the expiration date, which will be 5:00 p.m., Pacific Time, March 14, 2003, unless we extend the offering period.

o            Yes, I wish to tender for exchange each of the options listed below (and on any additional sheets which I have attached to this form).  I understand that if I wish to exchange any of my options, this list will automatically include all options granted to me since August 13, 2002, regardless of the exercise price:

 

Grant Number

 

Grant Date

 

Exercise Price

 

Total Number of Unexercised Shares

Subject to the Option (Shares to Be Cancelled)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

o            I have attached an additional sheet listing my name and any additional grants I wish to cancel.

 

 

 

 

 

 

Employee Signature

 

Location/Cost Center Number

 

 

 

 

 

 

 

 

 

 

 

 

Employee Name (Please print)

 

E-mail Address

 

 

 

Date and Time

RETURN TO THE STOCK OPTION ADMINISTRATOR NO LATER THAN
5:00 P.M., PACIFIC TIME, ON MARCH 14, 2003
VIA FACSIMILE AT (503) 268-8116 OR HAND DELIVERY

 

 

 

-2-



 

LATTICE SEMICONDUCTOR CORPORATION
OFFER TO EXCHANGE OPTIONS

INSTRUCTIONS

FORMING PART OF THE TERMS AND CONDITIONS OF THE OFFER

1.             Delivery of Election Form.

A properly completed and signed original of this election form (or a facsimile of it) must be received by the Stock Option Administrator either via hand delivery to the Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, or via facsimile (fax number: (503) 268-8116), on or before 5:00 p.m., Pacific Time, on March 14, 2003 (referred to as the expiration date).

The delivery of all required documents, including election forms, is at your risk.  Delivery will be deemed made only when actually received by the Stock Option Administrator of Lattice Semiconductor Corporation (sometimes referred to as the Company).  You may hand deliver your election form to the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, or you may fax it to the Stock Option Administrator at (503) 268-8116.  In all cases, you should allow sufficient time to ensure timely delivery.  We intend to confirm the receipt of your election form within two (2) business days.  If you have not received such a confirmation, it is your responsibility to ensure that your election form has been received by March 14, 2003.

Neither our receipt of your election form nor our delivery of a confirmation of receipt to you will constitute an acceptance of your options for exchange.  For purposes of the offer, we will be deemed to have accepted options for exchange that are validly tendered and not properly withdrawn as of when we give oral or written notice to the option holders generally of our acceptance for exchange of such options, which notice may be made by press release, e–mail or other method of communication.

Lattice will not accept any alternative, conditional or contingent tenders.  Although it is our intent to send you a confirmation of receipt of this election form, by signing this election form, you waive any right to receive any notice of the receipt of the tender of your options, except as provided for in the offer to exchange.  Any confirmation of receipt sent to you will merely be a notification that we have received your election form and does not mean that your options have been cancelled.  Your options that are accepted for exchange will be cancelled on the first business day following the expiration of the offer, which cancellation is scheduled to be March 17, 2003.

2.             Withdrawal and Additional Tenders.

Tenders of options made through the offer may be withdrawn at any time before 5:00 p.m., Pacific Time, on March 14, 2003.  If Lattice extends the offer beyond that time, you may withdraw your tendered options at any time until the extended expiration of the offer.  In addition, although Lattice currently intends to accept your validly tendered options promptly after the expiration of the offer, if we have not accepted your options by 9:00 p.m., Pacific Time, on April 10, 2003, you may withdraw your tendered options at any time thereafter.  To withdraw tendered options you must hand deliver (Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421) or fax (fax number: (503) 268-8116) a signed and dated withdrawal form, with the required information, to the Stock Option Administrator while you still have the right to withdraw the tendered options.  You may not rescind any withdrawal and any eligible options withdrawn will be deemed not properly tendered for purposes of the offer, unless you properly re-elect to exchange some or all of the withdrawn options before the expiration date.  To re-elect to exchange some or all of your withdrawn options, you must submit a new election form to the Stock Option Administrator before the expiration date by following the procedures described in these instructions.  Your new election form must include the required information regarding all of your tendered options and must be signed and clearly dated after the date of your original election

 

-1-



 

form and any withdrawal form you have submitted.  Upon the receipt of such a new, properly filled out, signed and dated election form, any previously submitted election form or withdrawal form will be disregarded and will be considered replaced in full by the new election form.  You will be bound by the last properly tendered election or withdrawal form we receive before the expiration date.

3.             Tenders.

As more fully set forth in the offer, Lattice will not accept partial tenders of options.  Each option grant that you elect to exchange must be for the entire portion that is outstanding and unexercised.  However, you may elect to exchange the remaining portion of an option that you have partially exercised.  As a result, you may elect to exchange one or more of your option grants, but you must elect to exchange all of the unexercised shares subject to each grant or none of the shares for that particular grant.  If you participate in this offer, you must also elect to exchange all options granted to you on or after August 13, 2002, regardless of the exercise price.

4.             Signatures on this Election Form.

If this election form is signed by the holder of the options, the signature must correspond with the name as written on the face of the option agreement or agreements to which the options are subject without alteration, enlargement or any change whatsoever.  If your name has been legally changed since your option agreement was signed, please submit proof of the legal name change.

If this election form is signed by a trustee, executor, administrator, guardian, attorney-in-fact, officer of a corporation or other person acting in a fiduciary or representative capacity, that person should so indicate when signing, and proper evidence satisfactory to Lattice of the authority of that person to act in that capacity must be submitted with this election form.

5.             Other Information on This Election Form.

In addition to signing this election form, you must print your name and indicate the date and time at which you signed.  You must also include a current e-mail address and your location/cost center number.

6.             Requests For Assistance or Additional Copies.

Any questions or requests for assistance may be directed to Bob Adam, Manager – Payroll and Benefits, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, telephone number (503) 268-8675, or to Terry Dols, Vice President – Human Resources, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8120.  If you need additional copies of the offer documents, you should contact the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8382. Copies will be furnished promptly at Lattice’s expense.  The offer documents are also available in the Human Resource Department at the following domestic locations: LHQ, LSV, LTX and LPA; on our intranet site at http://intra.latticesemi.com/; and in the Schedule TO relating to this offer that we filed with the SEC, which can be accessed on the SEC’s web site at www.sec.gov.

7.             Irregularities.

We will determine, in our discretion, all questions as to the form of documents and the validity, form, eligibility, including time of receipt, and acceptance of any options.  Our determination of these matters will be final and binding on all parties.  We reserve the right to reject any election form or any options elected to be exchanged that we determine are not in appropriate form or that we determine are unlawful to accept.  We will accept all properly tendered options that are not validly withdrawn.  We also reserve the right to waive any of the

 

-2-



 

conditions of the offer or any defect or irregularity in any tender of any particular options or for any particular option holder, provided that if we grant any such waiver, it will be granted with respect to all option holders and tendered options.  No tender of options will be deemed to have been properly made until all defects or irregularities have been cured by the tendering option holder or waived by us.  Neither we nor any other person is obligated to give notice of any defects or irregularities in tenders, nor will anyone incur any liability for failure to give any notice.  This is a one-time offer, and we will strictly enforce the offering period and expiration date, subject only to an extension that we may grant in our discretion.

Important:  The election form (or a facsimile copy of it) together with all other required documents must be received by the Stock Option Administrator on or before 5:00 p.m., Pacific Time, on March 14, 2003.

8.             Additional Documents to Read.

You should be sure to read the offer, all documents referenced therein, and the memorandum from Cyrus Y. Tsui, dated February 13, 2003, before deciding to participate in the offer.

9.             Important Tax Information.

If you are subject to tax in the United States, you should refer to Section 14 of the offer, which contains important federal income tax information.  If you are subject to tax in another country, you should refer to Schedules D through Q, as applicable, which contain important tax information.  We also recommend that you consult with your personal advisors before deciding whether or not to participate in this offer.

10.          Miscellaneous.

A.            Data Privacy.  By accepting this offer, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by and among, as applicable, Lattice Semiconductor Corporation and/or any of its subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing your participation in the offer.

You understand that Lattice Semiconductor Corporation and/or any of its subsidiaries and affiliates may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in Lattice Semiconductor Corporation and/or any of its subsidiaries and affiliates, details of all options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of implementing, administering and managing the offer (Data).  You understand that Data may be transferred to any third parties assisting in the implementation, administration and management of the offer, that these recipients may be located in your country, or elsewhere, and that the recipient’s country may have different data privacy laws and protections than your country.  You understand that you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative.  You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the offer, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares of stock acquired upon exercise of the option.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the offer.  You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or if you are a resident of certain countries, refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  You understand, however, that refusing or withdrawing your consent means that you may not participate in the offer.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.

 

-3-



 

B.            Acknowledgement and Waiver.  By accepting this offer, you acknowledge that: (1) the offer is established voluntarily by Lattice, it is discretionary in nature and it may be extended, modified or terminated by Lattice in accordance with the terms of the offer; (2) your acceptance of the offer is voluntary; (3) your acceptance of the offer shall not create a right to further employment with your employer and shall not interfere with the ability of your employer to terminate your employment relationship at any time with or without cause; (4) no claim or entitlement to compensation or damages arises from the termination or the diminution in value of the options involved in the offer; (5) the future value of Lattice’s shares is uncertain and cannot be predicted with certainty; and (6) the offer, the exchanged options and the new options are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.

C.            Responsibility for Taxes.  Regardless of any action that Lattice, its subsidiaries or its affiliates take with respect to any or all income tax, social insurance, payroll tax or other tax-related withholding related to the exchange, including the cancellation/exchange of eligible options and the grant of new options (“Applicable Withholdings”), you acknowledge that the ultimate liability for all Applicable Withholdings is and remains your sole responsibility.  In that regard, you authorize Lattice and/or its subsidiaries or its affiliates to withhold all Applicable Withholdings legally payable by you from your wages or other cash payment paid to you by Lattice and/or its subsidiaries or its affiliates or from proceeds of the sale of shares.  Alternatively, or in addition, if permissible under local law, Lattice may, in its discretion: (1) sell or arrange for the sale of shares of Lattice common stock that you acquire to meet the Applicable Withholding obligation; and/or (2) withhold in shares of Lattice common stock, provided that Lattice withholds only the amount of shares of Lattice common stock necessary to satisfy the minimum withholding amount.  Finally, you agree to pay to Lattice, its subsidiary or its affiliate any amount of Applicable Withholdings that Lattice, its subsidiary or its affiliate may be required to withhold as a result of your participation in the exchange offer if Lattice does not satisfy the Applicable Withholding through other means.

 

 

 

 

-4-





Exhibit (a)(1)(e)

COMPLETE AND RETURN THIS FORM ONLY
IF YOU HAVE CHANGED YOUR MIND
AND YOU DO NOT WANT TO EXCHANGE YOUR OPTIONS

 

 

LATTICE SEMICONDUCTOR CORPORATION
OFFER TO EXCHANGE OPTIONS

 

WITHDRAWAL FORM

 

You previously received (i) a copy of the offer to exchange; (ii) the memorandum from Cyrus Y. Tsui, dated February 13, 2003; (iii) the list of frequently asked questions; and (iv) an election form.  You signed and returned the election form, in which you elected to ACCEPT Lattice’s offer to exchange some or all of your eligible options.  You should submit this form only if you now wish to change that election and REJECT Lattice’s offer to exchange your eligible options.

 

To withdraw your election to exchange your eligible options, you must sign, date and deliver this withdrawal form to the Stock Option Administrator via facsimile, fax number: (503) 268-8116, or hand delivery to the Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421 by 5:00 p.m., Pacific Time, on March 14, 2003.

 

You should note that if you withdraw your acceptance of the offer, you will not receive any new options pursuant to the offer in replacement for the withdrawn options.  You will keep all of the options that you withdraw.  These options will continue to be governed by the stock option plan under which they were granted and by the existing option agreements between you and Lattice.

 

You may change this election, and again elect to exchange the withdrawn options by submitting a new election form to the Stock Option Administrator via facsimile (fax number: (503) 268-8116) or hand delivery to the Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, by 5:00 p.m., Pacific Time, on March 14, 2003.

 

 

 

-1-



 

Please check the appropriate box:

 

o            I wish to withdraw ALL the options listed on my election form and instead REJECT the offer to exchange options.  I do not wish to exchange any options.

 

OR

 

o            I wish to withdraw my election to exchange each of the options listed below (and on any additional sheets which I have attached to this form).  I still wish to exchange the rest of the options listed on the election form I submitted, as well as all options granted to me since August 13, 2002:

 

Grant Number

 

Grant Date

 

Exercise

Price

 

Total Number of Unexercised Shares

Subject to the Option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

o            I have attached an additional sheet listing my name and any additional grants I wish to withdraw from the offer.

 

Please sign this withdrawal form and print your name exactly as it appears on the election form.

 

 

 

 

 

 

Employee Signature

 

Location/Cost Center Number

 

 

 

 

 

 

 

 

 

 

 

 

Employee Name (Please print)

 

E-mail Address

 

 

 

 

 

 

 

Date and Time

 

 

 

 

 

RETURN TO THE STOCK OPTION ADMINISTRATOR NO LATER THAN
5:00 P.M., PACIFIC TIME, ON MARCH 14, 2003
VIA FACSIMILE AT (503) 268-8116 OR HAND DELIVERY

 

 

 

-2-



 

LATTICE SEMICONDCUTOR CORPORATION
OFFER TO EXCHANGE OPTIONS

INSTRUCTIONS TO THE WITHDRAWAL FORM

FORMING PART OF THE TERMS AND CONDITIONS OF THE OFFER

1.             Delivery of Withdrawal Form.

A properly completed and executed original of this withdrawal form (or a facsimile of it), must be received by the Stock Option Administrator, either via hand delivery at the Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421 or via facsimile, fax number (503) 268-8116 on or before 5:00 p.m., Pacific Time, on March 14, 2003 (referred to as the expiration date).  If Lattice Semiconductor Corporation (sometimes referred to as the Company) extends the offering period, this withdrawal form must be received by the Stock Option Administrator by the date and time of the extended expiration of the offer.

The delivery of all required documents, including withdrawal forms and any new election forms, is at your risk.  Delivery will be deemed made only when actually received by the Stock Option Administrator of Lattice Semiconductor Corporation.  You may hand deliver your election form to the Stock Option Administrator at the Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, or you may fax it to the Stock Option Administrator at fax number (503) 268-8116.  In all cases, you should allow sufficient time to ensure timely delivery.  We intend to confirm the receipt of your withdrawal form within two (2) business days; if you have not received such a confirmation of receipt, it is your responsibility to ensure that your withdrawal form has been received by the Stock Option Administrator.

As noted in the offer to exchange, you may select individual option grants to be tendered for exchange.  You may, if you wish, withdraw some of your options from the offer while continuing to elect others to be exchanged in the offer.  Any options previously elected for exchange and not withdrawn by you will still be tendered for the entire outstanding, unexercised portion of such options.  In addition, if you do not withdraw all your options from this offer, and as a result are still participating in the offer, all options granted to you since August 13, 2002 will still be deemed tendered for exchange.

Although by submitting a withdrawal form you have withdrawn some or all of your previously tendered options from the offer, you may change your mind and re-elect to exchange the withdrawn options until the expiration of the offer.  You should note that you may not rescind any withdrawal and any eligible options withdrawn will be deemed not properly tendered for purposes of the offer, unless you properly re-elect to exchange those options before the expiration date.  Tenders to re-elect to exchange options may be made at any time before the expiration date.  If Lattice extends the offer beyond that time, you may re-tender your options at any time until the extended expiration of the offer.  To re-elect to tender the withdrawn options, you must deliver a later dated and signed election form with the required information to the Stock Option Administrator, while you still have the right to participate in the offer.  Your options will not be properly tendered for purposes of the offer unless the withdrawn options are properly re-tendered before the expiration date by delivery of the new election form following the procedures described in the instructions to the election form.  This new election form must be signed and dated after your original election form and any withdrawal form you have submitted.  Upon the receipt of such a new, properly filled out, signed and dated election form, any previously submitted election form or withdrawal form will be disregarded and will be considered replaced in full by the new election form.  You will be bound by the last properly tendered election or withdrawal form we receive before the expiration date.

Although it is our intent to send you a confirmation of receipt of this withdrawal form, by signing this withdrawal form, you waive any right to receive any notice of the withdrawal of the tender of your options.

 

-1-



 

2.             Signatures on This Withdrawal Form.

If this withdrawal form is signed by the holder of the eligible options, the signature must correspond with the name as written on the face of the option agreement or agreements to which the options are subject without alteration, enlargement or any change whatsoever.  If your name has been legally changed since your option agreement was signed, please submit proof of the legal name change.

If this withdrawal form is signed by a trustee, executor, administrator, guardian, attorney-in-fact, officer of a corporation or other person acting in a fiduciary or representative capacity, that person should so indicate when signing, and proper evidence satisfactory to Lattice of the authority of that person so to act must be submitted with this withdrawal form.

3.             Other Information on This Withdrawal Form.

In addition to signing this withdrawal form, you must print your name and indicate the date and time at which you signed.  You must also include a current e-mail address and your location/cost center number.

4.             Requests for Assistance or Additional Copies.

Any questions or requests for assistance may be directed to Bob Adam, Manager – Payroll and Benefits, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, telephone number (503) 268-8675, or to Terry Dols, Vice President – Human Resources, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8120.  If you need additional copies of the offer documents, you should contact the Stock Option Administrator, Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, OR 97124-6421, telephone number (503) 268-8382. Copies will be furnished promptly at Lattice’s expense.  The offer documents are also available in the Human Resource Department at the following domestic locations: LHQ, LSV, LTX and LPA; on our intranet site at http://intra.latticesemi.com/; and in the Schedule TO relating to this offer that we filed with the SEC, which can be accessed on the SEC’s web site at www.sec.gov.

5.             Irregularities.

All questions as to the validity, form, eligibility (including time of receipt) and acceptance of this withdrawal from the offer will be determined by Lattice in its discretion.  Lattice’s determinations shall be final and binding on all parties.  Lattice reserves the right to reject any or all withdrawal forms that Lattice determines not to be in proper form or the acceptance of which may, in the opinion of Lattice’s counsel, be unlawful.  Lattice also reserves the right to waive any of the conditions of the offer and any defect or irregularity in the withdrawal form, and Lattice’s interpretation of the terms of the offer (including these instructions) will be final and binding on all parties.  No withdrawal form will be deemed to be properly made until all defects and irregularities have been cured or waived.  Unless waived, any defects or irregularities in connection with withdrawal forms must be cured within the time as Lattice shall determine.  Neither Lattice nor any other person is or will be obligated to give notice of any defects or irregularities in withdrawal forms, and no person will incur any liability for failure to give any such notice.

Important:  The withdrawal form (or a facsimile copy of it) together with all other required documents must be received by the Stock Option Administrator on or before the expiration date.

6.             Additional Documents to Read.

You should be sure to read the offer to exchange, all documents referenced therein, and the memorandum from Cyrus Y. Tsui dated February 13, 2003, before making any decisions regarding participation in, or withdrawal from, the offer.

 

-2-



 

7.             Important Tax Information.

If you are subject to tax in the United States, you should refer to Section 14 of the offer to exchange, which contains important federal income tax information.  If you are subject to tax in another country, you should refer to Schedules D through Q, as applicable, which contain important tax information.  We also recommend that you consult with your personal advisors before deciding whether or not to participate in this offer.

 

 

 

 

 

 

-3-





Exhibit (a)(1)(f)

FORM OF
PROMISE TO GRANT STOCK OPTION

TO

 

 

 

In exchange for your agreement to cancel one or more of your outstanding stock options to purchase shares of Lattice Semiconductor Corporation (Lattice) common stock that you received from Lattice with exercise prices equal to or greater than $12.00 per share along with all stock options that were granted to you on or after August 13, 2002, regardless of the exercise price, Lattice hereby promises to grant you a nonstatutory stock option to purchase ______ shares of Lattice’s common stock granted under the 1996 Stock Incentive Plan (the New Option).  Lattice will grant the New Option on _________, 2003 (the New Option Grant Date), which is the first business day that is at least six months and one day after the date your options were cancelled.

The exercise price of each New Option will be the closing price of Lattice common stock on the Nasdaq National Market on the New Option Grant Date.  However, if you are a resident of Italy, the exercise price per share of the New Option will be as set forth in the Offer.

Each New Option will have a new two year vesting schedule that will begin on the New Option Grant Date.  Pursuant to the new vesting schedule, 12.5% of the shares subject to the New Option will vest and become exercisable on the date three months from the New Option Grant Date and 12.5% of the shares subject to the New Option will vest and become exercisable every three months thereafter, subject to your continued employment with Lattice (or one of its subsidiaries or successors) through each relevant vesting date.

Each New Option will be subject to the standard terms and conditions of the stock option plan under which it is granted and the appropriate form of stock option agreement thereunder.

Before the grant of the New Option on the New Option Grant Date, it is possible that Lattice may merge or consolidate with or be acquired by another entity.  This promise to grant stock option (this Promise) is evidence of a binding commitment that Lattice’s successors must honor, if permissible under local laws.  In the event of any such transaction, the successor entity would be obligated to grant you a stock option on the New Option Grant Date.  However, the type of stock and the number of shares covered by each New Option would be determined in the same way as the consideration received by outstanding option holders is determined at the time of the acquisition.  Such New Option would generally have an exercise price equal to the fair market value of the acquiror’s stock on the grant date of the New Option.  Please note that if you are located outside of the U.S., the terms of the New Option may vary to comply with local law.

To receive your New Option, you must continue to be employed by Lattice (or one of its subsidiaries or successors) as of the New Option Grant Date.  This Promise does not constitute a guarantee of employment with Lattice or any of its subsidiaries for any period.  Unless expressly provided otherwise by the applicable laws of a non-U.S. jurisdiction, your employment with Lattice or its subsidiaries will remain “at will” and can be terminated by you or Lattice at any time, with or without cause or notice.  If your employment with Lattice or one of its subsidiaries or successors terminates before the New Option Grant Date, for any reason, you will lose all rights under this Promise to receive a New Option.

 

-1-



 

This Promise is subject to the terms and conditions of the offer as set forth in: (1) the Offer to Exchange Certain Outstanding Options for New Options (referred to as the offer to exchange); (2) the memorandum from Cyrus Y. Tsui, dated February 13, 2003; (3) the list of Frequently Asked Questions; (4) the Election Form; and (5) the Withdrawal Form (collectively, the Exchange Offer Documents), all of which are incorporated herein by reference.  This Promise and the Exchange Offer Documents reflect the entire agreement between you and Lattice with respect to this transaction.  This Promise may be amended only by means of a writing signed by you and an authorized officer of Lattice.

 

 

 

 

 

LATTICE SEMICONDUCTOR CORPORATION

 

 

 

 

 

 

 

 

 

 

By:

 

 

 

 

 

Date:

 

 

 

 

-2-





Exhibit 99(a)(1)(g)

 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

 

Link to searchable text of slide shown above

 



 

Exhibit 99(a)(1)(g)

 

 

STOCK OPTION

EXCHANGE PROGRAM

 

Employee Overview

 

 

 

 

February 2003

 

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

LATTICE MAKES NO RECOMMENDATION

 

                                          This presentation and the information contained in it are provided for informational purposes only.

 

                                          Neither Lattice, nor anyone acting on Lattice’s behalf, makes any recommendation as to whether you should participate in our Stock Option Exchange Program, nor has Lattice authorized any person to make such a recommendation.

 

                                          You should carefully read all of our Stock Option Exchange Program documents, which are available on the Lattice intranet site and from our Human Resources and Payroll departments, consult with your personal financial, legal and/or tax advisors, and fully understand the risks before making any decision about whether to participate in our Stock Option Exchange Program.

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

WHY ARE WE DOING THIS?

 

                                          We believe stock options can be a key employee motivation and retention tool.

 

                                          Currently, the majority of options held by our employees are “underwater”, and thus not a performance or retention incentive.

 

                                          We believe this Stock Option Exchange Program will foster retention of our employees and better align the interests of our employees and our stockholders to maximize stockholder value.

 

                                          We also want to decrease our option “overhang”

                                   Overhang means our outstanding options as a percentage of our total outstanding shares.

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

WHAT ARE WE OFFERING?

 

                                          Voluntary Stock Option Exchange

 

                                   An opportunity to exchange certain of your existing options for a new option.

 

                                   A new option will be granted 6 months and 1 day after the cancellation of existing options submitted in this Stock Option Exchange Program.

 

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

HOW CAN YOU PARTICIPATE IN THIS OFFER?

 

                                          To participate in this Stock Option Exchange Program, our Stock Option Administrator:  Michelle Bressman — LHQ,  Fax (503) 268-8116, must receive your properly completed and signed Election Form by Friday, March 14, 2003 at 5:00 pm (PT).

 

 

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

KEY TERMS OF THE STOCK OPTION EXCHANGE PROGRAM

ELIGIBILITY

                                          Eligible Employees

                                   All worldwide employees are eligible to participate

                                   Must currently have an Eligible Option

                                   Must be employed continuously until the date the new option is granted

 

              Eligible Options

                                   Any outstanding option, vested or unvested, with an exercise price greater than or equal to $12 per share.

                                   Employees may choose, on a grant by grant basis, which eligible options to exchange.

                                          If you choose to exchange a specific option grant, the entire grant must be exchanged.

                                          If you choose to exchange ANY option grant, ALL options granted to you since August 13, 2002 must also be exchanged REGARDLESS OF EXERCISE PRICE

 

              What is Not Included in this Offer

                                   Stock, whether obtained from prior exercise of options, ESPP or otherwise.

                                   Any options with an exercise price below $12 per share.
(Except as provided above.)

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

 

KEY TERMS OF THE STOCK OPTION EXCHANGE PROGRAM

NEW OPTION GRANTS

 

              Price

                                   New options will be priced at the closing price of our common stock on the date they are granted. (Six months and one day after cancellation.)

 

              Number of Shares

                                   All new option grants will be made based upon an Exchange Ratio of 4 new shares : 7 old shares. (1:1.75)

                                   Example:

                                   If you elect to exchange an option of 700 shares @ $24.88 / share.

                                   You will receive a new option of 400 shares @ future market price / share.

 

              Vesting

                                   The new option will vest on a linear basis over a 2-year period, subject to continued employment.

                                   0% vested on date of grant.

                                   12.5% vested three months after grant.

                                   100% vested two years after grant.

 

              Option expiration date

                                   The new option will expire 10 years after grant.

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

2003 REPLENISHMENT OPTION GRANTS

 

              Historically, Lattice has granted annual replenishment option grants to all eligible employees during August

 

              In light of this program, the Company does not currently plan to grant ANY replenishment options during 2003.

 

                                          Regardless of your decision to participate in our Stock Option Exchange Program, you should assume you WILL NOT receive a replenishment option grant during 2003.

 

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

IMPORTANT DATES

 

                DATE                                                     IMPORTANT EVENT

 

              February 13, 2003                              OFFER COMMENCES

 

              March 14, 2003 *                                OFFER CLOSES

 

              March 17, 2003 *                                OPTIONS CANCELLED

 

              September 18, 2003 *                        NEW OPTIONS GRANTED

 

 

* Dates subject to change in the event the offer period is extended.

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

RISKS OF PARTICIPATION

 

                                          Our stock price may increase and the exercise price of new option grants made under this Stock Option Exchange Program may be greater than the exercise price of the exchanged options.

 

                                          If your employment with Lattice terminates, for any reason, voluntarily or involuntarily (including death), before the new option grants are made, you will not receive any new options and your cancelled options will not be reinstated.

 

              Other Risks

                                   Participating in this Stock Option Exchange Program involves a number of additional risks including those described in our Stock Option Exchange Program documents, which are available on the Lattice intranet site, in our Human Resources and Payroll departments and on the SEC website.  You should carefully read all of our Stock Option Exchange Program documents and consult with your personal financial, legal and/or tax advisors, and fully understand the risks before making any decision about whether to participate in our Stock Option Exchange Program.

 

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

SUPPORTING INFORMATION

 

                                          The following materials are available on http://intra.latticesemi.com or from the Human Resources or Payroll departments.

                                   Letter from Cyrus Tsui

                                   Offer to Exchange Options

                                   Frequently Asked Questions

                                   Election Form

                                   Withdrawal Form

                                   Schedule TO

 

                                          Your Personal Option Status forms will be distributed on February 21, 2003 with your paycheck/pay stub.

 

                                          Any changes or updates to the Program will be posted on the Lattice intranet and filed with the SEC.

 

                                          Employee Briefing Sessions

                                   Human Resources and Stock Option Administration will coordinate informational sessions at LHQ, LSV, LTX and LPA during February.

                                   During these sessions, this presentation will be repeated.

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]

 



 

 

QUESTIONS?

 

              Terry Dols, Vice President Human Resources

                                          (503) 268-8120

 

              Bob Adam, Manager Payroll and Benefits

                                          (503) 268-8675

 

 

 

 

Lattice Semiconductor Corporation Confidential

 

[LOGO]





Exhibit (a)(1)(h)

 

FORM OF

CONFIRMATION OF STOCK OPTIONS ELECTED FOR EXCHANGE/WITHDRAWAL

 

Employee Name:

 

Location/Cost Center Number:

 

 

Below is a summary of the stock option grants you voluntarily elected to [exchange pursuant to/withdraw from] Lattice’s Stock Option Exchange Offer.  Please review the summary carefully, and immediately contact the Stock Option Administrator if discrepancies exist.

 

Grant Number

 

Grant Date

 

Exercise

Price

 

Total Number of Unexercised Shares Subject to

the Option (Shares to Be [Cancelled/Withdrawn])

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 





Exhibit (a)(1)(i)

 

FORM OF

REMINDER NOTICE

 

 

The Stock Option Exchange Program of Lattice Semiconductor Corporation will expire [soon/in __ days].

 

If you wish to participate, you must deliver your election form to the Stock Option Administrator via fax (fax number: (503) 268-8116) or hand delivery (Payroll and Stock Option Department, Lattice Semiconductor Corporation, 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421) before 5 p.m., Pacific Time, on March 14, 2003.

 

If you have already elected to participate and want to withdraw your election, we must receive your withdrawal form before the same deadline.  The last form received before the deadline will be the effective one.  All forms received after 5 p.m., Pacific Time, on March 14, 2003 will not be effective.

 

 

 

 

 

 

 





Exhibit 99(d)(1)

 

LATTICE SEMICONDUCTOR CORPORATION

 

1996 STOCK INCENTIVE PLAN

(as amended August 1, 2000)

 

 

1.             Purpose.  The purpose of this 1996 Stock Incentive Plan (the “Plan”) is to enable Lattice Semiconductor Corporation (the “Company”) to attract and retain experienced and able employees and to provide additional incentive to these employees to exert their best efforts for the Company and its stockholders.

 

2.             Shares Subject to the Plan.  Subject to adjustment as provided below and in paragraph 12, the stock to be offered under the Plan shall consist of shares of the Company’s Common Stock (“Stock”), and the number of shares of Stock that may be issued pursuant to this Plan shall not exceed, in the aggregate, 8,600,000 shares. Such shares may be authorized and unissued shares or may be treasury shares. If an option granted under the Plan expires or terminates for any reason without having been exercised in full, the unpurchased shares subject to such option shall again be available under the Plan. If Stock sold or awarded as a bonus under the Plan is forfeited to the Company or repurchased by the Company at its original purchase price pursuant to applicable restrictions, the number of shares forfeited or repurchased shall again be available under the Plan; provided, however, that, Stock which has actually been issued under the Plan and is not subject to a repurchase right at its original purchase price shall not in any event be returned to the Plan and shall not become available for future distribution under the Plan. Stock issued under the Plan may be subject to such restrictions on transfer, repurchase rights or other restrictions as determined by the Board of Directors of the Company (the “Board of Directors”).

 

3.             Effective Date and Duration of Plan.

 

(a)           Effective Date.  The Plan shall become effective when adopted by the Board of Directors. Options may be granted and Stock may be awarded as bonuses or sold under the Plan at any time after the effective date and before termination of the Plan.

 

(b)           Duration.  The Plan shall continue in effect until, in the aggregate, options and stock appreciation rights have been granted and exercised and Stock has been awarded as bonuses or sold and the restrictions on any such Stock have lapsed on all shares available for the Plan under paragraph 2 (subject to any adjustments under paragraph 12); provided, however, that unless sooner terminated by the Board of Directors, no incentive stock options shall be granted on or after the tenth anniversary of the effective date. The Board of Directors may suspend or terminate the Plan at any time except with respect to options and to Stock subject to restrictions then outstanding under the Plan. Termination shall not affect any right of the Company to repurchase shares or the forfeitability of shares issued under the Plan.

 

4.             Administration.

 

(a)           Composition of Administrator.

 

                (i)   Multiple Administrative Bodies.  If permitted by Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 16b-3”) and the legal requirements relating to the administration of stock option plans under applicable securities laws, Delaware corporate law and the Internal Revenue Code of 1986, as amended (the “Code”) (“Applicable Laws”), the Plan may (but need not) be administered by different administrative bodies with respect to (A) members of the Board of Directors (“Directors”) who are employees, (B) officers who are not Directors and (C) employees who are neither Directors nor officers.

 

                (ii)  Administration with Respect to Directors and Officers.  With respect to grants, awards and sales to eligible participants who are officers or Directors of the Company, the Plan shall be administered by (A) the Board of Directors, if the Board of Directors may administer the Plan in compliance with Rule 16b-3 as it applies to a plan intended to qualify thereunder as a discretionary grant or award plan, or (B) a committee designated by the Board of Directors to administer the Plan, which committee shall be constituted (1) in such a manner as to permit the Plan to comply

 

 

-1-



 

with Rule 16b-3 as it applies to a plan intended to qualify thereunder as a discretionary grant or award plan and (2) in such a manner as to satisfy the Applicable Laws.

 

                (iii) Administration with respect to Grants, Awards and Sales intended to Qualify as Performance-Based Compensation.  With respect to grants, awards and sales to eligible participants that are intended to qualify as “performance-based compensation” within the meaning of Section 162(m) of the Code, the Plan shall be administered by a committee designated by the Board of Directors, which committee shall consist of two or more members of the Board who are not employees of the Company and who otherwise qualify as “outside directors” within the meaning of Section 162(m) of the Code.

 

                (iv)  Administration with respect to Other Persons.  With respect to grants, awards and sales to eligible participants who are neither Directors nor officers of the Company, the Plan shall be administered by (A) the Board of Directors or (B) a committee designated by the Board of Directors, which committee shall be constituted in such a manner as to satisfy the Applicable Laws.

 

                (v)  General.  Once a committee has been appointed pursuant to subsection (ii) or (iii) of this Section 4(a), such Committee shall continue to serve in its designated capacity until otherwise directed by the Board of Directors. From time to time the Board of Directors may increase the size of any committee and appoint additional members thereof, remove members (with or without cause) and appoint new members in substitution therefor, fill vacancies (however caused) and remove all members of a committee and thereafter directly administer the Plan, all to the extent permitted by the Applicable Laws and, in the case of a committee appointed under subsection (ii), to the extent permitted by Rule 16b-3 as it applies to a plan intended to qualify thereunder as a discretionary grant or award plan.

 

(b)           Powers of the Board of Directors or its Committee (the “Administrator”).  Subject to the provisions of the Plan, and in the case of a committee, subject to the specific duties delegated by the Board of Directors to such committee, the Administrator shall have the authority, in its discretion:

 

                (i)  to determine the fair market value of the Stock;

 

                (ii)  to select the consultants and employees to whom grants, sales and awards may be made hereunder;

 

                (iii)  to determine whether and to what extent grants, sales and awards, or any combination thereof, are made hereunder;

 

                (iv)  to determine the number of shares of Stock to be covered by grants, sales and awards hereunder;

 

                (v)   to approve forms of agreement for use under the Plan;

 

                (vi)  to determine the terms and conditions, not inconsistent with the terms of the Plan, of any grants, sales and awards hereunder. Such terms and conditions include, but are not limited to, the exercise price, the time or times when grants, sales and awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any grant, sale or award, or the shares of Stock relating thereto, based in each case on such factors as the Administrator, in its sole discretion, shall determine;

 

                (vii)  to construe and interpret the terms of the Plan;

 

                (viii)  to prescribe, amend and rescind rules and regulations relating to the Plan;

 

-2-



 

                (ix)  to determine whether and under what circumstances grants, sales and awards may be settled in cash instead of Stock or Stock instead of cash;

 

                (x)   to reduce the exercise price of any grants, sales and awards;

 

                (xi)  subject to paragraph 14 of this Plan, to modify or amend grants, sales and awards, including the ability to correct any defect or supply any omission or reconcile any inconsistency in the Plan or in any stock bonus, stock purchase or option agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect;

 

                (xii)  to authorize any person to execute on behalf of the Company any instrument required to effect grants, sales and awards previously granted by the Administrator;

 

                (xiii) to determine the terms and restrictions applicable to grants, sales and awards and any restricted Stock; and

 

                (xiv) to make all other determinations deemed necessary or advisable for administering the Plan.

 

(c)           Effect of Administrator’s Decision.  The Administrator’s decisions, determinations and interpretations shall be final and binding on all optionees and any other holders of grants, sales and awards.

 

5.             Grants, Awards and Sales.

 

(a)           Type of Security.  The Administrator may, from time to time, separately or in combination: (i) grant Incentive Stock Options, as defined in Section 422 of the Code and as provided in paragraph 5(b); (ii) grant options other than Incentive Stock Options (“Non-Statutory Stock Options”) as provided in paragraph 5(c); (iii) grant stock appreciation rights or cash bonus rights as provided in paragraphs 10 and 11; (iv) award bonuses of Stock as provided in paragraph 5(d); and (v) sell Stock subject to restrictions as provided in paragraph 5(e). The Administrator shall select the employees to whom awards shall be made. The Administrator shall specify the action taken with respect to each person granted, awarded or sold any option or Stock under the Plan and shall specifically designate each option granted under the Plan as an Incentive Stock Option or Non-Statutory Stock Option.

 

(b)           Incentive Stock Options.  Incentive Stock Options shall be subject to the following terms and conditions:

 

                (i)  To the extent that the aggregate fair market value of (a) the Stock with respect to which options designated as Incentive Stock Options plus (b) the shares of stock of the Company, any parent and subsidiary with respect to which other Incentive Stock Options are exercisable for the first time by an optionee during any calendar year under all plans of the Company and any parent and subsidiary exceeds $100,000, such options shall be treated as Non-Statutory Stock Options. For purposes of the preceding sentence, (a) Incentive Stock Options shall be taken into account in the order in which they were granted, and (b) the fair market value of the Stock shall be determined as of the time the Incentive Stock Option is granted.

 

                (ii)  An Incentive Stock Option may be granted under the Plan to an employee possessing more than 10 percent of the total combined voting power of all classes of stock of the Company or of any parent or subsidiary of the Company only if the option price is at least 110 percent of the fair market value of the Stock subject to the option on the date it is granted, as described in paragraph 5(b)(v), and the option by its terms is not exercisable after the expiration of five years from the date it is granted.

 

                (iii)  Incentive Stock Options may be granted under the Plan only to employees of the Company or any parent or subsidiary of the Company, including employees who are directors. Except as provided in paragraph 8, no Incentive Stock Option granted under the Plan may be exercised unless at the time of such exercise the optionee is employed by the Company or any parent or subsidiary of the Company and shall have been so employed continuously since

 

-3-



 

the date such option was granted. Absence on leave or on account of illness or disability under rules established by the Administrator shall not, however, be deemed an interruption of employment for this purpose.

 

                (iv)  Subject to paragraphs 5(b)(ii) and 5(b)(iii), Incentive Stock Options granted under the Plan shall continue in effect for the period fixed by the Administrator, except that no Incentive Stock Option shall be exercisable after the expiration of 10 years from the date it is granted.

 

                (v)  The option price per share shall be determined by the Administrator at the time of grant.  Except as provided in paragraph 5(b)(ii), the option price shall not be less than 100 percent of the fair market value of the shares covered by the Incentive Stock Option at the date the option is granted. The fair market value of shares covered by an Incentive Stock Option shall be determined by the Administrator.

 

(c)           Non-Statutory Stock Options.  Non-Statutory Stock Options shall be subject to the following terms and conditions:

 

                (i)  Non-Statutory Stock Options granted under the Plan shall continue in effect for the period fixed by the Administrator, except that no Non-Statutory Stock Option shall be exercisable after the expiration of 10 years plus 7 days from the date it is granted.

 

                (ii)  The option price per share shall be determined by the Administrator at the time of grant. The option price may be more or less than or equal to the fair market value of the shares covered by the Non-Statutory Stock Option on the date the option is granted, and the option price may fluctuate based on criteria determined by the Administrator, provided that in no event and at no time shall the option price be less than 50 percent of the fair market value of the shares on the date of grant. The fair market value of shares covered by a Non-Statutory Stock Option shall be determined by the Administrator.

 

(d)           Stock Bonus.  Stock awarded as a bonus shall be subject to the terms, conditions, and restrictions determined by the Administrator at the time the Stock is awarded as a bonus. The Administrator may require the recipient to sign an agreement as a condition of the award, but may not require the recipient to pay any money consideration except as provided in this paragraph. The agreement may contain such terms, conditions, representations and warranties as the Administrator may require. The certificates representing the shares of Stock awarded shall bear such legends as shall be determined by the Administrator.

 

(e)           Restricted Stock.  The Administrator may issue shares of Stock under the Plan for such consideration (including promissory notes and services) as determined by the Administrator and with such restrictions concerning transferability, repurchase by the Company or forfeiture as determined by the Administrator, provided that in no event shall the consideration be less than 50 percent of fair market value at the time of issuance, nor shall any of the shares issued hereunder be or become freely transferable or not subject to such restrictions within six months of the date such shares are issued. All shares of Stock issued pursuant to this paragraph 5(e) shall be subject to a Purchase Agreement, which shall be executed by the Company and the prospective recipient of the Stock prior to the delivery of certificates representing such shares to the recipient. The Purchase Agreement shall contain such terms and conditions and representations and warranties as the Administrator shall require. The certificates representing such Stock shall bear such legends as determined by the Administrator.

 

6.             Exercise of Options.  Except as provided in paragraphs 8 and 11, options granted under the Plan may be exercised from time to time over the period stated in each option in such amounts and at such times as shall be prescribed by the Administrator, provided that options shall not be exercised for fractional shares. Unless otherwise determined by the Administrator, if the optionee does not exercise an option in any one year with respect to the full number of shares to which the optionee is entitled in that year, the optionee’s rights shall be cumulative and the optionee may purchase those shares in any subsequent year during the term of the option.

 

-4-



 

7.             Nontransferability.

 

(a)           Options and Awards.  During the lifetime of the Optionee, an Option shall be exercisable only by the Optionee or the Optionee’s guardian, legal representative or permitted transferees. Except as specified below, no Option shall be assignable or transferable by the Optionee except by will or by the laws of descent and distribution. At the sole discretion of the Board or its appointee, and subject to such terms and conditions as the Board or its appointee deems advisable, the Board or its appointee may allow, by means of a writing to the Optionee, for all or part of a vested Nonstatutory Stock Option to be assigned or transferred, including by means of sale, during an Optionee’s lifetime to a member of the Optionee’s immediate family or to a trust, LLC or partnership for the benefit of any one or more members of such Optionee’s immediate family. “Immediate family” as used herein means the spouse, lineal descendants, father, mother, brothers and sisters of the Optionee. In such case, the transferee shall receive and hold the Option subject to the provisions of this Section 7(a), and there shall be no further assignation or transfer of the Option. The terms of Options granted hereunder shall be binding upon the tranferees, purchasers, executors, administrators, heirs, successors and assigns of the Optionee.

 

(b)           Stock.  Stock issued upon exercise of an option or awarded as a bonus or sold under the Plan may have, in addition to restrictions on transfer imposed by law, any restrictions on transfer determined by the Administrator at the time the grant, sale or award is made.

 

8.             Termination of Employment or Death.

 

(a)           If an optionee’s employment by the Company or by any parent or subsidiary of the Company is terminated by retirement or for any reason, voluntarily or involuntarily, with or without cause, other than in the circumstances specified in paragraph 8(b) below, any option held by such optionee may be exercised at any time prior to its expiration date or the date specified by the Administrator in the optionee’s option grant, whichever is the shorter period, but only if and to the extent the optionee was entitled to exercise the option on the date of such termination. Subject to such terms and conditions as the Administrator may determine, the Administrator may extend the exercise period any length of time not later than the expiration date of the option and may increase the portion of the option that may be exercised on termination, provided that any extension of the exercise period of an Incentive Stock Option shall be subject to a written acknowledgment by the optionee that the extension disqualifies the option as an Incentive Stock Option.

 

(b)           If an optionee’s employment by the Company or by any parent or subsidiary of the Company is terminated because of death or physical disability (within the meaning of Section 22(e)(3) of the Code), the option, including portions not yet exercisable, may be exercised prior to the earlier of the expiration of 12 months from the date of death or the expiration of the option. If an optionee’s employment is terminated by death, any option held by the optionee shall be exercisable only by the person or persons to whom such optionee’s rights under such option shall pass by the optionee’s will or by the laws of descent and distribution of the state or country of the optionee’s domicile at the time of death. Subject to such terms and conditions as the Administrator may determine, the Administrator may extend the exercise period any length of time not later than the expiration date of the option, provided that any extension of the exercise period of an Incentive Stock Option shall be subject to a written acknowledgment by the optionee or the optionee’s personal representative that the extension disqualifies the option as an Incentive Stock Option.

 

(c)           To the extent an option held by any deceased optionee or by any optionee whose employment is terminated is not exercised within the limited periods provided above, all further rights to purchase shares pursuant to such option and all other related rights shall terminate at the end of such periods.

 

9.             Purchase of Shares Pursuant to Option.  Shares may be purchased or acquired pursuant to an option granted under the Plan only upon receipt by the Company of notice in writing from the optionee of the optionee’s intention to exercise, specifying the number of shares as to which the optionee desires to exercise the option and the date on which the optionee desires to complete the transaction, which shall not be more than 30 days after receipt of the notice, and unless in the opinion of counsel for the Company such a representation is not required in order to comply with the Securities Act of 1933, as amended, containing a representation that it is the optionee’s present intention to acquire the shares for investment

 

-5-



 

and not with a view to distribution. On or before the date specified for completion of the purchase of shares pursuant to an option, the optionee must have paid the Company the full purchase price of such shares in cash (including cash that may be the proceeds of a loan from the Company), in whole or in part in shares of Stock of the Company previously acquired and, if acquired directly or indirectly from the Company, held for at least six months by the optionee, unless the Administrator consents to accepting Stock held for a lesser period of time. Any shares surrendered on payment for the exercise of options shall be valued at fair market value at the time of surrender as determined by the Administrator. No shares shall be issued until full payment therefor has been made.  With the consent of the Administrator an optionee may request the Company to automatically apply the shares received upon the exercise of a portion of a stock option (even though stock certificates have not yet been issued) to satisfy the exercise price for additional portions of the option. With the consent of the Administrator the Company may allow the exercise price to be satisfied by delivery of a such documentation as the Administrator and any broker approved by the Company, if applicable, shall require to effect an exercise of the option and delivery to the Company of the sale or loan proceeds required to pay the exercise price.

 

10.          Stock Appreciation Rights.

 

(a)           Grant.  Stock appreciation rights may be granted under the Plan by the Administrator, subject to such rules, terms and conditions as the Administrator prescribes.

 

(b)           Exercise.

 

                (i)  A stock appreciation right shall be exercisable only at the time or times established by the Administrator.  If a stock appreciation right is granted in connection with an option, then it shall be exercisable only to the extent and on the same conditions that the related option could be exercised. Upon exercise of a stock appreciation right, any option or portion thereof to which the stock appreciation right relates must be surrendered. Stock appreciation rights granted independent of options shall expire not later than 10 years plus 7 days from the date of grant.

 

                (ii)  The Administrator may withdraw any stock appreciation right granted under the Plan at any time and may impose any conditions upon the exercise of a stock appreciation right or adopt rules and regulations from time to time affecting the rights of holders of stock appreciation rights. Such rules and regulations may govern the right to exercise stock appreciation rights granted before adoption or amendment or such rules and regulations as well as stock appreciation rights granted thereafter.

 

                (iii)  Each stock appreciation right shall entitle the holder, upon exercise, to receive from the Company in exchange therefor an amount equal in value to the excess of the fair market value on the date of exercise of one share of Stock of the Company over its fair market value on the date of grant (or, in the case of a stock appreciation right granted in connection with an option, the option price per share under the option to which the stock appreciation right relates), multiplied by the number of shares covered by the stock appreciation right or the option, or portion thereof, that is surrendered. No stock appreciation right shall be exercisable at a time that the amount determined under this subparagraph is negative. Payment by the Company upon exercise of a stock appreciation right may be made in Stock valued at its fair market value, in cash, or partly in Stock and partly in cash, as determined by the Administrator.

 

                (iv)  The fair market value of the Stock shall be determined for this purpose by the Administrator.

 

                (v)  No fractional shares shall be issued upon exercise of a stock appreciation right. In lieu thereof cash may be paid in an amount equal to the value of the fraction or, in the discretion of the Administrator, the number of shares may be rounded downward to the next whole share.

 

                (vi)  Cash payments of stock appreciation rights as well as Common Stock issued upon exercise of stock appreciation rights shall be applied against the maximum number of shares of Common Stock that may be issued pursuant to the Plan. The number of shares to be applied against such maximum number of shares in such circumstances shall be the number of shares subject to options surrendered upon exercise of a stock appreciation right or for stock

 

-6-



 

appreciation rights not granted in connection with an option, shares equal to the amount of the cash payment divided by the fair market value of a share of Common Stock on the date the stock appreciation right is granted.

 

11.          Cash Bonus Rights.

 

(a)           Grant.  The Administrator may grant bonus rights under the Plan in connection with (i) an option granted or previously granted, (ii) Stock awarded, or previously awarded, as a bonus and (iii) Stock sold or previously sold under the Plan. Bonus rights will be subject to rules, terms and conditions as the Administrator may prescribe.

 

(b)           Bonus Rights in Connection with Options.  A bonus right granted in connection with an option will entitle an optionee to a cash bonus when the related option is exercised (or terminates in connection with the exercise of a stock appreciation right related to the option) in whole or in part, or at such other time as determined by the Administrator as the bonus right is granted. If an optionee purchases shares and does not exercise a related stock appreciation right, then the amount of the bonus shall be determined by multiplying the excess of the total fair market value of the shares to be acquired upon the exercise over the total option price for shares by the applicable bonus percentage. If the optionee is exercising a related stock appreciation right in connection with the termination of an option, then the bonus shall be determined by multiplying the total fair market value of the shares and cash received pursuant to the exercise of the stock appreciation right by the applicable bonus percentage. For the purposes of this paragraph, the fair market value of shares shall be determined by the Administrator. The bonus percentage applicable to a bonus right shall be determined from time to time by the Administrator but shall in no event exceed 40 percent of the amount by which the fair market value of the Stock received on exercise of the related option at the time of exercise exceeds the option price of such option.

 

(c)           Bonus Rights in Connection with Stock Bonus.  A bonus right granted in connection with Stock awarded as a bonus will entitle the person awarded such Stock to a cash bonus at the time the Stock is awarded, at such time as restrictions, if any, to which the Stock is subject lapse, or at such other time as determined by the Administrator as the bonus right is granted. If Stock awarded is subject to restrictions and is repurchased by the Company or forfeited by the holder the bonus right granted in connection with such Stock shall terminate and may not be exercised. The amount of cash bonus to be awarded and the time such cash bonus is to be paid shall be determined from time to time by the Administrator.

 

(d)           Bonus Rights in Connection with Stock Purchase.  The bonus right granted in connection with Stock purchased hereunder (excluding Stock purchased pursuant to an option) shall terminate and may not be exercised in the event the Stock is repurchased by the Company or forfeited by the holder pursuant to restrictions applicable to the Stock. The amount of cash bonus to be awarded and the time such cash bonus is to be paid shall be determined from time to time by the Administrator.

 

12.          Changes in Capital Structure.  If the outstanding shares of Stock of the Company are hereafter increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of any reorganization, merger, consolidation, plan of exchange, recapitalization, reclassification, stock split-up, combination of shares or dividend payable in shares, appropriate adjustment shall be made by the Administrator in the number and kind of shares for which grants, sales and awards may be made under the Plan. In addition, the Administrator shall make appropriate adjustment in the number and kind of shares as to which outstanding grants, sales and awards, or portions thereof then unexercised, shall be exercisable. Adjustments in outstanding options shall be made without change in the total price applicable to the unexercised portion of any option and with a corresponding adjustment in the option price per share and shall neither (i) make the ratio, immediately after the event, of the option price per share to the fair market value per share more favorable to the optionee than that ratio immediately before the event, nor (ii) make the aggregate spread, immediately after the event, between the fair market value of shares as to which the option is exercisable and the option price of such shares more favorable to the optionee than that aggregate spread immediately before the event. The Administrator may also require that any securities issued in respect of or exchanged for Stock issued hereunder that is subject to restrictions be subject to similar restrictions. Notwithstanding the foregoing, the Administrator shall have no obligation to effect any adjustment that would or might result in the issuance of fractional shares, and any fractional shares resulting from any adjustment may be disregarded or provided for in any manner determined by the Administrator. Any such adjustment made by the Administrator shall be conclusive. In the event of dissolution of the Company or a merger,

 

-7-



 

consolidation or plan of exchange affecting the Company, in lieu of providing for options as provided above in this paragraph 12, the Administrator may, in its sole discretion, provide a 30-day period prior to such event during which optionees shall have the right to exercise options in whole or in part without any limitation on exercisability.

 

13.          Corporate Mergers, Acquisitions, etc.  The Administrator may also grant options and stock appreciation rights, award Stock bonuses and issue Stock subject to restrictions having terms, conditions and provisions that vary from those specified in this Plan provided that any options and stock appreciation rights granted, any stock bonuses awarded and any restricted stock issued pursuant to this section are granted in substitution for or in connection with the assumption of, existing options, stock appreciation rights, stock bonuses and restricted stock granted, awarded or issued by another corporation and assumed or otherwise agreed to be provided for by the Company pursuant to or by reason of a transaction involving a corporate merger consolidation, acquisition of property or stock, separation, reorganization or liquidation to which the Company or a subsidiary is a party.

 

14.          Amendment of Plan.  The Board of Directors may at any time and from time to time modify or amend the Plan in such respects as it shall deem advisable because of changes in the law while the Plan is in effect or for any other reason. Except as provided in paragraphs 8, 10 and 12, however no change in an option already granted or modification of restrictions on Stock already issued shall be made without the written consent of the holder of such option or Stock. Furthermore, unless the Company obtains stockholder approval in such a manner and degree as required by applicable law, no amendment or change shall be made in the Plan that increases the total number of shares that may be awarded or purchased under the Plan or that otherwise requires stockholder approval under applicable law.

 

15.          Approvals.  The obligations of the Company under the Plan are subject to the approval of state and federal authorities or agencies with jurisdiction in the matter. The Company will use its best efforts to take steps required by state or federal law or applicable regulations, including rules and regulations of the Securities and Exchange Commission and any stock exchange on which the Company’s shares may then be listed, in connection any grant, sale or award hereunder, or the listing of such shares of said exchange. The foregoing notwithstanding, the Company shall not be obligated to issue or deliver shares of Common Stock under the Plan if the Company is advised by its legal counsel that such issuance or delivery would violate applicable state or federal securities laws.

 

16.          Employment Rights.  Nothing in the Plan, nor any grant, award or sale hereunder, shall confer upon (i) any employee any right to be continued in the employment of the Company or any parent or subsidiary of the Company, or shall interfere in any way with the right of the Company or any parent or subsidiary of the Company by whom such employee is employed to terminate such employee’s employment at any time, for any reason, with or without cause, or to increase or decrease such employee’s compensation, or (ii) any person engaged by the Company any right to be retained or employed by the Company or to the continuation, extension, renewal, or modification of any compensation, contract, or arrangement with or by the Company.

 

17.          Rights as a Stockholder.  The holder of an option, the recipient of Stock awarded as a bonus or the purchaser of Stock shall have no rights as a stockholder with respect to any shares covered by any grant, sale or award until the date of issue of a stock certificate to him or her for such shares. Except as otherwise expressly provided in the Plan, no adjustment shall be made for dividends or other rights for which the record date is prior to the date such stock certificate is issued.

 

18.          Stock Withholding to Satisfy Withholding Tax Obligations.

 

(a)           Ability to Use Stock to Satisfy Withholding.  The Company may require any recipient of a grant, sale or award under the Plan to pay to the Company amounts necessary to satisfy any applicable federal, state or local tax withholding requirements. At the discretion of the Administrator, optionees and award recipients may satisfy withholding obligations as provided in this Section 18. When an optionee or award recipient incurs tax liability in connection with a grant, sale or award, which tax liability is subject to tax withholding under applicable tax laws (including federal, state and local laws), the optionee may satisfy the withholding tax obligation (up to an amount calculated by applying such optionee’s maximum marginal tax rate) by electing to have the Company withhold from the Stock to be issued in connection with a grant, sale or award that number of shares, or by delivering to the Company that number of previously owned shares (which,

 

-8-



 

in the case of Stock acquired directly or indirectly from the Company, has been held for at least six months), having a fair market value equal to the amount required to be withheld. The fair market value of the shares to be withheld or delivered, as the case may be, shall be determined on the date that the amount of tax to be withheld is determined (the “Tax Date”).

 

(b)           Election to Have Stock Withheld.  All elections by an optionee to have Stock withheld or to deliver previously owned Shares pursuant to this Section 18 shall be made in writing in a form acceptable to the Administrator and shall be subject to the following restrictions:

 

                (i)  the election must be made on or prior to the applicable Tax Date;

 

                (ii)  all elections shall be subject to the consent or disapproval of the Administrator; and

 

                (iii)  if the optionee is subject to liability under Section 16 of the Exchange Act, the election must comply with the applicable provisions of Rule 16b-3 and shall be subject to such additional conditions or restrictions as may be required thereunder to qualify for the maximum exemption from Section 16 of the Exchange Act with respect to Plan transactions.

 

(c)           Section 83(b) Elections.  In the event that (i) an election to have Shares withheld is made by an optionee, (ii) no election is filed under Section 83(b) of the Code by such optionee and (iii) the Tax Date is deferred under Section 83 of the Code, the optionee shall receive the full number of shares subject to the grant, sale or award, as the case may be, but such optionee shall be unconditionally obligated to tender back to the Company the proper number of shares on the Tax Date.

 

19.          Rule 16b-3.  Grants, sales and awards to Insiders must comply with the applicable provisions of Rule 16b-3 and shall contain such additional conditions or restrictions as may be required thereunder to qualify for the maximum exemption from Section 16 of the Exchange Act with respect to Plan transactions.

 

20.          Performance-Based Compensation.

 

(a)           Options and Stock Appreciation Rights.  The following limitations shall apply to grants of options and stock appreciation rights to employees of the Company.

 

                (i)  No employee shall be granted, in any fiscal year of the Company, options or stock appreciation rights to purchase, in the aggregate, more than 1,000,000 shares of Stock.

 

                (ii)  In connection with his or her initial employment, an employee may be granted options and stock appreciation rights to purchase, in the aggregate, up to an additional 1,000,000 shares of Stock which shall not count against the limit set forth in subsection (i) above.

 

                (iii)  The foregoing limitations shall be adjusted proportionately in connection with any change in the Company’s capitalization as described in Section 12.

 

                (iv)  If an option or stock appreciation right is cancelled in the same fiscal year of the Company in which it was granted (other than in connection with a transaction described in Section 12), the cancelled option will be counted against the limits set forth in subsections (i) and (ii) above. For this purpose, if the exercise price of an option is reduced, the transaction will be treated as a cancellation of the option and the grant of a new option.

 

(b)           Other Grants, Awards and Sales.  The Administrator shall have the discretion to set Performance Goals (as defined below) which, depending on the extent to which they are met during the Performance Period (as defined below), shall determine the number or value of grants, awards or sales (excluding options) that shall be made to Covered Employees (as defined below). The Performance Goals shall be set by the Administrator on or before the latest date permissible to enable the awards or sales to qualify as “performance-based compensation” within the meaning of Section 162(m) of the

 

-9-



 

Code. Each grant, sale or award pursuant to this Section 20(b) shall be evidenced by an agreement that shall specify the Performance Period, and such other terms and conditions as the Administrator, in its sole discretion, shall determine. To the extent necessary to qualify grants, awards or sales as “performance-based compensation” within the meaning of Section 162(m) of the Code, the Administrator shall certify in writing that the Performance Goals applicable to such grant, sale or award for the relevant Performance Period have been satisfied. Notwithstanding anything to the contrary contained herein, the maximum value of all grants, awards or sales pursuant to this Section 20(b) that an individual may receive for a fiscal year is 2.5% of operating profit for such fiscal year.

 

(c)           Definitions.  As used herein, the following definitions shall apply:

 

                (i)  “Covered Employee” means a “covered employee” within the meaning of Section 162(m) of the Code.

 

                (ii)  “Performance Goal” means the goal or goals determined by the Administrator, in its discretion, to be applicable with respect to a grant, sale or award intended to qualify as “performance-based compensation” within the meaning of Section 162(m) of the Code pursuant to this Section 20(b). As determined by the Administrator, the Performance Goal(s) applicable to a grant, sale or award shall provide for a targeted level or levels of achievement based upon any or all of the following for the Performance Period: corporate profitability; growth in sales; growth in income; share price appreciation; and return on investment. The Performance Goal(s) may differ from employee to employee and from grant, sale or award to grant, sale or award.

 

                (iii)  “Performance Period” means the period of time during which the Performance Goals must be met.

 

 

-10-



 



Exhibit 99(d)(2)

 

LATTICE SEMICONDUCTOR CORPORATION

1996 STOCK INCENTIVE PLAN

STOCK OPTION AGREEMENT

 

 

                Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.

 

 

I. NOTICE OF STOCK OPTION GRANT

 

                Dear

 

                You have been granted an option to purchase Common Stock of the Company, subject to the terms and conditions of the Plan and this Option Agreement, as follows:

 

 

GRANT NUMBER:

 

 

 

 

 

 

 

 

 

DATE OF GRANT:

 

 

 

 

 

 

 

 

 

VESTING COMMENCEMENT DATE:

 

 

 

 

 

 

 

 

 

EXERCISE PRICE PER SHARE:

 

 

 

 

 

 

 

 

 

TOTAL SHARES GRANTED:

 

 

 

 

 

 

 

 

 

TYPE OF OPTION:

 

Nonstatutory Stock Option

 

 

 

 

 

 

TERM/EXPIRATION DATE:

 

 

 

 

                Vesting Schedule:

 

                This option shall vest in accordance with the following schedule:

 

                Twenty five percent (25%) of the shares subject to the Option shall vest one year after the Vesting Commencement Date, and 6.25% of the shares subject to the Option shall vest on the last day of each three month period thereafter.

 

                Exercise Schedule:

 

                Except as provided in the Plan and in Section 4 of Part II of this Agreement, vested shares of the Option may be exercised, in whole or in part, at any time during the term of the Option.

 

 

 



 

                Termination Period:

 

                Vested shares of this Option may be exercised for three months after termination of Optionee’s employment relationship, or for such longer period and to such extent as may be applicable upon death or disability of Optionee as provided in the Plan and in Section 4 of Part II of this agreement, but in no event later than the Term/Expiration Date as provided above.

 

 

II.            ADDITIONAL PROVISIONS OF OPTION

 

                1.             Grant of Option. The Plan Administrator of the Company hereby grants to the optionee named in the Notice of Grant attached as Part I of this Agreement (the “Optionee”), an option (the “Option”) to purchase a number of Shares, as set forth in the Notice of Grant, at the exercise price per share set forth in the Notice of Grant (the “Exercise Price”), subject to the terms and conditions of the Plan, which is incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Option Agreement, the terms and conditions of the Plan shall prevail.

 

                If designated in the Notice of Grant as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code.

 

                2.             Exercise of Option.

 

                                (a)           Right to Exercise. This Option is exercisable during its term in accordance with the Exercise Schedule set out in the Notice of Grant (I, preceding) and the applicable provisions of the Plan and this Option Agreement. In the event of Optionee’s death, disability or other termination of Optionee’s employment relationship, the exercisability of the Option is governed by the applicable provisions of the Plan and this Option Agreement.

 

                                (b)           Method of Exercise. This Option is exercisable by delivery of an exercise notice, in the form attached as Exhibit A (the “Exercise Notice”), which shall state the election to exercise the Option, the number of Shares being exercised (the “Exercised Shares”), and such other representations and agreements (such as a stock restriction agreement) as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice and any other required agreements shall be signed by the Optionee and shall be delivered in person or by certified mail to the Stock Administrator of the Company. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice and any other required agreements accompanied by such aggregate Exercise Price (see 3. Method of Payment, below).

 

                No Shares shall be issued pursuant to the exercise of this Option unless such issuance and exercise complies with all relevant provisions of law and the requirements of any stock exchange or quotation service upon which the Shares are then listed. Assuming such compliance, for U.S. Federal income tax purposes the Exercised Shares shall be considered transferred to the Optionee on the date the Option is exercised with respect to such Exercised Shares.

 

 

2



 

                3.             Method of Payment.            Payment of the aggregate Exercise Price and applicable taxes shall be by any of the following, or a combination thereof, at the election of the Optionee:

 

                                (a)           cash; or

 

                                (b)           check; or

 

                                (c)           delivery of a properly executed exercise notice together with such other documentation as the Stock Administrator and the broker, if applicable, shall require to effect an exercise of the Option and delivery to the Company of the sale proceeds or broker loan proceeds required to pay the exercise price and taxes (commonly called same day sale); or

 

                                (d)           at the discretion of the Plan Administrator, either at the time of exercise in the case of Non-Statutory Stock Options or at the time of grant for Incentive Stock Options, by surrender of other Stock which (i) in the case of Stock acquired upon exercise of an option, has been owned by the Optionee for more than six (6) months on the date of surrender (unless the Plan Administrator consents to accepting Stock held for a lesser period of time), and (ii) has a fair market value on the date of surrender at least equal to the aggregate Exercise Price of the Exercised Shares.

 

                4.             Termination of Employment.

 

                                (a)           In the event the employment of the Optionee by the Company or by any parent or subsidiary of the Company is terminated by retirement or for any reason, voluntarily or involuntarily, with or without cause, other than in the circumstances specified in subsection (b) below, the Option held by the Optionee may be exercised at any time prior to its expiration date or the expiration of three months after the date of such termination of employment, whichever is the shorter period, but only if and to the extent the Optionee was entitled to exercise the Option on the date of such termination (i.e. no vesting occurs after termination).

 

                                (b)           In the event the Optionee’s employment by the Company or by any parent or subsidiary of the Company is terminated because of death or physical disability (within the meaning of Section 22(e)(3) of the IRC), the Option may be fully exercised with respect to all remaining unexercised shares, including those shares that would otherwise have been unvested on the date of death or disability, at any time prior to its expiration date or the expiration of one year after the date of such termination, whichever is the shorter period. If the Optionee’s employment is terminated by death, the Option shall be exercisable only by the person or persons to whom the Optionee’s rights under the Option shall pass by the Optionee’s will or by the laws of descent and distribution of the state or country of the Optionee’s domicile at the time of death.

 

                                (c)           In the event of the death or termination of employment of the Optionee, to the extent the Option shall not have been exercised within the limited periods provided above, all further rights to purchase shares pursuant to the Option shall cease and terminate at the expiration of such periods.

 

 

3



 

                5.             Transferability of Option.

 

(a) Option Generally Non-Transferable. During the lifetime of the Optionee, an Option shall be exercisable only by the Optionee or the Optionee’s guardian, legal representative or permitted transferees. Except as specified below, no Option shall be assignable or transferable by the Optionee except by will or by the laws of descent and distribution. The terms of the Plan and this Option Agreement shall be binding upon the transferees, purchasers, executors, administrators, heirs, successors and assigns of the Optionee.

 

(b) Limited Transferability of Option. At the sole discretion of the Plan Administrator or its appointee, and subject to such terms and conditions as the Plan Administrator or its appointee deems advisable, the Plan Administrator or its appointee may allow, by means of a writing to the Optionee, for all or part of this Option, to the extent such shares of this Option are fully vested, to be assigned or transferred, including by means of sale, during the Optionee’s lifetime to a member of the Optionee’s immediate family or to a trust, LLC or partnership for the benefit of any one or more members of the Optionee’s immediate family. “Immediate family” as used herein means the spouse, lineal descendants, father, mother, brothers and sisters of the Optionee. In such case, the transferee shall receive and hold the Option subject to the provision of this Option Agreement and the Plan, and there shall be no further assignation or transfer of the Option.

 

                6.             Term of Option. This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement.

 

                7.             Employment At-Will. Nothing in the Plan or this Agreement shall confer upon the Optionee any right to continue in an employment relationship with the Company or any parent or subsidiary of the Company, or shall interfere in any way with the right of the Company or any parent or subsidiary by whom the Optionee is employed to terminate the Optionee’s employment at any time, for any reason, with or without cause.

 

                8.             Tax Consequences. Some of the U.S. Federal tax consequences relating to this Option, as of the date of this Option, are set forth below. THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

 

                                (a)           Exercising the Option.

 

                                                (i)            Nonqualified Stock Option (“NSO”). If this Option does not qualify as an ISO, the Optionee may incur regular U.S. Federal income tax liability upon exercise. The Optionee will be treated as having received compensation income (taxable at ordinary income tax rates) equal to the excess, if any, of the fair market value of the Exercised Shares on the date of exercise over their aggregate Exercise Price. If the Optionee is an employee, the Company will be required to withhold from Optionee and pay to the applicable taxing authorities an amount equal to a percentage of this compensation income at the time of exercise.

 

 

4



 

                                                (ii)           Incentive Stock Option (“ISO”). If this Option qualifies as an ISO, the Optionee will have no regular U.S. Federal income tax liability upon its exercise, although the excess, if any, of the fair market value of the Exercised Shares on the date of exercise over their aggregate Exercise Price will be treated as an adjustment to the alternative minimum tax for U.S. Federal tax purposes and may subject the Optionee to alternative minimum tax in the year of exercise.

 

                                (b)           Disposition of Shares.

 

                                                (i)            NSO. Upon disposition of the Shares, any gain or loss will be treated as capital gain or loss for U.S. Federal income tax purposes.

 

                                                (ii)           ISO. If the Optionee holds ISO Shares for at least one year after exercise and two years after the grant date, any gain realized on disposition of the Shares will be treated as long-term capital gain for U.S. Federal income tax purposes. If the Optionee disposes of ISO Shares within one year after exercise or two years after the grant date, any gain realized on such disposition will be treated as compensation income (taxable at ordinary income rates) to the extent of the excess, if any, of the lesser of (A) the difference between the fair market value of the Shares acquired on the date of exercise and the aggregate Exercise Price, or (B) the difference between the sale price of such Shares and the aggregate Exercise Price.

 

                                (c)           Notice of Disqualifying Disposition of ISO Shares. If the Optionee sells or otherwise disposes of any of the Shares acquired pursuant to an ISO on or before the later of (i) two years after the grant date, or (ii) one year after the exercise date, the Optionee shall immediately notify the Company in writing of such disposition. The Optionee agrees that he or she may be subject to income tax withholding by the Company on the compensation income recognized from such early disposition of ISO shares.

 

                9.             Inside Information. By signing this Agreement, Optionee acknowledges that he or she has received, read and understood the Company’s policy with respect to trading Company securities while possessing Inside Information.

 

 

5



 

III.                                 SIGNATURES

 

                By your signature and the signature of the Company’s representative below, you and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan and this Option Agreement. Optionee has reviewed the Plan and this Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement and fully understands all provisions of the Plan and the Option Agreement. Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Plan Administrator upon any questions relating to the Plan and Option Agreement.

 

 

OPTIONEE:

 

Lattice Semiconductor Corporation:

 

 

 

 

 

 

 

 

 

 

By:

 

Signature

 

 

 

 

 

 

 

 

 

 

 

 

 

Title:

President & CEO

Print Name

 

 

 

 

 

 

 

 

 

 

6





Exhibit 99(d)(3)

LATTICE SEMICONDUCTOR CORPORATION

2001 STOCK PLAN

 (as amended August 7, 2001)

 

1.     Purposes of the Plan.  The purposes of this 2001 Stock Plan are:

                                          to attract and retain the best available personnel for positions of substantial responsibility,

                                          to provide additional incentive to Employees and Consultants, and

                                          to promote the success of the Company’s business.

                Options granted under the Plan may be Incentive Stock Options or Nonstatutory Stock Options, as determined by the Administrator at the time of grant.  Stock Purchase Rights may also be granted under the Plan.

2.     Definitions.  As used herein, the following definitions shall apply:

(a)   “Administrator” means the Board or any of its Committees as shall be administering the Plan, in accordance with Section 4 of the Plan.

(b)   “Applicable Laws” means the requirements relating to the administration of stock option plans under state corporate laws of the United States, U.S. federal and state securities laws, the Code, any other applicable federal or state law, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction where Options or Stock Purchase Rights are, or will be, granted under the Plan.

(c)   “Board” means the Board of Directors of the Company.

(d)   “Code” means the Internal Revenue Code of 1986, as amended.

(e)   “Committee” means a committee of Directors appointed by the Board in accordance with Section 4 of the Plan.

(f)    “Common Stock” means the common stock of the Company.

(g)   “Company” means Lattice Semiconductor Corporation, a Delaware corporation.

(h)   “Consultant” means any person, including an advisor, engaged by the Company or a Parent or Subsidiary to render services to such entity.

(i)    “Director” means a member of the Board.

(j)    “Disability” means total and permanent disability as defined in Section 22(e)(3) of the Code.

(k)   “Employee” means any person, including Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company.  A Service Provider shall not cease to be an Employee in the case of (i) any leave of absence approved by the Company or (ii) transfers between locations of the Company or between the Company, its Parent, any Subsidiary, or any successor.  For purposes of Incentive Stock Options, no such leave may exceed ninety days, unless reemployment upon expiration of such leave is guaranteed by statute or contract.  If

 

-1-



 

reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, on the 181st day of such leave any Incentive Stock Option held by the Optionee shall cease to be treated as an Incentive Stock Option and shall be treated for tax purposes as a Nonstatutory Stock Option.  Neither service as a Director nor payment of a director’s fee by the Company shall be sufficient to constitute “employment” by the Company.

(l)    “Exchange Act” means the Securities Exchange Act of 1934, as amended.

(m)  “Fair Market Value” means, as of any date, the value of Common Stock determined as follows:

(i)    If the Common Stock is listed on any established stock exchange or a national market system, including without limitation the Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system on the day of determination, or, if the day of determination is not a market trading day, on the first market day following the day of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable;

(ii)   If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the day of determination, or, if the day of determination is not a market trading day, on the first market trading day following the day of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or

(iii)  In the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Administrator.

(n)   “Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.

(o)   “Immediate Family” means the spouse, lineal descendants, father, mother, brothers and sisters of the Optionee.

(p)   “Nonstatutory Stock Option” means an Option not intended to qualify as an Incentive Stock Option.

(q)   “Notice of Grant” means a written or electronic notice evidencing certain terms and conditions of an individual Option or Stock Purchase Right grant.  The Notice of Grant is part of the Option Agreement.

(r)    “Officer” means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.

(s)   “Option” means a stock option granted pursuant to the Plan.

 

-2-



 

(t)    “Option Agreement” means an agreement between the Company and an Optionee evidencing the terms and conditions of an individual Option grant.  The Option Agreement is subject to the terms and conditions of the Plan.

(u)   “Optioned Stock” means the Common Stock subject to an Option or Stock Purchase Right.

(v)   “Optionee” means the holder of an outstanding Option or Stock Purchase Right granted under the Plan.

(w)  “Parent” means a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code.

(x)    “Plan” means this Lattice Semiconductor Corporation 2001 Stock Plan.

(y)   “Restricted Stock” means shares of Common Stock acquired pursuant to a grant of Stock Purchase Rights under Section 11 of the Plan.

(z)    “Restricted Stock Purchase Agreement” means a written agreement between the Company and the Optionee evidencing the terms and restrictions applying to stock purchased under a Stock Purchase Right.  The Restricted Stock Purchase Agreement is subject to the terms and conditions of the Plan and the Notice of Grant.

(aa) “Rule 16b-3” means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the Plan.

(bb) “Section 16(b)” means Section 16(b) of the Exchange Act.

(cc) “Service Provider” means an Employee or Consultant.

(dd) “Share” means a share of the Common Stock, as adjusted in accordance with Section 13 of the Plan.

(ee) “Stock Purchase Right” means the right to purchase Common Stock pursuant to Section 11 of the Plan, as evidenced by a Notice of Grant.

(ff)   “Subsidiary” means a “subsidiary corporation”, whether now or hereafter existing, as defined in Section 424(f) of the Code.

3.     Stock Subject to the Plan.  Subject to the provisions of Section 13 of the Plan, the maximum aggregate number of Shares that may be optioned and sold under the Plan is nine million (9,000,000) Shares.  The Shares may be authorized, but unissued, or reacquired Common Stock.

                If an Option or Stock Purchase Right expires or becomes unexercisable without having been exercised in full, the unpurchased Shares which were subject thereto shall become available for future grant or sale under the Plan (unless the Plan has terminated); provided, however, that Shares that have actually been issued under the Plan, whether upon exercise of an Option or Right, shall not be returned to the Plan and shall not become available for future distribution under the Plan, except that if Shares of Restricted Stock are repurchased by the Company at their original purchase price, such Shares shall become available for future grant under the Plan.

 

-3-



 

4.     Administration of the Plan.

(a)   Procedure.

(i)    Multiple Administrative Bodies.  Different Committees with respect to different groups of Service Providers may administer the Plan.

(ii)   Section 162(m).  To the extent that the Administrator determines it to be desirable to qualify Options granted hereunder as “performance-based compensation” within the meaning of Section 162(m) of the Code, the Plan shall be administered by a Committee of two or more “outside directors” within the meaning of Section 162(m) of the Code.

(iii)  Rule 16b-3.  To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder shall be structured to satisfy the requirements for exemption under Rule 16b-3.

(iv)  Other Administration.  Other than as provided above, the Plan shall be administered by (A) the Board or (B) a Committee, which committee shall be constituted to satisfy Applicable Laws.

(b)   Powers of the Administrator.  Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator shall have the authority, in its discretion:

(i)    to determine the Fair Market Value;

(ii)   to select the Service Providers to whom Options and Stock Purchase Rights may be granted hereunder;

(iii)  to determine the number of shares of Common Stock to be covered by each Option and Stock Purchase Right granted hereunder;

(iv)  to approve forms of agreement for use under the Plan;

(v)   to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Option or Stock Purchase Right granted hereunder.  Such terms and conditions include, but are not limited to, the exercise price, the time or times when Options or Stock Purchase Rights may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Option or Stock Purchase Right or the shares of Common Stock relating thereto, based in each case on such factors as the Administrator, in its sole discretion, shall determine;

(vi)  to construe and interpret the terms of the Plan and awards granted pursuant to the Plan;

(vii) to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of qualifying for preferred tax treatment under foreign tax laws;

 

-4-



 

(viii)                to modify or amend each Option or Stock Purchase Right (subject to Section 15 of the Plan), including the discretionary authority to extend the post-termination exercisability period of Options longer than is otherwise provided for in the Plan;

(ix)   to allow Optionees to satisfy withholding tax obligations by electing to have the Company withhold from the Shares to be issued upon exercise of an Option or Stock Purchase Right that number of Shares having a Fair Market Value equal to the amount required to be withheld.  The Fair Market Value of the Shares to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined.  All elections by an Optionee to have Shares withheld for this purpose shall be made in such form and under such conditions as the Administrator may deem necessary or advisable;

(x)    to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Option or Stock Purchase Right previously granted by the Administrator;

(xi)   to make all other determinations deemed necessary or advisable for administering the Plan.

(c)   Limitations on the Powers of the Administrator.  No person shall have any discretion to reduce the exercise price of any Option or Stock Purchase Right regardless of any decline in the Fair Market Value of the Common Stock covered by such Option or Stock Purchase Right since the date of grant.

(d)   Effect of Administrator’s Decision.  The Administrator’s decisions, determinations and interpretations shall be final and binding on all Optionees and any other holders of Options or Stock Purchase Rights.

5.     Eligibility.  Nonstatutory Stock Options and Stock Purchase Rights may be granted to Service Providers.  Incentive Stock Options may be granted only to Employees.

6.     Limitations.

(a)   Each Option shall be designated in the Option Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option.  However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Optionee during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds $100,000, such Options shall be treated as Nonstatutory Stock Options.  For purposes of this Section 6(a), Incentive Stock Options shall be taken into account in the order in which they were granted.  The Fair Market Value of the Shares shall be determined as of the time the Option with respect to such Shares is granted.

(b)   Neither the Plan nor any Option or Stock Purchase Right shall confer upon an Optionee any right with respect to continuing the Optionee’s relationship as a Service Provider with the Company, nor shall they interfere in any way with the Optionee’s right or the Company’s right to terminate such relationship at any time, with or without cause.

 

-5-



 

(c)   The following limitations shall apply to grants of Options:

(i)    No Service Provider shall be granted, in any fiscal year of the Company, Options to purchase more than 2,000,000 Shares.

(ii)   In connection with his or her initial service, a Service Provider may be granted Options to purchase up to an additional 2,000,000 Shares, which shall not count against the limit set forth in subsection (i) above.

(iii)  The foregoing limitations shall be adjusted proportionately in connection with any change in the Company’s capitalization as described in Section 13.

(iv)  If an Option is cancelled in the same fiscal year of the Company in which it was granted (other than in connection with a transaction described in Section 13), the cancelled Option will be counted against the limits set forth in subsections (i) and (ii) above.

(d)   The number of shares granted pursuant to Stock Purchase Rights under the Plan shall not exceed five percent (5%) of the total shares available for issuance under the Plan.

7.     Term of Plan.  Subject to Section 19 of the Plan, the Plan shall become effective upon its adoption by the Board.  It shall continue in effect for a term of ten (10) years unless terminated earlier under Section 15 of the Plan.

8.     Term of Option.  The term of each Option shall be stated in the Option Agreement.  In the case of an Incentive Stock Option, the term shall be ten (10) years from the date of grant or such shorter term as may be provided in the Option Agreement.  Moreover, in the case of an Incentive Stock Option granted to an Optionee who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option shall be five (5) years from the date of grant or such shorter term as may be provided in the Option Agreement.

9.     Option Exercise Price and Consideration.

(a)   Exercise Price.  The per share exercise price for the Shares to be issued pursuant to exercise of an Option shall be determined by the Administrator, subject to the following:

(i)    In the case of an Incentive Stock Option

(A)  granted to an Employee who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price shall be no less than 110% of the Fair Market Value per Share on the date of grant.

(B)   granted to any Employee other than an Employee described in paragraph (A) immediately above, the per Share exercise price shall be no less than 100% of the Fair Market Value per Share on the date of grant.

(ii)   In the case of a Nonstatutory Stock Option, the per Share exercise price shall be no less than 100% of the Fair Market Value per Share on the date of grant.

 

-6-



 

(iii)  Notwithstanding the foregoing, Options may be granted with a per Share exercise price of less than 100% of the Fair Market Value per Share on the date of grant pursuant to a merger or other corporate transaction.

(b)   Waiting Period and Exercise Dates.  At the time an Option is granted, the Administrator shall fix the period within which the Option may be exercised and shall determine any conditions that must be satisfied before the Option may be exercised.

(c)   Form of Consideration.  The Administrator shall determine the acceptable form of consideration for exercising an Option, including the method of payment.  In the case of an Incentive Stock Option, the Administrator shall determine the acceptable form of consideration at the time of grant.  Such consideration may consist entirely of:

(i)        cash;

(ii)       check;

(iii)      promissory note;

(iv)      other Shares which (A) in the case of Shares acquired upon exercise of an option, have been owned by the Optionee for more than six months on the date of surrender, and (B) have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised;

(v)       consideration received by the Company under a cashless exercise program implemented by the Company in connection with the Plan;

(vi)      a reduction in the amount of any Company liability to the Optionee, including any liability attributable to the Optionee’s participation in any Company-sponsored deferred compensation program or arrangement;

(vii)     any combination of the foregoing methods of payment; or

(viii)    such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws.

10.   Exercise of Option.

(a)   Procedure for Exercise; Rights as a Stockholder.  Any Option granted hereunder shall be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Option Agreement.  An Option may not be exercised for a fraction of a Share.

                                An Option shall be deemed exercised when the Company receives: (i) written or electronic notice of exercise (in accordance with the Option Agreement) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which the Option is exercised.  Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Option Agreement and the Plan.  Shares issued upon exercise of an Option shall be issued in the name of the Optionee or, if requested by the Optionee, in the name of the Optionee and his or her spouse.  Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Optioned Stock, notwithstanding the exercise of the Option.  The Company shall issue (or cause to be issued) such Shares promptly after the Option is

 

-7-



 

exercised.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 13 of the Plan.

                                Exercising an Option in any manner shall decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.

(b)   Termination of Relationship as a Service Provider.  If an Optionee ceases to be a Service Provider, other than upon the Optionee’s death or Disability, the Optionee may exercise his or her Option prior to the earlier of its expiration date or the date specified in the Option Agreement, to the extent that the Option is vested on the date of termination.  If, on the date of termination, the Optionee is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall revert to the Plan.  If, after termination, the Optionee does not exercise his or her Option within the time specified by the Administrator, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan.

(c)   Disability of Optionee.  If an Optionee ceases to be a Service Provider as a result of the Optionee’s Disability, the Option, including portions not yet vested, may be exercised prior to the earlier of the expiration of twelve (12) months from the date of termination or the expiration of the Option.  If, after termination, the Optionee does not exercise his or her Option within the time specified herein, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan.

(d)   Death of Optionee.  If an Optionee dies while a Service Provider, the Option, including portions not yet vested, may be exercised prior to the earlier of the expiration of twelve (12) months from the date of death or the expiration of the Option.  The Option may be exercised by the executor or administrator of the Optionee’s estate or, if none, by the person(s) entitled to exercise the Option under the Optionee’s will or the laws of descent or distribution.  If the Option is not so exercised within the time specified herein, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan.

(e)   Buyout Provisions.  The Administrator may at any time offer to buy out for a payment in cash or Shares an Option previously granted based on such terms and conditions as the Administrator shall establish and communicate to the Optionee at the time that such offer is made.

11.   Stock Purchase Rights.

(a)   Rights to Purchase.  Stock Purchase Rights may be issued either alone, in addition to, or in tandem with other awards granted under the Plan and/or cash awards made outside of the Plan.  After the Administrator determines that it will offer Stock Purchase Rights under the Plan, it shall advise the offeree in writing or electronically, by means of a Notice of Grant, of the terms, conditions and restrictions related to the offer, including the number of Shares that the offeree shall be entitled to purchase, the price to be paid, and the time within which the offeree must accept such offer.  The offer shall be accepted by execution of a Restricted Stock Purchase Agreement in the form determined by the Administrator.

(b)   Repurchase Option.  Unless the Administrator determines otherwise, the Restricted Stock Purchase Agreement shall grant the Company a repurchase option exercisable upon the voluntary or involuntary termination of the purchaser’s service with the Company for any reason (other than death or Disability).  The purchase price for Shares repurchased pursuant to the Restricted Stock Purchase Agreement shall be the original price paid by the purchaser and

 

-8-



 

may be paid by cancellation of any indebtedness of the purchaser to the Company.  The repurchase option shall lapse at a rate determined by the Administrator.

(c)   Other Provisions.  The Restricted Stock Purchase Agreement shall contain such other terms, provisions and conditions not inconsistent with the Plan as may be determined by the Administrator in its sole discretion.

(d)   Rights as a Stockholder.  Once the Stock Purchase Right is exercised, the purchaser shall have the rights equivalent to those of a stockholder, and shall be a stockholder when his or her purchase is entered upon the records of the duly authorized transfer agent of the Company.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the Stock Purchase Right is exercised, except as provided in Section 13 of the Plan.

12.   Non-Transferability of Options and Stock Purchase Rights.  During the lifetime of the Optionee, the Option shall be exercisable only by the Optionee or the Optionee’s guardian, legal representative or permitted transferrees.  Except as specified below, an Option or Stock Purchase Right may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution.  At the sole discretion of the Administrator or its appointee, the Administrator or its appointee may allow, by means of a writing to the Optionee, for all or part of a vested Nonstatutory Stock Option to be assigned or transferred, including by means of sale, during an Optionee’s lifetime to a member of the Optionee’s Immediate Family or to a trust, LLC or partnership for the benefit of any one or more members of such Optionee’s Immediate Family.  If the Administrator or its appointee makes an Option or Stock Purchase Right transferable, such Option or Stock Purchase Right shall contain such additional terms and conditions as the Administrator deems appropriate.  In such case, the transferee shall receive and hold the Option subject to the provisions of this Section 12 and there shall be no further assignment or transfer of the Option.  The terms of Options granted hereunder shall be binding upon the transferees, purchasers, executors, administrators, heirs, successors and assigns of the Optionee.

13.   Adjustments Upon Changes in Capitalization, Dissolution, Merger or Asset Sale.

(a)   Changes in Capitalization.  Subject to any required action by the stockholders of the Company, the number of shares of Common Stock covered by each outstanding Option and Stock Purchase Right, and the number of shares of Common Stock which have been authorized for issuance under the Plan but as to which no Options or Stock Purchase Rights have yet been granted or which have been returned to the Plan upon cancellation or expiration of an Option or Stock Purchase Right, as well as the price per share of Common Stock covered by each such outstanding Option or Stock Purchase Right, shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a reorganization, merger, consolidation, plan of exchange, recapitalization, stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.”  Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive.  Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an Option or Stock Purchase Right.

 

-9-



 

(b)   Dissolution or Liquidation.  In the event of the proposed dissolution or liquidation of the Company, the Administrator shall notify each Optionee as soon as practicable prior to the effective date of such proposed transaction.  The Administrator in its discretion may provide for an Optionee to have the right to exercise his or her Option until thirty (30) days prior to such transaction as to all of the Optioned Stock covered thereby, including Shares as to which the Option would not otherwise be exercisable.  In addition, the Administrator may provide that any Company repurchase option applicable to any Shares purchased upon exercise of an Option or Stock Purchase Right shall lapse as to all such Shares, provided the proposed dissolution or liquidation takes place at the time and in the manner contemplated.  To the extent it has not been previously exercised, an Option or Stock Purchase Right will terminate immediately prior to the consummation of such proposed action.

(c)   Merger or Asset Sale.  In the event of a merger of the Company with or into another corporation, or the sale of substantially all of the assets of the Company, each outstanding Option and Stock Purchase Right shall be assumed or an equivalent option or right substituted by the successor corporation or a Parent or Subsidiary of the successor corporation.  In the event that the successor corporation refuses to assume or substitute for the Option or Stock Purchase Right, the Optionee shall fully vest in and have the right to exercise the Option or Stock Purchase Right as to all of the Optioned Stock, including Shares as to which it would not otherwise be vested or exercisable.  If an Option or Stock Purchase Right becomes fully vested and exercisable in lieu of assumption or substitution in the event of a merger or sale of assets, the Administrator shall notify the Optionee in writing or electronically that the Option or Stock Purchase Right shall be fully vested and exercisable for a period of thirty (30) days from the date of such notice, and the Option or Stock Purchase Right shall terminate upon the expiration of such period.  For the purposes of this paragraph, the Option or Stock Purchase Right shall be considered assumed if, following the merger or sale of assets, the option or right confers the right to purchase or receive, for each Share of Optioned Stock subject to the Option or Stock Purchase Right immediately prior to the merger or sale of assets, the consideration (whether stock, cash, or other securities or property) received in the merger or sale of assets by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the merger or sale of assets is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise of the Option or Stock Purchase Right, for each Share of Optioned Stock subject to the Option or Stock Purchase Right, to be solely common stock of the successor corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the merger or sale of assets.

14.   Date of Grant.  The date of grant of an Option or Stock Purchase Right shall be, for all purposes, the date on which the Administrator makes the determination granting such Option or Stock Purchase Right, or such other later date as is determined by the Administrator.  Notice of the determination shall be provided to each Optionee within a reasonable time after the date of such grant.

15.   Amendment and Termination of the Plan.  The Board may amend, alter, or suspend or terminate the Plan, but no amendment, alteration or discontinuation shall be made which would impair the rights of any Optionee under any award theretofore granted without the Optionee’s or recipient’s consent, except such an amendment made to cause the Plan to comply with applicable law, stock exchange rules or accounting rules.  In addition, no such amendment shall be made

 

-10-



 

without the approval of the Company’s stockholders to the extent such approval is required by law or agreement or if such amendment would:

(i)    expand the classes of persons to whom awards may be made under Section 5 of this Plan;

(ii)   increase the number of shares of Common Stock authorized for grant under Section 3 of this Plan;

(iii)  increase the number of shares which may be granted under awards to any one participant under Section 6(c) of this Plan;

(iv)  allow the creation of additional types of awards;

(v)   change the provisions of Section 4(c); or

(vi)  change any of the provisions of this paragraph of Section 15.

The Administrator may amend the terms of any Option or other award theretofore granted, prospectively or retroactively, but no such amendment (a) shall cause a qualified performance-based award to cease to qualify for the Section 162(m) exemption or (b) impair the rights of any holder without the holder’s consent except such an amendment made to cause the Plan or award to qualify for any exemption provided by Rule 16b-3 or (c) modify the terms of any Options or other award in a manner inconsistent with the provisions of this Plan.

Subject to the above provisions, the Board shall have authority to amend the Plan to take into account changes in law and tax and accounting rules as well as other developments, and to grant awards which qualify for beneficial treatment under such rules without stockholder approval.

16.   Conditions Upon Issuance of Shares.

(a)   Legal Compliance.  Shares shall not be issued pursuant to the exercise of an Option or Stock Purchase Right unless the exercise of such Option or Stock Purchase Right and the issuance and delivery of such Shares shall comply with Applicable Laws and shall be further subject to the approval of counsel for the Company with respect to such compliance.

(b)   Investment Representations.  As a condition to the exercise of an Option or Stock Purchase Right, the Company may require the person exercising such Option or Stock Purchase Right to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.

17.   Inability to Obtain Authority.  The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

18.   Reservation of Shares.  The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.

 

-11-



 

19.   Stockholder Approval.  The Plan shall be subject to approval by the stockholders of the Company within twelve (12) months after the date the Plan is adopted.  Such stockholder approval shall be obtained in the manner and to the degree required under Applicable Laws.

 

 

-12-





Exhibit 99(d)(4)

LATTICE SEMICONDUCTOR CORPORATION

2001 STOCK PLAN

STOCK OPTION AGREEMENT

 

Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.

I.              NOTICE OF STOCK OPTION GRANT

                [Optionee’s Name and Address]

You have been granted an option to purchase Common Stock of the Company, subject to the terms and conditions of the Plan and this Option Agreement, as follows:

 

 

Grant Number

 

 

 

 

 

 

 

 

 

Date of Grant

 

 

 

 

 

 

 

 

 

Vesting Commencement Date

 

 

 

 

 

 

 

 

 

Exercise Price per Share

$

 

 

 

 

 

 

 

 

 

Total Number of Shares Granted

 

 

 

 

 

 

 

 

 

Total Exercise Price

$

 

 

 

 

 

 

 

 

 

Type of Option:

 

Incentive Stock Option

 

 

 

 

 

 

 

 

 

 

Nonstatutory Stock Option

 

 

 

 

 

 

 

 

Term/Expiration Date:

 

 

 

                Vesting Schedule:

This Option may be exercised, in whole or in part, in accordance with the following schedule:

[To be determined by Administrator].

 



                Termination Period:

This Option may be exercised for three months after Optionee ceases to be a Service Provider.  Upon the death or Disability of the Optionee, this Option may be exercised for twelve months after Optionee ceases to be a Service Provider.  In no event shall this Option be exercised later than the Term/Expiration Date as provided above.

II.            AGREEMENT

A.            Grant of Option.

                The Plan Administrator of the Company hereby grants to the Optionee named in the Notice of Grant attached as Part I of this Agreement (the “Optionee”) an option (the “Option”) to purchase the number of Shares, as set forth in the Notice of Grant, at the exercise price per share set forth in the Notice of Grant (the “Exercise Price”), subject to the terms and conditions of the Plan, which is incorporated herein by reference.  Subject to Section 15(c) of the Plan, in the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Option Agreement, the terms and conditions of the Plan shall prevail.

                If designated in the Notice of Grant as an Incentive Stock Option (“ISO”), this Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code.  However, if this Option is intended to be an Incentive Stock Option, to the extent that it exceeds the $100,000 rule of Code Section 422(d) it shall be treated as a Nonstatutory Stock Option (“NSO”).

B.            Exercise of Option.

(a)           Right to Exercise.  This Option is exercisable during its term in accordance with the Vesting Schedule set out in the Notice of Grant and the applicable provisions of the Plan and this Option Agreement.  Consistent with Applicable Law and unless the Administrator provides otherwise, vesting of Options granted hereunder shall be suspended during any leave of absence in excess of one pay period.

(b)           Method of Exercise.  This Option is exercisable by delivery of an exercise notice (the “Exercise Notice”), which shall state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “Exercised Shares”), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan.  The Exercise Notice shall be completed by the Optionee and delivered to the Stock Administrator of the Company.  The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares.  This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price.

                No Shares shall be issued pursuant to the exercise of this Option unless such issuance and exercise complies with Applicable Laws.  Assuming such compliance, for income tax purposes the Exercised Shares shall be considered transferred to the Optionee on the date the Option is exercised with respect to such Exercised Shares.

 



C.            Method of Payment.

                Payment of the aggregate Exercise Price shall be by any of the following, or a combination thereof, at the election of the Optionee:

1.           cash; or

2.           check; or

3.           consideration received by the Company under a cashless exercise program implemented by the Company in connection with the Plan; or

4.           surrender of other Shares which (i) in the case of Shares acquired upon exercise of an option, have been owned by the Optionee for more than six (6) months on the date of surrender, and (ii) have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Exercised Shares; or

5.           to the extent permitted by the Administrator, delivery of a properly executed exercise notice together with such other documentation as the Administrator and the broker, if applicable, shall require to effect an exercise of the Option and delivery to the Company of the sale proceeds required to pay the Exercise Price.

D.            Termination of Employment.

                (a)           In the event the employment of the Optionee by the Company or by any parent or subsidiary of the Company is terminated by retirement or for any reason, voluntarily or involuntarily, with or without cause, other than in the circumstances specified in subsection (b) below, the Option held by the Optionee may be exercised at any time prior to its expiration date or the expiration of three months after the date of such termination of employment, whichever is the shorter period, but only if and to the extent the Optionee was entitled to exercise the Option on the date of such termination (i.e. no vesting occurs after termination).

                (b)           In the event the Optionee’s employment by the Company or by any parent or subsidiary of the Company is terminated because of death or physical disability (within the meaning of Section 22(e)(3) of the IRC), the Option may be fully exercised with respect to all remaining unexercised shares, including those shares that would otherwise have been unvested on the date of death or disability, at any time prior to its expiration date or the expiration of one year after the date of such termination, whichever is the shorter period. If the Optionee’s employment is terminated by death, the Option shall be exercisable only by the person or persons to whom the Optionee’s rights under the Option shall pass by the Optionee’s will or by the laws of descent and distribution of the state or country of the Optionee’s domicile at the time of death.

                (c)           In the event of the death or termination of employment of the Optionee, to the extent the Option shall not have been exercised within the limited periods provided above, all further rights to purchase shares pursuant to the Option shall cease and terminate at the expiration of such periods.

 



E.             Transferability of Option.

(a)           Option Generally Non-Transferable. During the lifetime of the Optionee, an Option shall be exercisable only by the Optionee or the Optionee’s guardian, legal representative or permitted transferees. Except as specified below, no Option shall be assignable or transferable by the Optionee except by will or by the laws of descent and distribution. The terms of the Plan and this Option Agreement shall be binding upon the transferees, purchasers, executors, administrators, heirs, successors and assigns of the Optionee.

(b)           Limited Transferability of Option.  At the sole discretion of the Plan Administrator or its appointee, and subject to such terms and conditions as the Plan Administrator or its appointee deems advisable, the Plan Administrator or its appointee may allow, by means of a writing to the Optionee, for all or part of this Option, to the extent such shares of this Option are fully vested, to be assigned or transferred, including by means of sale, during the Optionee’s lifetime to a member of the Optionee’s immediate family or to a trust, LLC or partnership for the benefit of any one or more members of the Optionee’s immediate family. “Immediate family” as used herein means the spouse, lineal descendants, father, mother, brothers and sisters of the Optionee. In such case, the transferee shall receive and hold the Option subject to the provision of this Option Agreement and the Plan, and there shall be no further assignation or transfer of the Option.

F.             Term of Option.

                This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement.

G.            Tax Consequences.

                Some of the federal tax consequences relating to this Option, as of the date of this Option, are set forth below.  THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE.  THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

H.            Exercising the Option.

1.           Nonstatutory Stock Option.  The Optionee may incur regular federal income tax liability upon exercise of a NSO.  The Optionee will be treated as having received compensation income (taxable at ordinary income tax rates) equal to the excess, if any, of the Fair Market Value of the Exercised Shares on the date of exercise over their aggregate Exercise Price.  If the Optionee is an Employee or a former Employee, the Company will be required to withhold from his or her compensation or collect from Optionee and pay to the applicable taxing authorities an amount in cash equal to a percentage of this compensation income at the time of exercise, and may refuse to honor the exercise and refuse to deliver Shares if such withholding amounts are not delivered at the time of exercise.

2.           Incentive Stock Option.  If this Option qualifies as an ISO, the Optionee will have no regular federal income tax liability upon its exercise, although the excess, if any, of the Fair Market Value of the Exercised Shares on the date of exercise over their aggregate Exercise Price will be treated as an adjustment to alternative minimum taxable income for federal tax purposes and may

 



subject the Optionee to alternative minimum tax in the year of exercise.  In the event that the Optionee ceases to be an Employee but remains a Service Provider, any Incentive Stock Option of the Optionee that remains unexercised shall cease to qualify as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option on the date three (3) months and one (1) day following such change of status.

3.           Disposition of Shares.

(a)           NSO.  If the Optionee holds NSO Shares for at least one year, any gain realized on disposition of the Shares will be treated as long-term capital gain for federal income tax purposes.

(b)           ISO.  If the Optionee holds ISO Shares for at least one year after exercise and two years after the grant date, any gain realized on disposition of the Shares will be treated as long-term capital gain for federal income tax purposes.  If the Optionee disposes of ISO Shares within one year after exercise or two years after the grant date, any gain realized on such disposition will be treated as compensation income (taxable at ordinary income rates) to the extent of the excess, if any, of the lesser of (A) the difference between the Fair Market Value of the Shares acquired on the date of exercise and the aggregate Exercise Price, or (B) the difference between the sale price of such Shares and the aggregate Exercise Price.  Any additional gain will be taxed as capital gain, short-term or long-term depending on the period that the ISO Shares were held.

(c)           Notice of Disqualifying Disposition of ISO Shares.  If the Optionee sells or otherwise disposes of any of the Shares acquired pursuant to an ISO on or before the later of (i) two years after the grant date, or (ii) one year after the exercise date, the Optionee shall immediately notify the Company in writing of such disposition.  The Optionee agrees that he or she may be subject to income tax withholding by the Company on the compensation income recognized from such early disposition of ISO Shares by payment in cash or out of the current earnings paid to the Optionee.

I.              Entire Agreement; Governing Law.

                The Plan is incorporated herein by reference.  The Plan and this Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by means of a writing signed by the Company and Optionee.  This agreement is governed by the internal substantive laws, but not the choice of law rules, of California.

J.             NO GUARANTEE OF CONTINUED SERVICE.

                OPTIONEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED AN OPTION OR PURCHASING SHARES HEREUNDER).  OPTIONEE FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE WITH

 



OPTIONEE’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE OPTIONEE’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE.

By your signature and the signature of the Company’s representative below, you and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan and this Option Agreement.  Optionee has reviewed the Plan and this Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement and fully understands all provisions of the Plan and Option Agreement.  Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and Option Agreement.  Optionee further agrees to notify the Company upon any change in the residence address indicated below.

 

OPTIONEE:

 

LATTICE SEMICONDUCTOR

 

 

CORPORATION

 

 

 

 

 

 

Signature

 

By

 

 

 

 

 

 

Print Name

 

Title

 

 

 

 

 

 

Residence Address

 

 

 

 

 

 

 

 

 

 

 



EXHIBIT A

LATTICE SEMICONDUCTOR CORPORATION

STOCK OPTION EXERCISE NOTICE

 

1) One form per intended exercise; all shares listed must be exercised on same transaction.

2) This exercise notice is valid for 30 days from the date below.

3) Section 16 filers and other insiders must have approval form attached.

 

Name (print)

 

 

Social Security #

 

 

 

 

 

 

Day Time Phone

 

 

 

 

 

I hereby elect to exercise options (as listed below) to purchase shares of Common Stock of Lattice Semiconductor Corporation under and pursuant to the option(s) granted to me by Lattice Semiconductor Corporation as listed below.

 

Grant Number

 

Option Date

 

Option Price

 

Number of Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL

 

 

I wish to exercise using the following method:

 

 

 

Exercise and hold all shares. Payment of option price and taxes will be made by cash or check.

 

 

 

 

 

Same Day Sales of all shares. Payment of option price and taxes will be made through proceeds of the sale.

 

 

 

 

 

 

 

 

Combination of Exercise and Hold and Same Day Sale. Payment of option price and taxes will be made

 

 

through proceeds of the sale.

 

 

 

 

 

Other (as provided for in the plan). Please attach memo.

 

I am using the services of the following brokerage firm:

 

 

 

(Name of Firm)

 

 

 

 

 

(Broker Name)

 

 

 

 

 

(Broker Phone)

 

Tax Consultation: I understand that I may suffer adverse tax consequences as a result of my purchase or disposition of the shares acquired hereunder. I represent that I have consulted with any tax consultants I deem advisable in connection with the purchase or disposition of these shares and that I am not relying on the Company for any tax advice.

 

I acknowledge that I have received, read and understood the Plan(s) and the Option Agreement(s) representing my options (as listed above) and I agree to abide by and be bound by their terms and conditions. In making the decision to exercise at this time, I certify that I am not acting on any “inside” information.

 

Please use this form as authorization to remit to Lattice Semiconductor Corp. any monies due (including taxes) as a result of this option exercise.

 

 

Date

 

 

Signature:

 

 

(Please fax to the Lattice Stock Administrator at (503) 268-8116)